{"meta":{"query_hash":"1574a31d792e","filters":{"venue":"Endocrine Related Cancer"},"cohort_total":133,"direct_labels_cover":0,"predictions_cover":133,"exported":133,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1574a31d792e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Endocrine+Related+Cancer"},"results":[{"id":"W1990584739","doi":"10.1530/erc-13-0349","title":"Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome–wide interaction study","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Universitätsklinikum Hamburg-Eppendorf; Cancer Council Tasmania; Canadian Institutes of Health Research; U.S. Army; Rheinische Friedrich-Wilhelms-Universität Bonn; National Health and Medical Research Council; Institut National Du Cancer; Cancer Council Victoria; Deutsche Krebshilfe; National Institutes of Health; Deutsche Gesetzliche Unfallversicherung; CHIST-ERA; Agence Nationale de la Recherche; Bundesministerium für Bildung und Forschung; National Breast Cancer Foundation; Fondation de France; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; National Institute for Health and Care Research; Robert Bosch Stiftung; U.S. Department of Health and Human Services; Ovarian Cancer Research Fund; Medical Research and Materiel Command; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; McGill University; European Commission; Breast Cancer Research Foundation; Cancer Research UK","keywords":"Single-nucleotide polymorphism; Breast cancer; SNP; Genome-wide association study; Genetic association; Oncology; Medicine; Internal medicine; Biology; Genetics; Cancer; Genotype; Gene","score_opus":0.006269507330037659,"score_gpt":0.25490830177661755,"score_spread":0.24863879444657988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990584739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724342,0.026032943,0.000017908671,0.00016048011,0.00018629625,0.0009177674,0.000031548283,0.000020908175,0.00019789823],"genre_scores_gemma":[0.9637407,0.03507828,0.00004996226,0.000044441927,0.000092017115,0.00037244157,0.000019523468,0.000040119477,0.00056250027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986125,0.000133126,0.0003531279,0.00043681904,0.00016104225,0.00030337385],"domain_scores_gemma":[0.9992054,0.000015771862,0.00023207636,0.00031465298,0.000111238376,0.000120836274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088361,0.00024148039,0.00024306487,0.00007579135,0.000086667314,0.000020868469,0.00011575932,0.00010785267,0.00021089897],"category_scores_gemma":[0.000012137682,0.00019742447,0.00005436829,0.00013986079,0.0000755656,0.000012165746,0.00008448528,0.00026143886,0.0000092183855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011818089,0.00045253066,0.118682876,0.000022110924,0.0020361515,0.000014455611,0.0004960894,0.0026887262,0.84633386,0.0000032796272,0.0017574345,0.02633065],"study_design_scores_gemma":[0.01179095,0.0053265234,0.89262897,0.00006656457,0.00044815065,0.00019987085,0.00075518084,0.001194681,0.08257078,0.000053868825,0.0041346587,0.000829815],"about_ca_topic_score_codex":0.0033086082,"about_ca_topic_score_gemma":0.00003773048,"teacher_disagreement_score":0.7739461,"about_ca_system_score_codex":0.000056831675,"about_ca_system_score_gemma":0.000063128085,"threshold_uncertainty_score":0.80507356},"labels":[],"label_agreement":null},{"id":"W2045440590","doi":"10.1530/erc-14-0465","title":"Is IGSF1 involved in human pituitary tumor formation?","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; Canadian Institutes of Health Research; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Government of Canada","keywords":"Gigantism; Biology; Acromegaly; Germline; Adenoma; Pituitary adenoma; Hyperplasia; Internal medicine; Endocrinology; Immunohistochemistry; Population; Pathology; Gene; Hormone; Genetics; Medicine; Growth hormone","score_opus":0.014463509985765935,"score_gpt":0.2952028099007312,"score_spread":0.28073929991496527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045440590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748342,0.0023194465,0.000014448941,0.0021231493,0.00013341467,0.0003288414,0.000014304284,0.00008422486,0.020147942],"genre_scores_gemma":[0.9961772,0.00026777337,0.0000614227,0.0012735996,0.00006443351,0.00008668827,0.00012741885,0.000021986238,0.0019194986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989703,0.000028190945,0.0003029749,0.00022120996,0.00017247118,0.0003048112],"domain_scores_gemma":[0.99953187,0.000018041073,0.0000639151,0.00023763385,0.000035749952,0.000112779264],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000054208936,0.00016210928,0.0002734719,0.0001526748,0.000070230526,0.000007804337,0.000060653783,0.000038514972,0.001136134],"category_scores_gemma":[0.000018151362,0.00013177913,0.000080850914,0.00022556532,0.000027964745,0.00015494695,0.000026655634,0.0002025642,0.00010136304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021625112,0.00077655213,0.9579589,0.00022756748,0.00032336134,0.00047975092,0.0009602112,0.0001022701,0.0013397401,0.0019320967,0.025442572,0.010240747],"study_design_scores_gemma":[0.05159988,0.0015068114,0.7848615,0.0011568208,0.00063162786,0.00033060284,0.00051028293,0.0062233456,0.013197745,0.018896159,0.11997563,0.0011096172],"about_ca_topic_score_codex":0.001459768,"about_ca_topic_score_gemma":0.0004659172,"teacher_disagreement_score":0.1730974,"about_ca_system_score_codex":0.00012841998,"about_ca_system_score_gemma":0.000042086223,"threshold_uncertainty_score":0.99977696},"labels":[],"label_agreement":null},{"id":"W2058126552","doi":"10.1677/erc.0.0100225","title":"Prostate cancer susceptibility genes: lessons learned and challenges posed.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval","funders":"","keywords":"Prostate cancer; Genetics; Biology; Breast cancer; Genetic predisposition; Candidate gene; Cancer; Ovarian cancer; Genetic linkage; Gene; Oncology; Medicine","score_opus":0.08343600812111382,"score_gpt":0.38991444283555177,"score_spread":0.3064784347144379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058126552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021958977,0.9951053,0.0000027685887,0.0011590541,0.0008825289,0.0010341449,0.00044473118,0.000050966028,0.001100869],"genre_scores_gemma":[0.00009993128,0.9896556,0.00012293688,0.000073418465,0.00039962208,0.0013827228,0.00031315608,0.00018958586,0.0077630416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99658483,0.00034600697,0.0007085506,0.001466133,0.00023416437,0.0006603099],"domain_scores_gemma":[0.99822986,0.000037329784,0.00043348476,0.00093306444,0.00018029152,0.0001859731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024045623,0.0007321152,0.0011472902,0.00013792104,0.00015819336,0.00004504993,0.0003325922,0.00054268475,0.00039090615],"category_scores_gemma":[0.00006086978,0.00065881276,0.00036333964,0.0003035421,0.00024448166,0.000008597056,0.00022414161,0.0006008791,0.000028866316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017183967,0.000043464235,0.000024709609,0.0047388426,0.0008072875,0.000013932807,0.000074573254,0.000052339696,0.00018181404,0.00008875604,0.0019681829,0.9919889],"study_design_scores_gemma":[0.0005654155,0.00009097944,0.000009497494,0.0016071539,0.00074718497,0.00009895217,0.000047652702,0.0000027127896,0.00033616,0.00007866741,0.99569803,0.00071756233],"about_ca_topic_score_codex":0.00019132125,"about_ca_topic_score_gemma":0.000689893,"teacher_disagreement_score":0.9937299,"about_ca_system_score_codex":0.00043103893,"about_ca_system_score_gemma":0.0015312285,"threshold_uncertainty_score":0.9995863},"labels":[],"label_agreement":null},{"id":"W2072744994","doi":"10.1530/erc-12-0250","title":"IGF2 increases de novo steroidogenesis in prostate cancer cells","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; University of British Columbia","funders":"Prostate Cancer Foundation of Australia; Pfizer; National Cancer Institute; Prostate Cancer Foundation","keywords":"LNCaP; Endocrinology; Insulin-like growth factor 1 receptor; Androgen receptor; Biology; Internal medicine; Prostate cancer; Receptor; Androgen; Growth factor; Insulin-like growth factor; Insulin-like growth factor 2; Cancer research; Hormone; Cancer; Medicine","score_opus":0.005434775953347526,"score_gpt":0.24558713231058105,"score_spread":0.24015235635723353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072744994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95769525,0.039753236,0.000007594223,0.00038205954,0.00091776066,0.00045433012,0.00008442594,0.000029878507,0.00067547354],"genre_scores_gemma":[0.9440499,0.044241365,0.00013180335,0.0006112888,0.0009338789,0.00089647935,0.000052387008,0.00006627727,0.009016597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983955,0.000076666845,0.0003216383,0.00045853955,0.00014166725,0.0006059787],"domain_scores_gemma":[0.99927926,0.000011468135,0.000103723476,0.00033242392,0.000101253645,0.00017187631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007888723,0.00025260297,0.00026023982,0.000092186645,0.000052865427,0.000032061573,0.00019397654,0.000107245236,0.0008809534],"category_scores_gemma":[0.000025567277,0.00024072046,0.00010421747,0.00023050453,0.00006951666,0.00001405627,0.000103756596,0.00018073549,0.00004706504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009626269,0.000095093375,0.015874403,0.000042766744,0.00012714014,0.000012714204,0.0001058523,0.0013077098,0.94236225,0.000012907527,0.013204462,0.026758412],"study_design_scores_gemma":[0.002590308,0.000082525425,0.01845084,0.00008324639,0.00007696544,0.000057532347,0.000079953745,0.00009004828,0.6253638,0.00007258236,0.35254833,0.0005038754],"about_ca_topic_score_codex":0.016240258,"about_ca_topic_score_gemma":0.0026110008,"teacher_disagreement_score":0.33934385,"about_ca_system_score_codex":0.000102890524,"about_ca_system_score_gemma":0.00031247822,"threshold_uncertainty_score":0.99031067},"labels":[],"label_agreement":null},{"id":"W2074161808","doi":"10.1530/erc-13-0450","title":"COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Epidermal growth factor; PI3K/AKT/mTOR pathway; Cancer research; Ovarian cancer; CREB; Protein kinase B; Cell growth; Cadherin; Signal transduction; Biology; Cancer cell; Cell biology; Cell; Cancer; Cell culture; Internal medicine; Medicine; Transcription factor","score_opus":0.01233573774889245,"score_gpt":0.2800495222313698,"score_spread":0.26771378448247735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074161808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839329,0.0031112072,0.0000072158277,0.00078315666,0.0013773191,0.00065515906,0.000009526267,0.00018799027,0.009935528],"genre_scores_gemma":[0.99216694,0.0020535318,0.00003758164,0.0004960365,0.0008508693,0.00020927029,0.000030232108,0.00009355415,0.0040620044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997662,0.00013788292,0.00049212336,0.00057876663,0.00049589615,0.000633338],"domain_scores_gemma":[0.99865407,0.00008373765,0.00021399738,0.00044495505,0.000114401984,0.00048884354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033931326,0.00038455598,0.0005895159,0.00012386954,0.00020571871,0.000029222363,0.00012858643,0.00021806514,0.0018995169],"category_scores_gemma":[0.000065750784,0.0003241667,0.00011565252,0.00020295342,0.00007180841,0.00014962196,0.00010587689,0.00066715834,0.000095923846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048209025,0.00030170355,0.086422496,0.0010821319,0.00050080847,0.0006855285,0.0015365536,0.000072123665,0.8519611,0.0012477194,0.00802045,0.047687344],"study_design_scores_gemma":[0.031248502,0.0018798454,0.19465491,0.0016619269,0.0013810688,0.00038449603,0.00024474796,0.0025919639,0.6326787,0.0004559395,0.13092154,0.0018963622],"about_ca_topic_score_codex":0.0031332069,"about_ca_topic_score_gemma":0.0009062625,"teacher_disagreement_score":0.21928237,"about_ca_system_score_codex":0.00032756507,"about_ca_system_score_gemma":0.00018492239,"threshold_uncertainty_score":0.999921},"labels":[],"label_agreement":null},{"id":"W2077083761","doi":"10.1530/erc-14-0188","title":"The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; Pituitary tumors; Protein kinase B; Medicine; Pituitary adenoma; Therapeutic modalities; Cancer research; Adenoma; Pathophysiology; Pituitary neoplasm; Therapeutic approach; Internal medicine; Pituitary gland; Oncology; Bioinformatics; Hormone; Signal transduction; Biology","score_opus":0.023620419471311046,"score_gpt":0.32293785317264934,"score_spread":0.2993174337013383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077083761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022716334,0.99426174,2.172504e-7,0.0003910118,0.00023768934,0.0013299871,0.0000742059,0.000017534116,0.0014159866],"genre_scores_gemma":[0.003483929,0.9942415,0.000007125661,0.000063203675,0.00014829624,0.00064925087,0.00017436783,0.00004032555,0.0011920497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815977,0.00027515437,0.00062073005,0.00038980297,0.00017377584,0.00038075104],"domain_scores_gemma":[0.9986566,0.00041095784,0.00026872114,0.0005584257,0.000028405737,0.00007694783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000974783,0.0004390727,0.0015479875,0.00010548545,0.0001087306,0.000008821237,0.00015241682,0.00015833353,0.000059187845],"category_scores_gemma":[0.000028373252,0.00018362737,0.0003687566,0.00024371999,0.00014994749,0.00002369806,0.00003702194,0.00028704896,0.000018640305],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006564289,0.00029049866,0.00039850088,0.0011423997,0.00069358473,0.00030392417,0.00015998504,7.404429e-7,8.640709e-7,0.00023893948,0.0003942009,0.9963107],"study_design_scores_gemma":[0.0025165828,0.0011215465,0.0005767895,0.0020117508,0.0011769672,0.00018672807,0.000053630643,0.000004135766,0.0000018299093,0.00033421893,0.9918425,0.00017330014],"about_ca_topic_score_codex":0.00070415647,"about_ca_topic_score_gemma":0.00018026175,"teacher_disagreement_score":0.99613744,"about_ca_system_score_codex":0.00015639958,"about_ca_system_score_gemma":0.0002622836,"threshold_uncertainty_score":0.7488107},"labels":[],"label_agreement":null},{"id":"W2095673803","doi":"10.1530/erc-12-0229","title":"Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case–control study within the B∼FIT cohort","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Wake Forest University; University of Pittsburgh; University of Miami; University of California, San Francisco; University of California, San Diego; Kaiser Permanente","keywords":"Nested case-control study; Endometrial cancer; Postmenopausal women; Medicine; Obesity; Hormone; Cohort study; Cohort; Case-control study; Oncology; Internal medicine; Physiology; Obstetrics; Cancer; Gynecology; Endocrinology","score_opus":0.0138618815743322,"score_gpt":0.29752862944209735,"score_spread":0.28366674786776513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095673803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722406,0.02128777,0.0000021298574,0.0005048184,0.0018918168,0.00326888,0.00012905455,0.00023196299,0.00044296865],"genre_scores_gemma":[0.99408823,0.0014245958,0.000005858124,0.00025371302,0.00068472204,0.0011969579,0.000009774859,0.00010137741,0.0022347395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966771,0.00028341686,0.0008392213,0.00058489945,0.00059546635,0.0010198919],"domain_scores_gemma":[0.99800736,0.0002978635,0.0003873659,0.00055631425,0.00016464246,0.0005864544],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081141974,0.0005273448,0.0009481555,0.00031412317,0.00037804997,0.000066400826,0.00015060301,0.00017502927,0.0014613406],"category_scores_gemma":[0.00018399529,0.00034880184,0.00012823517,0.0011281277,0.0002717601,0.00033124178,0.000105461135,0.0010690533,0.000021760621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009306855,0.00054631004,0.98242,0.00003110314,0.0028388,0.0010264404,0.006407046,0.00012587245,0.00051694294,0.000047127218,0.00030614724,0.0048034755],"study_design_scores_gemma":[0.015247129,0.0011687372,0.9731741,0.00008798972,0.0024190892,0.0026343865,0.00238398,0.00028757594,0.00017047946,0.00001727294,0.001912312,0.0004969295],"about_ca_topic_score_codex":0.018693997,"about_ca_topic_score_gemma":0.0016291846,"teacher_disagreement_score":0.021847662,"about_ca_system_score_codex":0.0007779161,"about_ca_system_score_gemma":0.000246305,"threshold_uncertainty_score":0.9998964},"labels":[],"label_agreement":null},{"id":"W2097150975","doi":"10.1677/erc-06-0080","title":"Body shape throughout life and correlations with IGFs and GH","year":2007,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Anthropometry; Body mass index; Waist; Medicine; Internal medicine; Endocrinology; Breast cancer; Waist–hip ratio; Cross-sectional study; Demography; Young adult; Physiology; Cancer","score_opus":0.012347460513524594,"score_gpt":0.3145323565576772,"score_spread":0.3021848960441526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097150975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97806364,0.011342608,0.00015350412,0.0015253214,0.00020858503,0.00033001014,0.000017488308,0.000119723074,0.008239141],"genre_scores_gemma":[0.99253976,0.0037742897,0.00014435194,0.00043572375,0.00016526024,0.000016198901,0.000017478069,0.000033071727,0.002873857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904823,0.000008037701,0.00021919279,0.00026686653,0.00017184182,0.00028584636],"domain_scores_gemma":[0.9994013,0.00005947212,0.00007095121,0.0001542605,0.000057838384,0.0002562229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006761362,0.00015861639,0.00024876313,0.000082852486,0.0000970477,0.000016122272,0.000026204512,0.00006237221,0.000567724],"category_scores_gemma":[0.000030213387,0.00011847348,0.00002974339,0.00022778049,0.00012880375,0.00009684089,0.000027160773,0.0003296799,0.000008934638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005071758,0.00006671051,0.96349126,0.00006303699,0.00033639043,0.00017471184,0.0007797,0.000028673549,0.0006866699,0.0011236198,0.002412517,0.030329553],"study_design_scores_gemma":[0.004975846,0.00041130005,0.8984221,0.00018042786,0.0003610745,0.0005568921,0.00029481348,0.00088436337,0.00035509572,0.000090487054,0.09317615,0.00029144966],"about_ca_topic_score_codex":0.0012058368,"about_ca_topic_score_gemma":0.00035160003,"teacher_disagreement_score":0.090763636,"about_ca_system_score_codex":0.000079837206,"about_ca_system_score_gemma":0.00011450137,"threshold_uncertainty_score":0.621618},"labels":[],"label_agreement":null},{"id":"W2098524712","doi":"10.1530/erc-12-0389","title":"A bi-faceted role of estrogen receptor β in breast cancer","year":2013,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Cure Brain Cancer Foundation; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Estrogen receptor; Breast cancer; Cancer research; Estrogen; In vivo; Cancer; In vitro; Human breast; Estrogen receptor alpha; Apoptosis; Estrogen receptor beta; Internal medicine; Oncology; Receptor; Biology; Medicine","score_opus":0.008586919141592047,"score_gpt":0.29730630680022974,"score_spread":0.2887193876586377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098524712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068812207,0.9904734,3.507328e-7,0.00006094895,0.00051066617,0.0010709177,0.00041351496,0.000030829327,0.0005581431],"genre_scores_gemma":[0.0004149354,0.9956894,0.000045970613,0.00001564799,0.00030476347,0.0009363291,0.00050700404,0.0001490895,0.0019368551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973269,0.00023297407,0.0008790064,0.0007253997,0.00021350897,0.00062222],"domain_scores_gemma":[0.99857837,0.000024402863,0.00054576696,0.0005640998,0.00011239146,0.00017495592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010138026,0.0006393599,0.0014017406,0.00024320213,0.00003895832,0.000016185466,0.00042659315,0.00080151996,0.000762119],"category_scores_gemma":[0.000021722135,0.00051447167,0.0005820165,0.00060668687,0.000112764545,0.000007773741,0.00019476854,0.0007901624,0.00011042944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006160921,0.0001560396,0.00039200645,0.0027909651,0.0017166196,0.000020284688,0.000030567066,0.00007999058,0.014484276,0.000047074638,0.0052116406,0.9750089],"study_design_scores_gemma":[0.0008180056,0.00010271356,0.000015316944,0.005336068,0.00056154456,0.000149592,0.000012388114,0.00001584303,0.004513669,0.000008565701,0.9878644,0.0006019108],"about_ca_topic_score_codex":0.0011549758,"about_ca_topic_score_gemma":0.00001891448,"teacher_disagreement_score":0.9826527,"about_ca_system_score_codex":0.00016556394,"about_ca_system_score_gemma":0.00066582544,"threshold_uncertainty_score":0.9997307},"labels":[],"label_agreement":null},{"id":"W2099643741","doi":"10.1530/erc-11-0136","title":"IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Cancer Society Research Institute; McGill University; Terry Fox Research Institute; Joslin Diabetes Center","keywords":"Insulin receptor; Insulin; Hyperinsulinemia; Metformin; Endocrinology; Internal medicine; Tyrosine kinase; Medicine; Tyrosine-kinase inhibitor; Pharmacology; Cancer; Insulin resistance; Receptor","score_opus":0.011098154442006678,"score_gpt":0.26730728257571285,"score_spread":0.25620912813370617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099643741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8059106,0.19209354,0.000001466166,0.00021472196,0.00023736236,0.00080124656,0.0006399021,0.000014825854,0.00008633086],"genre_scores_gemma":[0.9315425,0.06616621,0.000044760814,0.0005466407,0.0002112431,0.0010676216,0.00023860815,0.00005310633,0.00012928831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979616,0.00024220961,0.00046826198,0.0006357504,0.00023419863,0.0004579738],"domain_scores_gemma":[0.9990773,0.000032112835,0.00023712471,0.00038714218,0.00014249545,0.00012382047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001248904,0.00044176055,0.00046364477,0.00010691754,0.00008545524,0.000019001325,0.0001576346,0.00021849354,0.000379662],"category_scores_gemma":[0.000016986949,0.0003253729,0.00015628233,0.00030921248,0.00015196967,0.000027227814,0.00005411982,0.000205535,0.000005766123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016986905,0.00076381,0.004550207,0.000030392368,0.00046244758,0.00002579068,0.005507045,0.0000069317102,0.9086358,0.000012736374,0.0024324362,0.07587373],"study_design_scores_gemma":[0.0048461794,0.0008280453,0.010977181,0.0000912749,0.00012578495,0.00002381087,0.0007114641,0.000030827192,0.96544635,0.000016060822,0.01652289,0.00038012737],"about_ca_topic_score_codex":0.0032877899,"about_ca_topic_score_gemma":0.00022155086,"teacher_disagreement_score":0.12592733,"about_ca_system_score_codex":0.00016265988,"about_ca_system_score_gemma":0.00013241054,"threshold_uncertainty_score":0.99991983},"labels":[],"label_agreement":null},{"id":"W2099691308","doi":"10.1530/erc-14-0088","title":"Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Guelph; Toronto General Hospital; University of Toronto; University Health Network; Canadian Blood Services; Mount Sinai Hospital","funders":"","keywords":"Prostate cancer; Relaxin; Docetaxel; Androgen receptor; Androgen; Internal medicine; Medicine; Prostate; Endocrinology; Hormone; Hormonal therapy; Cancer research; Cancer","score_opus":0.008825798346866707,"score_gpt":0.2843311878937023,"score_spread":0.2755053895468356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099691308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462226,0.02146347,0.000016213762,0.0064928923,0.0006615262,0.001928176,0.00004929554,0.0004050188,0.022760805],"genre_scores_gemma":[0.93063235,0.020609446,0.0003075069,0.00033408275,0.00021800534,0.00052736513,0.00019157863,0.00015871054,0.047020953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955375,0.00021478943,0.0007453019,0.0008924411,0.001289031,0.0013209293],"domain_scores_gemma":[0.9979094,0.0001845636,0.00020013157,0.0007281453,0.00021121732,0.00076652726],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005487739,0.0004516664,0.00076581066,0.00038871358,0.00016440869,0.00003457316,0.0002732054,0.00026140144,0.0030154167],"category_scores_gemma":[0.00048361038,0.00033743153,0.0001220303,0.0010652184,0.00035599503,0.00017099958,0.00021036196,0.001743615,0.0005777471],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018911311,0.0045897644,0.32348463,0.002463179,0.003395949,0.011690029,0.0023929896,0.0010587419,0.060915615,0.003107173,0.06474258,0.50324804],"study_design_scores_gemma":[0.07475104,0.004361393,0.024425177,0.0185309,0.0006786229,0.0022235354,0.00021322974,0.003710298,0.083655335,0.00038604863,0.78499943,0.0020650092],"about_ca_topic_score_codex":0.0010039805,"about_ca_topic_score_gemma":0.0006231536,"teacher_disagreement_score":0.7202568,"about_ca_system_score_codex":0.0009850321,"about_ca_system_score_gemma":0.00051695295,"threshold_uncertainty_score":0.9999078},"labels":[],"label_agreement":null},{"id":"W2101695180","doi":"10.1677/erc.1.00883","title":"Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Raloxifene; Tamoxifen; Selective estrogen receptor modulator; Aromatase; Breast cancer; Medicine; Estrogen; Internal medicine; Cancer; Endocrinology; Endometrial cancer; Estrogen receptor; Cancer research; Oncology","score_opus":0.005495821984045674,"score_gpt":0.27149832543571495,"score_spread":0.26600250345166926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101695180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07393056,0.9248613,0.0000031576496,0.00003306794,0.00011724596,0.00078447856,0.00004916346,0.000017955537,0.00020305732],"genre_scores_gemma":[0.019222565,0.97942394,0.00009256612,0.0000026147864,0.00014924217,0.00015615356,0.0004282861,0.000084561616,0.00044008493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832284,0.00018225805,0.0004237488,0.00059469586,0.00016624533,0.00031021948],"domain_scores_gemma":[0.99919915,0.000021708478,0.0003525264,0.0002525224,0.00010178984,0.000072282586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082277365,0.0004392849,0.0009463561,0.00020426525,0.000043987926,0.0000106772,0.00012648401,0.00048762865,0.000012796783],"category_scores_gemma":[0.000014342592,0.0003391969,0.00018479933,0.00049685844,0.00012685734,0.000007722116,0.00005486003,0.0005615577,0.0000022222841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001388633,0.002105532,0.0065182527,0.015571389,0.010587991,0.0002458164,0.0014874291,0.0009850733,0.012443308,0.001418972,0.005474834,0.94177276],"study_design_scores_gemma":[0.008333869,0.0024472442,0.00040066327,0.008750635,0.0023062567,0.00049733446,0.00041415266,0.000053577827,0.01749331,0.00005867524,0.9571262,0.0021180871],"about_ca_topic_score_codex":0.00016948875,"about_ca_topic_score_gemma":0.000039937026,"teacher_disagreement_score":0.95165133,"about_ca_system_score_codex":0.00013855078,"about_ca_system_score_gemma":0.00028515435,"threshold_uncertainty_score":0.999906},"labels":[],"label_agreement":null},{"id":"W2110104390","doi":"10.1677/erc-08-0266","title":"Resistance to chemotherapy and hormone therapy in endometrial cancer","year":2009,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Endometrial cancer; Medicine; Cancer; Malignancy; Oncology; Hormone therapy; Internal medicine; Chemotherapy; Targeted therapy; Ovarian cancer; Uterine cancer; Cancer research; Bioinformatics; Breast cancer; Biology","score_opus":0.01561313703578337,"score_gpt":0.33372719996739825,"score_spread":0.31811406293161487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110104390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003692719,0.993339,0.0000023007995,0.0002753637,0.0003590629,0.0014863297,0.000062279905,0.0000346315,0.0007482966],"genre_scores_gemma":[0.0003229608,0.9932299,0.000073117306,0.0002285541,0.0005339991,0.00060394435,0.00011192529,0.00012555123,0.0047700442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736995,0.00019566974,0.00066282257,0.00092903676,0.00021637804,0.00062617566],"domain_scores_gemma":[0.99893963,0.000045154346,0.0002594434,0.00048558525,0.000052242278,0.00021792359],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018722135,0.0006634265,0.0013346298,0.00036613428,0.00006732148,0.000037885256,0.00031912053,0.0006102827,0.00005816738],"category_scores_gemma":[0.000054122098,0.0005395403,0.00033256217,0.0009245422,0.000065775916,0.000006111378,0.00007986019,0.00069837173,0.000015235212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003731234,0.00006949657,0.000017676915,0.00034431144,0.0005056308,0.000056188503,0.000029148187,0.000012040726,0.0015084168,0.000020439777,0.006633829,0.9904297],"study_design_scores_gemma":[0.0028036856,0.00042591683,0.00003639829,0.0021674111,0.00014032921,0.000036439404,0.000002118842,7.8729676e-7,0.001096616,0.000017306502,0.99265313,0.0006198417],"about_ca_topic_score_codex":0.00013751393,"about_ca_topic_score_gemma":0.00007617685,"teacher_disagreement_score":0.9898099,"about_ca_system_score_codex":0.00016217303,"about_ca_system_score_gemma":0.00033879382,"threshold_uncertainty_score":0.9997056},"labels":[],"label_agreement":null},{"id":"W2112031253","doi":"10.1530/erc-11-0180","title":"Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation Medic; Breast Cancer Research Foundation","keywords":"Letrozole; Breast cancer; Oncology; Medicine; Estrogen receptor; Neoadjuvant therapy; Internal medicine; Cancer; Cancer research; Aromatase","score_opus":0.010611062138524894,"score_gpt":0.2623182601018027,"score_spread":0.2517071979632778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112031253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506396,0.0022123253,0.000014642375,0.00045875084,0.00015853648,0.0007654499,0.001160927,0.000023114777,0.00014227594],"genre_scores_gemma":[0.99604803,0.0015514541,0.0000598571,0.00018096938,0.00018932197,0.0014636309,0.00009582849,0.00005672821,0.00035417988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808794,0.00024657676,0.00039699755,0.0006327235,0.00023284175,0.0004029007],"domain_scores_gemma":[0.99909216,0.000017255634,0.00014080749,0.00035137756,0.00030582093,0.00009255817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011801536,0.00034983605,0.0003408715,0.00012190408,0.00006859541,0.000013942664,0.00014480736,0.00015539666,0.000344598],"category_scores_gemma":[0.000011300225,0.00030301537,0.00008573816,0.00021500392,0.00018880599,0.000045375997,0.00008008513,0.00021313911,0.0000030007202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057958793,0.0006512107,0.87793815,0.000021910333,0.001090404,0.00006513524,0.006232059,0.00007107759,0.05183909,0.000013695662,0.00022828224,0.0038901703],"study_design_scores_gemma":[0.0019713282,0.00075226225,0.7077324,0.00010943595,0.00005420501,0.000017573113,0.000085424814,0.000013084706,0.2890016,0.000020511425,0.000021963047,0.00022020987],"about_ca_topic_score_codex":0.0015734158,"about_ca_topic_score_gemma":0.00064368924,"teacher_disagreement_score":0.23716253,"about_ca_system_score_codex":0.00018444809,"about_ca_system_score_gemma":0.00026406042,"threshold_uncertainty_score":0.9999422},"labels":[],"label_agreement":null},{"id":"W2112187558","doi":"10.1677/erc.1.01010","title":"Progesterone metabolites in breast cancer","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Susan G. Komen","keywords":"Corpus luteum; Enzyme; Cell growth; Reductase; Internal medicine; Metabolism; Pregnane; Cell; Chemistry; Cell culture; Endocrinology; Oxidoreductase; Biology; Biochemistry; Hormone; Medicine; Stereochemistry; Genetics","score_opus":0.0109600901615291,"score_gpt":0.3199203581185874,"score_spread":0.3089602679570583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112187558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010306356,0.99594223,7.641676e-7,0.00010982566,0.00057798607,0.00091082585,0.0003079365,0.00004737943,0.0010724337],"genre_scores_gemma":[0.00016663152,0.9904722,0.000023035569,0.000034893532,0.0005417995,0.0010639263,0.0007781626,0.00016586762,0.0067534596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997241,0.00022210203,0.00076848094,0.00084863737,0.00020339982,0.0007163811],"domain_scores_gemma":[0.9989199,0.000019499392,0.00035326608,0.0005112831,0.00006215347,0.00013390083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001154944,0.0007047117,0.0013454665,0.00022865146,0.000055449407,0.00003302118,0.00035316855,0.0006996707,0.00017946887],"category_scores_gemma":[0.000010799547,0.00055777,0.0005170418,0.0005610328,0.00009382897,0.000007159694,0.00016787641,0.00085710676,0.000054306332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041719093,0.00019351754,0.0005960288,0.00411015,0.0012543213,0.00017735256,0.000009180888,0.00010042389,0.00073775026,0.000059432477,0.009356283,0.98336387],"study_design_scores_gemma":[0.00073596265,0.000042806274,0.000066995744,0.0039645853,0.00082557835,0.00036841028,0.0000014656412,0.000004555919,0.00049995084,0.0000074295117,0.9928432,0.00063902646],"about_ca_topic_score_codex":0.0006587388,"about_ca_topic_score_gemma":0.000076912416,"teacher_disagreement_score":0.98348695,"about_ca_system_score_codex":0.00016095616,"about_ca_system_score_gemma":0.0005255824,"threshold_uncertainty_score":0.9996874},"labels":[],"label_agreement":null},{"id":"W2113902100","doi":"10.1530/erc-14-0516","title":"Deubiquitinases and the new therapeutic opportunities offered to cancer","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Institutes of Health Research; University of Sydney","keywords":"Neurodegeneration; Prostate cancer; Carcinogenesis; Cancer; Thyroid cancer; Biology; Cancer research; Deubiquitinating enzyme; Medicine; Bioinformatics; Neuroscience; Computational biology; Disease; Ubiquitin; Internal medicine; Gene; Genetics","score_opus":0.09523177076560643,"score_gpt":0.3638748980179886,"score_spread":0.26864312725238215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113902100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009710605,0.994209,0.000009974794,0.0011581605,0.0004349445,0.0012340809,0.0002174234,0.000035447996,0.002603852],"genre_scores_gemma":[0.00011044292,0.97050583,0.000024095343,0.00069860404,0.00075452315,0.00100963,0.00017291598,0.00009968361,0.026624288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803895,0.00030825337,0.00046822743,0.00053208123,0.00020919139,0.0004432733],"domain_scores_gemma":[0.9987724,0.00005246331,0.0002453094,0.0005100251,0.00011102765,0.0003087697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024493234,0.0005108683,0.0010188296,0.000082925515,0.00010802767,0.00006137127,0.00038752286,0.00024461944,0.00032749042],"category_scores_gemma":[0.00006275816,0.0003216493,0.00027471906,0.0001731008,0.00017208423,0.0000042432894,0.0002871317,0.000364984,0.000022997225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008004703,0.000009812701,0.000001800729,0.00086469046,0.00054267026,0.000013030572,0.000093496325,0.0000036430158,0.000031033756,0.00056698767,0.020220624,0.97757214],"study_design_scores_gemma":[0.0009718369,0.00010404613,6.1755765e-7,0.0019463201,0.00073503744,0.000111896596,0.0000313604,0.0000016755228,0.00044774136,0.00024809354,0.9949767,0.00042470454],"about_ca_topic_score_codex":0.0005736379,"about_ca_topic_score_gemma":0.00013014958,"teacher_disagreement_score":0.97714746,"about_ca_system_score_codex":0.00007179506,"about_ca_system_score_gemma":0.0013725036,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W2115163916","doi":"10.1530/erc-15-0137","title":"Regulation of tumor cell plasticity by the androgen receptor in prostate cancer","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Prostate Cancer Canada; Movember Foundation; Prostate Cancer Foundation","keywords":"Prostate cancer; Androgen receptor; Transdifferentiation; Androgen deprivation therapy; Cancer research; Cancer; Biology; Androgen; Tumor progression; Medicine; Bioinformatics; Internal medicine; Stem cell; Hormone; Cell biology","score_opus":0.03718822712498839,"score_gpt":0.3640658753312958,"score_spread":0.32687764820630744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115163916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016340436,0.9927932,2.850351e-7,0.00036907077,0.0003178295,0.0027474998,0.0007539554,0.00003929566,0.001344813],"genre_scores_gemma":[0.00053987384,0.975443,0.00001425704,0.000018991059,0.00013387995,0.0012957463,0.00050449965,0.00009323857,0.021956531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972669,0.00021261447,0.0008645506,0.0005134652,0.00059080095,0.00055167574],"domain_scores_gemma":[0.9985614,0.00012919432,0.00051766564,0.00035836684,0.00024516994,0.00018821328],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024691204,0.00045293136,0.00159161,0.00023518076,0.00005476647,0.000015102315,0.00021022685,0.00014430481,0.000998212],"category_scores_gemma":[0.000047966983,0.00026057128,0.00026506226,0.0009833609,0.00018204623,0.00007506735,0.00009379884,0.00091261487,0.000046649373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073968724,0.00043099083,0.001254392,0.0228819,0.001075728,0.0001647723,0.00043559854,0.000069531314,0.00033252596,0.000017914273,0.096297175,0.8762998],"study_design_scores_gemma":[0.002789947,0.00021369293,0.000028292048,0.010244755,0.0009620022,0.000052682077,0.000025919675,0.000032210024,0.0012837567,0.000017855804,0.984096,0.00025289503],"about_ca_topic_score_codex":0.0014417799,"about_ca_topic_score_gemma":0.00007786979,"teacher_disagreement_score":0.88779885,"about_ca_system_score_codex":0.0013579216,"about_ca_system_score_gemma":0.0020754235,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W2116534677","doi":"10.1530/erc-10-0204","title":"Androgen receptor levels are upregulated by Akt in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of California, Los Angeles; School of Medicine, New York University; York University; American Cancer Society","keywords":"LNCaP; Protein kinase B; Androgen receptor; Prostate cancer; AKT1; PI3K/AKT/mTOR pathway; Biology; AKT2; Endocrinology; Cancer research; Internal medicine; Transgene; Phosphorylation; Signal transduction; Chemistry; Cell biology; Cancer; Medicine; Biochemistry","score_opus":0.03953331237177583,"score_gpt":0.32293153682708375,"score_spread":0.28339822445530793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116534677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94958645,0.039946537,9.98891e-7,0.0029199799,0.00042189268,0.0013113905,0.0003730716,0.00018393373,0.0052557695],"genre_scores_gemma":[0.93909425,0.01172548,0.00008052791,0.00019841194,0.00008386657,0.00077577925,0.00013137981,0.00009192223,0.04781841],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769384,0.000074011994,0.0004600781,0.0005734095,0.00037859968,0.0008200707],"domain_scores_gemma":[0.99899805,0.000022270715,0.00015353876,0.00035341812,0.00017422599,0.0002985106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011501448,0.00032720403,0.00051140424,0.00021947865,0.000079924896,0.000016013393,0.00014618103,0.00011969083,0.008229192],"category_scores_gemma":[0.000026713593,0.0002575359,0.000110068955,0.0007989278,0.00014377665,0.00017595563,0.00007084225,0.0005577475,0.00012631444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00358568,0.0009536388,0.81402,0.00040770852,0.0014512901,0.0016369729,0.003483825,0.000043182692,0.054091223,0.000059478727,0.07014354,0.0501235],"study_design_scores_gemma":[0.025019981,0.00075366226,0.12592132,0.0022025865,0.00037695895,0.00016315126,0.0004492372,0.00023388193,0.7282863,0.00033400266,0.11519547,0.001063432],"about_ca_topic_score_codex":0.0037627236,"about_ca_topic_score_gemma":0.0002360092,"teacher_disagreement_score":0.6880986,"about_ca_system_score_codex":0.00068911834,"about_ca_system_score_gemma":0.00037000896,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W2119255622","doi":"10.1677/erc.1.01057","title":"Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"GNRHR; Autocrine signalling; Paracrine signalling; Endocrinology; Internal medicine; Gonadotropin-releasing hormone; Luteinizing hormone; Gonadotropin-releasing hormone receptor; Biology; Gonadotropin; Receptor; Hormone; Follicle-stimulating hormone; Ovary; Ovarian cancer; Cancer; Medicine","score_opus":0.007084500605257545,"score_gpt":0.2710778418676892,"score_spread":0.2639933412624316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119255622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536056,0.011718035,0.000066994915,0.0010140162,0.00023812144,0.00081201043,0.00027401387,0.000046265937,0.00046995957],"genre_scores_gemma":[0.994178,0.004385826,0.00030643592,0.000029208994,0.0001176061,0.00009035024,0.00020509191,0.000079845944,0.00060760824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974714,0.0000792619,0.0009845598,0.00055208645,0.00040413806,0.00050856406],"domain_scores_gemma":[0.9987806,0.00003800542,0.00050365884,0.00040034496,0.00014224878,0.0001351253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060445753,0.00039453528,0.0009286718,0.00020264993,0.00008430501,0.000018787921,0.000098804616,0.00013764891,0.00094574335],"category_scores_gemma":[0.0000066439225,0.0003414348,0.00017135845,0.00046146294,0.00017132127,0.00015413582,0.00005768152,0.00029936837,0.0000017507024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043043695,0.00062217086,0.042048495,0.00019672884,0.0005033207,0.00003809495,0.00014933659,0.0007747219,0.9495923,0.0026356739,0.000724557,0.0022841962],"study_design_scores_gemma":[0.016874695,0.00029322974,0.59563,0.0006097099,0.00061643624,0.000020191823,0.00002149105,0.0007089632,0.38353932,0.0005177751,0.00082395744,0.0003442207],"about_ca_topic_score_codex":0.031123815,"about_ca_topic_score_gemma":0.001107539,"teacher_disagreement_score":0.566053,"about_ca_system_score_codex":0.0004666587,"about_ca_system_score_gemma":0.0001647136,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2121121428","doi":"10.1677/erc-07-0132","title":"Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)","year":2007,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Medical Research Council; Canadian Institutes of Health Research; Deutsche Krebshilfe; Fondation pour la Recherche Médicale; Cancerfonden; Fondation de France; Bundesministerium für Bildung und Forschung; Instituto de Salud Carlos III; 3M; University of Sydney; Institut National de la Santé et de la Recherche Médicale; Cancer Institute NSW; European Commission; Wellcome Trust; British Heart Foundation; Norges Forskningsråd; Cancer Research UK; Deutsches Krebsforschungszentrum","keywords":"Medicine; Endometrial cancer; Internal medicine; Endocrinology; Metabolic syndrome; Body mass index; European Prospective Investigation into Cancer and Nutrition; Quartile; Relative risk; Prospective cohort study; Confidence interval; Risk factor; Cancer; Obesity","score_opus":0.009063529339974424,"score_gpt":0.254749518786764,"score_spread":0.24568598944678957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121121428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88832283,0.10833303,0.000020403126,0.0004077331,0.0016621043,0.00087746535,0.00012032405,0.00002009216,0.00023602376],"genre_scores_gemma":[0.89586234,0.09886672,0.00016103542,0.0001404119,0.0042433194,0.00037494945,0.00003348125,0.000043107735,0.00027462668],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981099,0.00026640392,0.00040532296,0.0006133821,0.00020854957,0.00039648172],"domain_scores_gemma":[0.9992642,0.000055140397,0.0002110235,0.00023070749,0.000089775276,0.00014915419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007389696,0.00029380523,0.00033712768,0.00020285141,0.0001817576,0.00006003029,0.0001268095,0.0001236427,0.000024973835],"category_scores_gemma":[0.00017932359,0.00024154577,0.000053639953,0.00046923946,0.0002509329,0.000032439573,0.000111812995,0.00040019667,0.0000013719506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017089521,0.0002509048,0.15039414,0.00034422264,0.00087735435,0.000022475993,0.005052288,0.00013682777,0.2800109,0.0008969324,0.0037735235,0.5565314],"study_design_scores_gemma":[0.0137880575,0.00039586468,0.5540179,0.0002836789,0.00042372788,0.0002658683,0.0005468244,0.00007966237,0.09495981,0.0007663932,0.33366948,0.00080272235],"about_ca_topic_score_codex":0.012316918,"about_ca_topic_score_gemma":0.012751723,"teacher_disagreement_score":0.55572873,"about_ca_system_score_codex":0.00006592186,"about_ca_system_score_gemma":0.00010761576,"threshold_uncertainty_score":0.99426013},"labels":[],"label_agreement":null},{"id":"W2123921391","doi":"10.1530/erc-13-0132","title":"Differential sensitivities to lactate transport inhibitors of breast cancer cell lines","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia","keywords":"Cancer research; Monocarboxylate transporter; Breast cancer; Cell culture; Cell growth; Gene silencing; Downregulation and upregulation; Cancer cell; Apoptosis; Cell; Biology; Cancer; Extracellular; Glucose transporter; Programmed cell death; Chemistry; Cell biology; Transporter; Internal medicine; Endocrinology; Medicine; Biochemistry","score_opus":0.004110703754306889,"score_gpt":0.22580470464613406,"score_spread":0.22169400089182717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123921391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901326,0.0055631865,0.000034633857,0.00057270116,0.0021175467,0.00033487275,0.000330079,0.000026923668,0.00088749453],"genre_scores_gemma":[0.9828952,0.0071050744,0.00003911966,0.00017471488,0.0017435388,0.00016465849,0.00007403812,0.000049263013,0.007754373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987012,0.000032426473,0.0003428798,0.00036725035,0.00017443497,0.00038180398],"domain_scores_gemma":[0.99926704,0.000006568901,0.00011533787,0.00025831105,0.00019124986,0.00016146418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000027448443,0.00024672388,0.00031173383,0.000054186366,0.000046443558,0.000011056868,0.000119868804,0.00010473257,0.0012038989],"category_scores_gemma":[0.000004683809,0.00022226149,0.00016694983,0.00013036122,0.00007221102,0.000013076457,0.00005228223,0.0001258855,0.000013721145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001126597,0.0000682588,0.0024251253,0.00006140997,0.0001397525,0.0000020709838,0.00019516044,0.00042410044,0.97459364,0.000008787632,0.011168521,0.010800537],"study_design_scores_gemma":[0.0013082621,0.000081434024,0.02843747,0.00007652179,0.00012885992,0.000026726964,0.0001341296,0.00003264876,0.90123177,0.000012770143,0.06813675,0.00039266952],"about_ca_topic_score_codex":0.00944733,"about_ca_topic_score_gemma":0.0015254832,"teacher_disagreement_score":0.07336186,"about_ca_system_score_codex":0.00003278742,"about_ca_system_score_gemma":0.00013484208,"threshold_uncertainty_score":0.9997091},"labels":[],"label_agreement":null},{"id":"W2125056490","doi":"10.1530/erc-12-0125","title":"Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Novo Nordisk; Deutsche Forschungsgemeinschaft","keywords":"Hyperinsulinemia; Insulin; Insulin receptor; Endocrinology; Internal medicine; Cell growth; Serine; Cancer research; Downregulation and upregulation; Biology; Neoplastic cell; Gene expression; Chemistry; Gene; Phosphorylation; Cell biology; Cell; Biochemistry; Insulin resistance; Medicine","score_opus":0.007025789224235278,"score_gpt":0.23821543648451096,"score_spread":0.2311896472602757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125056490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7009707,0.29783675,0.000030586812,0.00008541088,0.0003198724,0.00015552843,0.00009218101,0.000021192936,0.00048776978],"genre_scores_gemma":[0.95637465,0.042391703,0.000047222245,0.00024618476,0.00036284034,0.00011513718,0.00006305173,0.000042319738,0.00035691643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879247,0.00010805591,0.00032014408,0.00023639068,0.00017591761,0.0003669996],"domain_scores_gemma":[0.99924415,0.00003626193,0.00018664847,0.00032565196,0.0001109243,0.00009638436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001816677,0.00019261749,0.00023490633,0.000040006707,0.00006781413,0.000009407113,0.00019464323,0.00007655346,0.00037275587],"category_scores_gemma":[0.00013995808,0.0001408808,0.000109880966,0.00020269066,0.00009616168,0.000014264608,0.00007386511,0.00014342638,0.000015271822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003342768,0.00044275768,0.069146715,0.00023312599,0.0009874109,0.000004143898,0.0003769083,0.0008780584,0.72328883,0.0012786058,0.033155497,0.16987365],"study_design_scores_gemma":[0.00055608194,0.000056044795,0.0058115604,0.000030488389,0.00009338382,0.0000052598793,0.000041099007,0.00007531604,0.7111959,0.00007946127,0.28184313,0.00021225149],"about_ca_topic_score_codex":0.00031431727,"about_ca_topic_score_gemma":0.00004384085,"teacher_disagreement_score":0.25544503,"about_ca_system_score_codex":0.000026865493,"about_ca_system_score_gemma":0.00007345355,"threshold_uncertainty_score":0.57449526},"labels":[],"label_agreement":null},{"id":"W2125346129","doi":"10.1530/erc-13-0293","title":"TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth","year":2013,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Cancer Institute; National Institutes of Health; DOD Prostate Cancer Research Program; National Center for Research Resources; Office of Research and Development; U.S. Department of Veterans Affairs; U.S. Department of Defense","keywords":"Coactivator; Androgen receptor; Prostate cancer; Cancer research; Corepressor; Nuclear receptor coactivator 3; Nuclear receptor; Endocrinology; Androgen; Biology; Ectopic expression; LNCaP; Internal medicine; Cell growth; Prostate; Cancer; Chemistry; Cell biology; Medicine; Cell culture; Hormone; Gene; Transcription factor; Genetics","score_opus":0.013000437079938474,"score_gpt":0.31160680758527864,"score_spread":0.29860637050534017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125346129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97514784,0.008160414,0.0000041235744,0.010777783,0.00040459234,0.0030504602,0.00018620557,0.00032461592,0.0019439904],"genre_scores_gemma":[0.9531387,0.010553514,0.00065379246,0.0009064719,0.0005884624,0.00409773,0.00025774477,0.00020989982,0.029593647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965843,0.00013099797,0.00047807276,0.00095997023,0.00065422826,0.0011924239],"domain_scores_gemma":[0.9976504,0.00006987555,0.00016240528,0.00041665806,0.0007744928,0.00092617463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011030604,0.00054298976,0.0006971547,0.00034161436,0.0002710337,0.00010092626,0.00022572206,0.00016545161,0.007697391],"category_scores_gemma":[0.00009411474,0.00041551678,0.0001541074,0.0012373728,0.00014255337,0.00069914,0.00012789684,0.000673678,0.0006785498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039456184,0.00093182485,0.2163117,0.00031453956,0.0025697867,0.00028110915,0.0028018928,0.00012961756,0.67059326,0.00018000042,0.050148793,0.05179184],"study_design_scores_gemma":[0.004997079,0.0012451197,0.010708103,0.00034765693,0.00015996065,0.000077085,0.00033203023,0.00009647363,0.91887844,0.000508897,0.062049806,0.0005993352],"about_ca_topic_score_codex":0.010193389,"about_ca_topic_score_gemma":0.00008777539,"teacher_disagreement_score":0.24828516,"about_ca_system_score_codex":0.001152765,"about_ca_system_score_gemma":0.0009962262,"threshold_uncertainty_score":0.99982965},"labels":[],"label_agreement":null},{"id":"W2126464915","doi":"10.1677/erc-09-0252","title":"Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Metformin; Fatty acid synthase; AMPK; Endocrinology; Internal medicine; PI3K/AKT/mTOR pathway; Protein kinase B; Apoptosis; Colorectal cancer; In vivo; Cancer research; Medicine; Insulin; Cancer; Phosphorylation; Biology; Protein kinase A; Lipid metabolism; Biochemistry","score_opus":0.004109245404270566,"score_gpt":0.23381651425769112,"score_spread":0.22970726885342055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126464915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468095,0.014585134,0.000005662419,0.000031922118,0.00013936922,0.00023444516,0.00012197812,0.0000061209503,0.00019441597],"genre_scores_gemma":[0.99650186,0.003053781,0.000018768189,0.000046885663,0.000043921118,0.000114608614,0.000026129726,0.000024030705,0.00016999827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888474,0.00014178247,0.00025368104,0.0003115598,0.00017458573,0.0002336676],"domain_scores_gemma":[0.9992536,0.00008786184,0.00023723011,0.0002592111,0.00010422414,0.00005789942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001617066,0.00020618743,0.00037468455,0.00007191966,0.000042993095,0.0000052199407,0.00012990549,0.00014205104,0.00011248894],"category_scores_gemma":[0.0001483834,0.00012775276,0.000062141844,0.00020798562,0.00015016302,0.0000066296852,0.00006112233,0.00023008918,1.4173402e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017945608,0.00008264263,0.006536345,0.000037211088,0.00016850242,0.000008052693,0.00016861576,0.00007849971,0.9862053,0.00010875996,0.00038068552,0.0044308314],"study_design_scores_gemma":[0.0028165323,0.0011714743,0.0027317354,0.00011750157,0.00009469153,0.0000030548706,0.000015422713,0.000076184246,0.99201095,0.00005540138,0.00075950293,0.00014755028],"about_ca_topic_score_codex":0.00079654355,"about_ca_topic_score_gemma":0.0002561167,"teacher_disagreement_score":0.0118209245,"about_ca_system_score_codex":0.000020960924,"about_ca_system_score_gemma":0.00006914123,"threshold_uncertainty_score":0.5209607},"labels":[],"label_agreement":null},{"id":"W2127717082","doi":"10.1530/erc-15-0319","title":"Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Human Genome Research Institute; Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Vincent Fairfax Family Foundation; Cancer Council Victoria; Deutsche Krebshilfe; Norges Forskningsråd; Universitetet i Bergen; Helse Vest; Karolinska Institutet; National Institutes of Health; David F. and Margaret T. Grohne Family Foundation; Deutsche Gesetzliche Unfallversicherung; Canadian Institutes of Health Research; Cancerfonden; Robert Bosch Stiftung; Agency for Science, Technology and Research; Deutsches Krebsforschungszentrum; Hunter Medical Research Institute; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Roswell Park Cancer Institute; Susan G. Komen; Stockholms Läns Landsting; QIMR Berghofer Medical Research Institute; Mayo Foundation for Medical Education and Research; Francis Crick Institute; Cancer Research UK; Wellcome Trust; Breast Cancer Research Foundation; University of Cambridge; Kreftforeningen; Ovarian Cancer Research Fund; European Commission","keywords":"Single-nucleotide polymorphism; Estrogen receptor alpha; Endometrial cancer; Locus (genetics); SNP; Breast cancer; Estrogen receptor; Biology; Cancer; Oncology; Medicine; Genetics; Gene; Internal medicine; Genotype","score_opus":0.02028614065841257,"score_gpt":0.32424924953364703,"score_spread":0.3039631088752345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127717082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649715,0.031344596,0.00038876373,0.00027634526,0.0017501786,0.0008286731,0.000071120005,0.000017881022,0.00035096644],"genre_scores_gemma":[0.99052614,0.0069431285,0.0001897185,0.000049035687,0.00033949083,0.0002757131,0.000028203736,0.000038546732,0.0016100114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986347,0.00016375132,0.00033788572,0.0003404943,0.00022434343,0.0002988418],"domain_scores_gemma":[0.9988528,0.000049762315,0.00031777303,0.00039067885,0.00028691828,0.00010205811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097421114,0.00020097621,0.00025860532,0.000064798194,0.00009788339,0.000015297475,0.00024073629,0.0001538949,0.000014172831],"category_scores_gemma":[0.0001189608,0.00014176549,0.00024327768,0.0002742265,0.00013610031,0.0000050287404,0.00013205361,0.0002366295,0.0000018162607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017750667,0.00038282192,0.09175492,0.0002932793,0.0040894495,0.000045258028,0.00041237305,0.05412763,0.7535682,0.00033982797,0.0635187,0.029692486],"study_design_scores_gemma":[0.017038228,0.0013947691,0.01701413,0.00024206517,0.001134247,0.00014376696,0.00022772359,0.0022246498,0.8229987,0.0007202795,0.13607655,0.00078491017],"about_ca_topic_score_codex":0.00068151136,"about_ca_topic_score_gemma":0.000046925437,"teacher_disagreement_score":0.07474079,"about_ca_system_score_codex":0.00008857202,"about_ca_system_score_gemma":0.00035573015,"threshold_uncertainty_score":0.5781029},"labels":[],"label_agreement":null},{"id":"W2130691274","doi":"10.1677/erc.0.0100169","title":"Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"College of Veterinary Medicine, Seoul National University; Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University; Seoul National University; Canadian Institutes of Health Research; Dongguk University; Michael Smith Health Research BC","keywords":"Internal medicine; Autocrine signalling; Endocrinology; Ovary; Paracrine signalling; Gonadotropin-releasing hormone; Biology; Hypothalamus; Hormone; Receptor; Luteinizing hormone; Medicine","score_opus":0.015848395486196043,"score_gpt":0.30569808566234397,"score_spread":0.2898496901761479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130691274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020869577,0.9751681,0.000002320741,0.0010248559,0.00026569463,0.0016865489,0.00007113555,0.00003641337,0.00087535416],"genre_scores_gemma":[0.011924215,0.9861529,0.00012591829,0.00006791865,0.0003858841,0.00029161735,0.000038397506,0.00010939102,0.00090379704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675477,0.00033867077,0.0010081385,0.0008823516,0.00045434298,0.0005617152],"domain_scores_gemma":[0.9983894,0.00011960846,0.0005527524,0.00067519397,0.0001260714,0.00013695605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031463182,0.0006388455,0.002291425,0.00038468736,0.00013238315,0.000025095458,0.00020592411,0.000279162,0.00011847049],"category_scores_gemma":[0.0001227337,0.00044227054,0.00029690185,0.0006163481,0.00027214512,0.00011466953,0.00014376649,0.0013278509,0.0000034150773],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014273282,0.0001262448,0.00014038444,0.002445216,0.0009483467,0.00028851154,0.00027509834,0.000008476286,0.0005666339,0.00023378571,0.0003186507,0.99450594],"study_design_scores_gemma":[0.0036682463,0.0002917188,0.008620067,0.0058079753,0.004289405,0.0030778837,0.000092292365,0.000049629823,0.000009237321,0.00023403951,0.97331715,0.00054235547],"about_ca_topic_score_codex":0.0021133334,"about_ca_topic_score_gemma":0.000032424105,"teacher_disagreement_score":0.99396354,"about_ca_system_score_codex":0.0002808335,"about_ca_system_score_gemma":0.0006090778,"threshold_uncertainty_score":0.9998029},"labels":[],"label_agreement":null},{"id":"W2132323473","doi":"10.1677/erc-09-0004","title":"Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Glucagon; Transfection; Cell culture; Pancreas; Biology; Ornithine decarboxylase antizyme; Cell; Molecular biology; Internal medicine; Chemistry; Ornithine decarboxylase; Insulin; Cell biology; Endocrinology; Biochemistry; Enzyme; Medicine","score_opus":0.01041442938834292,"score_gpt":0.27019991322642867,"score_spread":0.25978548383808575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132323473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286056,0.003101027,0.00008066526,0.0012626704,0.0007119138,0.00068873307,0.0000426175,0.00012229066,0.0011295094],"genre_scores_gemma":[0.99181014,0.00096545316,0.0005578219,0.0012597588,0.00013478441,0.000032949858,0.00007863365,0.00003374526,0.0051267142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983968,0.00003546952,0.0005100898,0.00042320427,0.00025111806,0.00038331142],"domain_scores_gemma":[0.9989035,0.00011555281,0.0002375242,0.00038185224,0.000191659,0.00016988092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009312335,0.00025259043,0.00064782036,0.00018164684,0.00008241948,0.000011038918,0.00009171459,0.00007240394,0.0013869477],"category_scores_gemma":[0.00007320303,0.00021108329,0.00019901691,0.0003672241,0.000059418773,0.00009366167,0.000022361335,0.00019634541,0.000041449275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051330996,0.00024337789,0.0043265577,0.0006476547,0.0002926404,0.000021526517,0.00041410758,0.00004444047,0.9647674,0.000031662614,0.02688066,0.0018166909],"study_design_scores_gemma":[0.0048345528,0.0005598238,0.005061129,0.0005809901,0.00066048116,0.0000114068425,0.000119139884,0.0020238091,0.9799063,0.00015981129,0.0058679027,0.0002146528],"about_ca_topic_score_codex":0.00034393673,"about_ca_topic_score_gemma":0.0000010275304,"teacher_disagreement_score":0.021012757,"about_ca_system_score_codex":0.00011692236,"about_ca_system_score_gemma":0.00012993449,"threshold_uncertainty_score":0.9995259},"labels":[],"label_agreement":null},{"id":"W2135141157","doi":"10.1530/erc-14-0096","title":"Intratumoural inflammation and endocrine resistance in breast cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Victoria General Hospital; University of British Columbia; BC Cancer Agency; University of Manitoba; CancerCare Manitoba","funders":"BC Cancer Agency; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; BC Cancer Foundation; CancerCare Manitoba Foundation; Cancer Research Institute","keywords":"Endocrine system; Breast cancer; Inflammation; Medicine; Estrogen receptor alpha; Estrogen receptor; Biomarker; Cancer; Estrogen; Oncology; Internal medicine; Cancer research; Biology; Hormone","score_opus":0.006683266483683017,"score_gpt":0.29257938735187233,"score_spread":0.28589612086818933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135141157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045902045,0.9928806,0.0000021768763,0.00034140178,0.0004547336,0.0006727214,0.00010031488,0.000036580015,0.0009212857],"genre_scores_gemma":[0.0021715926,0.9930724,0.00003244649,0.000026733926,0.00061061926,0.00048445916,0.0003317919,0.000107635264,0.0031623377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752355,0.00025138006,0.0007362499,0.00074749015,0.00017797196,0.00056337786],"domain_scores_gemma":[0.99894434,0.000034284465,0.00039078612,0.00040776006,0.00006803721,0.00015476157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014674943,0.0005887728,0.0010890187,0.00019659675,0.00007419644,0.000039662384,0.00023907771,0.00044522894,0.000077108154],"category_scores_gemma":[0.00003448871,0.00049135595,0.00024303637,0.0003702815,0.00011279277,0.000011096133,0.00015287286,0.00083686167,0.000019335757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019072322,0.00006333575,0.00039299566,0.010894081,0.0010508557,0.00022877849,0.000048926875,0.00005203149,0.0017792385,0.0010745592,0.005795983,0.9784285],"study_design_scores_gemma":[0.0010181214,0.00004921927,0.00008370733,0.0067328378,0.00043612442,0.00036853095,0.000003110126,0.00001568519,0.00049930473,0.00006163912,0.9900891,0.0006425894],"about_ca_topic_score_codex":0.00018434142,"about_ca_topic_score_gemma":0.00028268987,"teacher_disagreement_score":0.98429316,"about_ca_system_score_codex":0.00015187403,"about_ca_system_score_gemma":0.0003023399,"threshold_uncertainty_score":0.99975383},"labels":[],"label_agreement":null},{"id":"W2136453695","doi":"10.1677/erc.1.01033","title":"Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Protein kinase C; Endocrinology; MAPK/ERK pathway; Internal medicine; Ovarian cancer; Gonadotropin-releasing hormone receptor; Gonadotropin-releasing hormone; Kinase; Cell growth; Biology; Signal transduction; Protein kinase A; Cancer research; Chemistry; Cell biology; Hormone; Cancer; Medicine; Luteinizing hormone; Biochemistry","score_opus":0.005134026798583379,"score_gpt":0.2058889019849654,"score_spread":0.20075487518638202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136453695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810644,0.015090136,0.00001245464,0.0017378677,0.00012033928,0.0012660855,0.00004473493,0.000027887008,0.000636132],"genre_scores_gemma":[0.9975348,0.0012105104,0.00025915066,0.000025414673,0.00013290135,0.00015386763,0.0000074707004,0.000047305817,0.00062859163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818796,0.00011818728,0.0005650214,0.0004811523,0.0003144251,0.00033327704],"domain_scores_gemma":[0.99902093,0.0000314477,0.00036666554,0.00030926775,0.00019867186,0.00007301861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013868707,0.00026206532,0.0005216039,0.00019182489,0.00007926256,0.000007676849,0.00006155731,0.00011805243,0.00005354235],"category_scores_gemma":[0.00005901233,0.00020590724,0.000081157305,0.00042345357,0.00012370893,0.00012048448,0.00010784813,0.00041199,0.0000010059376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028074297,0.00019232217,0.0012121511,0.00014958392,0.000052555824,0.000019090905,0.00030284887,0.00001851574,0.99300843,0.0015095889,0.000043779375,0.003210412],"study_design_scores_gemma":[0.0047312733,0.0002927876,0.029085008,0.0004564289,0.0001168714,0.000028701657,0.00012088911,0.00015866262,0.9629056,0.0015498808,0.00035817243,0.00019571128],"about_ca_topic_score_codex":0.011559595,"about_ca_topic_score_gemma":0.00022722119,"teacher_disagreement_score":0.030102797,"about_ca_system_score_codex":0.00021134822,"about_ca_system_score_gemma":0.00020599511,"threshold_uncertainty_score":0.99502254},"labels":[],"label_agreement":null},{"id":"W2139143788","doi":"10.1677/erc-10-0091","title":"Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncosuisse; McGill University; Novartis Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Cancer Institute; National Science Foundation","keywords":"PI3K/AKT/mTOR pathway; Hyperinsulinemia; Mammary tumor; Endocrinology; Internal medicine; Insulin; Tumor progression; Cancer research; Type 2 diabetes; Biology; Cancer; Medicine; Diabetes mellitus; Breast cancer; Insulin resistance; Signal transduction; Cell biology","score_opus":0.0046876117734836725,"score_gpt":0.26061239493935145,"score_spread":0.2559247831658678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139143788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904397,0.0075333808,0.000006578549,0.00032906278,0.0008380268,0.00028732282,0.000048904472,0.00004047137,0.0004765162],"genre_scores_gemma":[0.9973386,0.0007819567,0.00080875185,0.00012971275,0.00019846017,0.00010318293,0.0003599123,0.00004704236,0.00023239486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984806,0.00007136349,0.00043413803,0.000420404,0.00019500601,0.00039845778],"domain_scores_gemma":[0.9991294,0.000025256497,0.00022150336,0.00036032437,0.00016500377,0.00009847144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000174142,0.00022774773,0.00025554287,0.0001347525,0.00003661939,0.000013289826,0.00019572634,0.00018724754,0.00030185835],"category_scores_gemma":[0.00018858687,0.00021454615,0.00007624079,0.00040837433,0.000116457035,0.00001569768,0.000113547954,0.0004290294,0.000013805129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011984402,0.00009393533,0.05396788,0.000061685634,0.000050920342,0.00002740704,0.000033877204,0.00014670375,0.9416285,0.000030468787,0.0011569122,0.0026818595],"study_design_scores_gemma":[0.0014550632,0.00028537516,0.008776864,0.00015382528,0.000016677097,0.0000118494245,0.0000097577695,0.00021714429,0.9697087,0.00018570028,0.018912567,0.0002664941],"about_ca_topic_score_codex":0.000063362735,"about_ca_topic_score_gemma":0.0000936083,"teacher_disagreement_score":0.045191016,"about_ca_system_score_codex":0.000039010483,"about_ca_system_score_gemma":0.00021186251,"threshold_uncertainty_score":0.87489384},"labels":[],"label_agreement":null},{"id":"W2139242212","doi":"10.1677/erc-08-0056","title":"Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre hospitalier universitaire de Québec; Université Laval; Hôpital Saint-François d'Assise","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Cancer Research Society","keywords":"FokI; Calcitriol receptor; Breast cancer; Odds ratio; Medicine; Oncology; Internal medicine; Vitamin D and neurology; Case-control study; Single-nucleotide polymorphism; Population; Genotype; Confidence interval; Gynecology; Cancer; Gastroenterology; Genetics; Biology; Polymorphism (computer science); Gene","score_opus":0.01626375204889504,"score_gpt":0.3246845836374833,"score_spread":0.3084208315885883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139242212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726982,0.015028963,0.0000024653846,0.010297402,0.0004047709,0.0009090837,0.00039815143,0.00008264745,0.00017831293],"genre_scores_gemma":[0.9816328,0.013162586,0.00011578002,0.00019088351,0.00027107005,0.000547181,0.000053525913,0.000044476456,0.0039816573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974496,0.00022891787,0.00058794586,0.0006314411,0.0004583345,0.000643773],"domain_scores_gemma":[0.9983539,0.00020757817,0.0003484149,0.00038749506,0.00040993455,0.0002926833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005668522,0.0002810579,0.0005700208,0.00047101252,0.00042083368,0.000015978092,0.00006970064,0.000108556014,0.00023119006],"category_scores_gemma":[0.0010778464,0.0002495419,0.00006793979,0.00073637394,0.00011467949,0.00021731282,0.000042500156,0.0007008275,0.000015510363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005342216,0.00004376194,0.9789523,0.000044838343,0.0007053199,0.00063869444,0.001728381,0.0004373009,0.00044326953,0.000014887863,0.005951456,0.010986386],"study_design_scores_gemma":[0.0049035954,0.000070360235,0.99039865,0.00028588568,0.00027205248,0.0013808534,0.0002928023,0.0014108543,0.00026392247,0.000048687474,0.00041441343,0.0002579485],"about_ca_topic_score_codex":0.74552387,"about_ca_topic_score_gemma":0.60338455,"teacher_disagreement_score":0.14213936,"about_ca_system_score_codex":0.004174232,"about_ca_system_score_gemma":0.0004026906,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2139923838","doi":"10.1677/erc.1.01141","title":"Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?","year":2006,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Strong; CancerCare Manitoba Foundation; U.S. Department of Defense","keywords":"BETA (programming language); Breast cancer; Estrogen receptor alpha; Estrogen receptor beta; Endocrine system; Alpha (finance); Internal medicine; Estrogen receptor; Oncology; Oestrogen receptor; Medicine; Endocrinology; Human breast; Receptor; Cancer; Cancer research; Hormone","score_opus":0.016644800811905468,"score_gpt":0.33738130206538414,"score_spread":0.3207365012534787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139923838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036455415,0.96003723,8.1938094e-7,0.000088290624,0.00047599332,0.0012562633,0.0012505456,0.000042056163,0.00039337072],"genre_scores_gemma":[0.0024981606,0.9915326,0.000017697237,0.000033681357,0.00049425766,0.0008009297,0.0011323754,0.00020462724,0.0032856532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961954,0.00044521352,0.0012361606,0.0010138361,0.00034051778,0.0007689127],"domain_scores_gemma":[0.9980569,0.00004456162,0.00075495004,0.0008103666,0.0001705273,0.00016272243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001703513,0.0008563473,0.0017761725,0.00037307423,0.000086170556,0.0000198638,0.0005839046,0.0007043097,0.00041901795],"category_scores_gemma":[0.000018760455,0.0007122461,0.0008279502,0.0007429847,0.00019104185,0.000009804742,0.00019143579,0.0008917992,0.000015046667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093642174,0.0009647369,0.004622821,0.009208887,0.005727287,0.000369825,0.00010002283,0.00024619038,0.04046207,0.00014639918,0.026349166,0.9108662],"study_design_scores_gemma":[0.0024099424,0.0003326688,0.0001859334,0.006168222,0.00046839906,0.0002709179,0.000005202244,0.0000030146484,0.01474102,0.00001545795,0.9746244,0.00077482825],"about_ca_topic_score_codex":0.0013333249,"about_ca_topic_score_gemma":0.00005263816,"teacher_disagreement_score":0.9482752,"about_ca_system_score_codex":0.00024200408,"about_ca_system_score_gemma":0.00087005907,"threshold_uncertainty_score":0.9995329},"labels":[],"label_agreement":null},{"id":"W2140724756","doi":"10.1677/erc-10-0030","title":"A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; CancerCare Manitoba Foundation","keywords":"Breast cancer; Tamoxifen; Oncology; Medicine; Internal medicine; Hazard ratio; Univariate analysis; Estrogen receptor; Multivariate analysis; Oestrogen receptor; Tissue microarray; Cancer; Confidence interval","score_opus":0.01599316687746645,"score_gpt":0.34936681173430245,"score_spread":0.333373644856836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140724756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108154,0.002867677,0.00007561057,0.0021263782,0.0019950313,0.0011905667,0.00040484272,0.000060052113,0.00019832395],"genre_scores_gemma":[0.9886509,0.005888188,0.0009608391,0.00059090764,0.00088293984,0.0009284849,0.00021866018,0.000100469886,0.0017786224],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777377,0.000072160656,0.00068743096,0.0006838181,0.00018081095,0.00060201203],"domain_scores_gemma":[0.99892354,0.000057043842,0.0001633753,0.0004312,0.00015170377,0.0002731549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028076998,0.00032274533,0.0003765693,0.000102643535,0.00008107375,0.000023490631,0.00027570187,0.000320559,0.00027097095],"category_scores_gemma":[0.00010744519,0.0002811046,0.00023986446,0.0002765792,0.00008452343,0.0000119942015,0.00008626997,0.0006393829,0.000031222764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023010622,0.00032373925,0.42597345,0.000028217235,0.00043986714,0.000018708273,0.000068508336,0.0009890551,0.46996757,0.00013454909,0.012724795,0.08703046],"study_design_scores_gemma":[0.017760163,0.001610157,0.10856159,0.00016404403,0.00015501502,0.00018640359,0.000032764754,0.0008049794,0.3549685,0.0001531794,0.5142969,0.0013062899],"about_ca_topic_score_codex":0.0003934723,"about_ca_topic_score_gemma":0.0004441464,"teacher_disagreement_score":0.50157213,"about_ca_system_score_codex":0.000070418115,"about_ca_system_score_gemma":0.00024096329,"threshold_uncertainty_score":0.9999641},"labels":[],"label_agreement":null},{"id":"W2142338868","doi":"10.1677/erc-07-0126","title":"Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Grading (engineering); Cytology; Medicine; Fine needle aspiration cytology; Pathology; Nuclear medicine; Radiology; Biology","score_opus":0.08607067883810446,"score_gpt":0.4237927335452021,"score_spread":0.3377220547070976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142338868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654824,0.0016179185,0.0001193296,0.0023413457,0.00014736516,0.0016503604,0.00003802839,0.00013699257,0.0074004442],"genre_scores_gemma":[0.9839365,0.0032119201,0.0013807914,0.00037995368,0.00022648438,0.0010575041,0.00013417224,0.000048254453,0.009624407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724513,0.0002709495,0.0006547485,0.0005803043,0.00035498742,0.00089388335],"domain_scores_gemma":[0.9982895,0.00041868945,0.00012524212,0.00039912073,0.00020763137,0.0005597727],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033420962,0.00031996565,0.0010302536,0.0002746574,0.0002313927,0.000011563841,0.00018330889,0.00014353872,0.0017065173],"category_scores_gemma":[0.00082627253,0.00025316357,0.00014470618,0.00042839427,0.00033662602,0.00020062579,0.00006721331,0.0008035491,0.00002696992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014909678,0.00080594694,0.98484445,0.00012982219,0.00029976963,0.0029541026,0.0013430716,0.00007293327,0.0023281244,0.0012077355,0.0023209525,0.0022021506],"study_design_scores_gemma":[0.018313939,0.004274255,0.94329655,0.00056014786,0.0005559036,0.0050080908,0.0007856558,0.01320777,0.0037318736,0.0016353056,0.00790017,0.00073036464],"about_ca_topic_score_codex":0.0012608613,"about_ca_topic_score_gemma":0.00023038269,"teacher_disagreement_score":0.0415479,"about_ca_system_score_codex":0.0004893416,"about_ca_system_score_gemma":0.0009617016,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W2143541838","doi":"10.1677/erc.1.00896","title":"Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells","year":2005,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Epidermal growth factor; Endocrinology; Biology; Kinase; Internal medicine; Epidermal growth factor receptor; Cell culture; LY294002; Protein kinase A; Growth factor; Luteinizing hormone; Receptor; Cell biology; Cancer research; Hormone; Phosphatidylinositol; Medicine","score_opus":0.015184780583373232,"score_gpt":0.2784467402773903,"score_spread":0.26326195969401706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143541838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851539,0.0020214631,0.000012493756,0.010614781,0.00023249447,0.0015437034,0.00015299463,0.00006315736,0.00020502595],"genre_scores_gemma":[0.9965638,0.001342434,0.00053257233,0.00018937101,0.00020676565,0.0001920183,0.000060414943,0.000058602407,0.00085404876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979739,0.00014479384,0.0006133795,0.00050068804,0.00032061498,0.00044658154],"domain_scores_gemma":[0.9989624,0.000102564685,0.00031746938,0.00036553305,0.00013429564,0.00011772972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007399074,0.00035606252,0.0005418016,0.00008170392,0.00014610282,0.000024816709,0.00011502708,0.00012310613,0.00081043283],"category_scores_gemma":[0.000038559545,0.0002608861,0.00012086394,0.00044119015,0.00015161124,0.00029272103,0.000057265588,0.00037182786,0.000009469981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007214567,0.0007379614,0.021005735,0.00019696465,0.0005797294,0.00003932837,0.0015420433,0.00055268174,0.96354795,0.0014448088,0.001031879,0.008599454],"study_design_scores_gemma":[0.005546248,0.0002900687,0.060341228,0.00053738937,0.0001217356,0.000009806881,0.000055390512,0.00008698939,0.92372185,0.0000943732,0.008957184,0.00023770808],"about_ca_topic_score_codex":0.007972294,"about_ca_topic_score_gemma":0.00019013182,"teacher_disagreement_score":0.03982608,"about_ca_system_score_codex":0.00048200134,"about_ca_system_score_gemma":0.0001779753,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W2144160519","doi":"10.1530/erc-10-0303","title":"Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Dalhousie University; University of British Columbia; Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Canada Research Chairs; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Alberta Cancer Foundation","keywords":"Medicine; Adiponectin; IGFBP3; Adipokine; Insulin resistance; Leptin; Internal medicine; Aerobic exercise; Endocrinology; Homeostatic model assessment; Breast cancer; Insulin; Randomized controlled trial; Confidence interval; Cancer; Obesity; Receptor","score_opus":0.013378768863917452,"score_gpt":0.2516330503033222,"score_spread":0.23825428143940477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144160519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875755,0.009563941,1.2849488e-7,0.00025414213,0.00017785489,0.00089305936,0.0000126962295,0.000030057148,0.0014926693],"genre_scores_gemma":[0.9878732,0.011071229,0.00006185793,0.000051802657,0.00004362376,0.00029693448,0.000015199439,0.000038471182,0.0005476779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812114,0.00007347285,0.000662415,0.00039071345,0.00023253083,0.0005197251],"domain_scores_gemma":[0.9993291,0.000041803294,0.00018640106,0.00025858555,0.000035150053,0.00014895729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002572947,0.00024076574,0.00067552883,0.0010369794,0.000015877436,0.0000050095005,0.00011534444,0.00016016317,0.0002365487],"category_scores_gemma":[0.0000976133,0.00022163229,0.00003193888,0.0012935485,0.0001073094,0.0001270496,0.000064522865,0.00051852054,0.0000053245376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064791195,0.0014861535,0.8962331,0.00063732255,0.00014915987,0.0011382999,0.014491443,0.000002795109,0.004329888,0.00035180044,0.00031189225,0.016076986],"study_design_scores_gemma":[0.06415991,0.0010186862,0.922647,0.0014015343,0.00006072751,0.000012885472,0.00050657964,0.0000058285978,0.0087515125,0.00028482318,0.000830573,0.00031995383],"about_ca_topic_score_codex":0.0015968757,"about_ca_topic_score_gemma":0.002474971,"teacher_disagreement_score":0.026413927,"about_ca_system_score_codex":0.00026428045,"about_ca_system_score_gemma":0.00016676255,"threshold_uncertainty_score":0.90379024},"labels":[],"label_agreement":null},{"id":"W2144184261","doi":"10.1530/erc-12-0003","title":"Epigenetic modification and cancer: mark or stamp?","year":2012,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenetics; Cancer; Biology; Genetics; Computational biology; Gene","score_opus":0.023702000307412367,"score_gpt":0.308320928211024,"score_spread":0.28461892790361165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144184261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14420721,0.6012693,0.0005839561,0.24416614,0.003750905,0.0017294041,0.00080815743,0.0001169613,0.003367954],"genre_scores_gemma":[0.14246653,0.59961164,0.0008422888,0.10576436,0.015759178,0.001655072,0.005620449,0.0005969028,0.12768357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980269,0.00012703784,0.0004113065,0.0006445141,0.00024252913,0.0005477311],"domain_scores_gemma":[0.99892545,0.000028932784,0.00028343796,0.00052441965,0.00012737789,0.00011035595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011188648,0.0003981835,0.00032399793,0.00009901639,0.00010269086,0.00003897207,0.00019529132,0.0006911686,0.00053847086],"category_scores_gemma":[0.00004076381,0.0003484882,0.00009994586,0.00013972801,0.00009267126,0.0000054999605,0.000113434166,0.00068703725,0.000018672908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001576114,0.00005593768,0.0048190574,0.00043863032,0.00072994514,0.000055553926,0.00009714077,0.00044535188,0.10419359,0.000016292643,0.7707221,0.11826882],"study_design_scores_gemma":[0.0005016053,0.0000965746,0.0010152917,0.0000611885,0.00019326608,0.000011640699,0.0000042315182,0.000053317635,0.040936287,0.00007421528,0.95658904,0.0004633206],"about_ca_topic_score_codex":0.0004990303,"about_ca_topic_score_gemma":0.00009990205,"teacher_disagreement_score":0.185867,"about_ca_system_score_codex":0.00008057867,"about_ca_system_score_gemma":0.00020758739,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W2144500191","doi":"10.1677/erc-08-0038","title":"Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Hyperinsulinemia; Internal medicine; Endocrinology; Medicine; Cancer; Insulin resistance; Insulin; AMPK; Lewis lung carcinoma; Biology; Kinase; Protein kinase A; Metastasis","score_opus":0.005693660719074212,"score_gpt":0.2290040648496136,"score_spread":0.2233104041305394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144500191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8667129,0.13208863,0.000004994256,0.000052424384,0.0003169758,0.00015426314,0.000035818088,0.000011109444,0.00062287744],"genre_scores_gemma":[0.95916426,0.039451726,0.00000771052,0.00020353995,0.0002012714,0.00015026038,0.000026628302,0.000035756213,0.00075883075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863017,0.00015749459,0.00030529508,0.00035114365,0.00020072065,0.0003551564],"domain_scores_gemma":[0.9992944,0.0000614317,0.00012939765,0.00038607375,0.000063767344,0.000064940636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013678329,0.00024114031,0.0003513759,0.000077802615,0.00006768905,0.0000044401077,0.00023068793,0.000106579486,0.00015717212],"category_scores_gemma":[0.00006669764,0.00016320297,0.00014123463,0.00022663055,0.0001365273,0.0000060181355,0.000071481816,0.00017946218,0.000004610748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010588956,0.0009708533,0.33994445,0.00071826344,0.0029136026,0.00047323765,0.0011466242,0.013193093,0.34778103,0.014032135,0.09117086,0.1770669],"study_design_scores_gemma":[0.0029818465,0.00097876,0.007091015,0.000050822742,0.00008348694,0.000020317375,0.000014401643,0.00008431633,0.9236903,0.00017168923,0.06454122,0.0002918332],"about_ca_topic_score_codex":0.0017954049,"about_ca_topic_score_gemma":0.00012968156,"teacher_disagreement_score":0.57590926,"about_ca_system_score_codex":0.000043783133,"about_ca_system_score_gemma":0.00009232651,"threshold_uncertainty_score":0.66552246},"labels":[],"label_agreement":null},{"id":"W2144800090","doi":"10.1677/erc-08-0012","title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update","year":2008,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Jarislowsky Foundation","keywords":"Cancer research; Securin; Biology; Endocrine system; Pituitary tumors; Thyroid; Angiogenesis; Prostate cancer; Cancer; Pathology; Cell cycle; Internal medicine; Medicine; Endocrinology; Hormone","score_opus":0.020814743753227685,"score_gpt":0.32416638355487176,"score_spread":0.3033516398016441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144800090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048890925,0.99476975,7.659351e-7,0.00041650867,0.000119208395,0.002127776,0.0001940861,0.00007411486,0.0018088566],"genre_scores_gemma":[0.00007147621,0.99689466,0.00010168699,0.0010736778,0.00007131269,0.0005161801,0.00023813079,0.00012238373,0.000910501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973484,0.00009065091,0.0009390086,0.00076627947,0.00022676343,0.00062886364],"domain_scores_gemma":[0.9990104,0.000065198496,0.00022381506,0.00038718595,0.000031912536,0.0002815313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006765756,0.0007539742,0.0028335247,0.0003333532,0.00008538143,0.000011617361,0.000101223515,0.00010523124,0.00045418786],"category_scores_gemma":[0.000028722841,0.00055119727,0.0002927986,0.0004990292,0.00011323269,0.00011981471,0.00007878264,0.0007217571,0.000040518804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052629144,0.00023191758,0.0021085904,0.046778064,0.0014423693,0.0072714044,0.000061728,6.1971986e-7,5.547585e-7,0.00005969007,0.0023891819,0.93960327],"study_design_scores_gemma":[0.00317618,0.00012530888,0.000068443536,0.038502913,0.0033150192,0.015565587,0.0000050942376,0.0000031499203,0.0000020970801,0.00004146229,0.9387254,0.00046934662],"about_ca_topic_score_codex":0.0009927668,"about_ca_topic_score_gemma":0.00017002513,"teacher_disagreement_score":0.9391339,"about_ca_system_score_codex":0.00017400311,"about_ca_system_score_gemma":0.00032618022,"threshold_uncertainty_score":0.99969393},"labels":[],"label_agreement":null},{"id":"W2148311665","doi":"10.1677/erc-09-0002","title":"Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Thyroid cancer; Tissue microarray; Immunohistochemistry; Pathology; Cancer; Thyroid; Cancer research; Biology; Thyroid carcinoma; Medicine; Cytoplasm; Internal medicine","score_opus":0.009335676480627069,"score_gpt":0.2792343146878075,"score_spread":0.26989863820718046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148311665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610046,0.036905542,0.0000010376917,0.00053966034,0.00028857656,0.0003970006,0.00008296771,0.00006338684,0.0007172156],"genre_scores_gemma":[0.9908173,0.0017557704,0.000003801901,0.000114591436,0.000009071274,0.00003719098,0.000048150247,0.000027411998,0.007186714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821883,0.00041256397,0.00054631045,0.00027250868,0.00012928099,0.00042051967],"domain_scores_gemma":[0.99851465,0.00008561075,0.0007698641,0.0004088194,0.00020551692,0.000015552921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017592208,0.0002594692,0.0005241422,0.0001029116,0.0002723694,0.00000617171,0.00037235435,0.0002512193,0.0013170199],"category_scores_gemma":[0.00006805198,0.00015593685,0.0001811112,0.00048860186,0.00027523245,0.00009794818,0.00005788029,0.000461241,0.000005374882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006126562,0.00033892965,0.018246204,0.00000903143,0.00058274827,0.0000035363937,0.0009104508,0.000019417243,0.9724042,0.00004790934,0.002381623,0.004443302],"study_design_scores_gemma":[0.0033012407,0.00073411135,0.10971091,0.0011421585,0.000103480226,0.0000099292365,0.000058955673,0.0000018007806,0.8822874,0.000060780334,0.0024010655,0.00018818447],"about_ca_topic_score_codex":0.00047657063,"about_ca_topic_score_gemma":0.000049083017,"teacher_disagreement_score":0.091464706,"about_ca_system_score_codex":0.00011502233,"about_ca_system_score_gemma":0.00017550439,"threshold_uncertainty_score":0.99959594},"labels":[],"label_agreement":null},{"id":"W2148665009","doi":"10.1677/erc.1.01149","title":"Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Breast cancer; Insulin-like growth factor-binding protein; Insulin-like growth factor; Growth hormone; Growth factor; Internal medicine; Medicine; Hormone; Oncology; Cancer; Endocrinology; Receptor","score_opus":0.011655934283273857,"score_gpt":0.2753151585177875,"score_spread":0.2636592242345136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148665009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479745,0.04314636,0.000002532701,0.004956249,0.0002762124,0.002822006,0.0003496223,0.00013504544,0.00033744922],"genre_scores_gemma":[0.96334463,0.03487433,0.000031869953,0.00040190612,0.00027243837,0.0004179487,0.000038890266,0.00009155534,0.00052645116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617827,0.00032309233,0.000935255,0.0009512949,0.0006414804,0.0009706002],"domain_scores_gemma":[0.99852645,0.00014791098,0.00041517834,0.00036150435,0.00019298446,0.00035594625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042181337,0.0006528274,0.000939211,0.00051195076,0.00064467447,0.000098845034,0.00018885193,0.0001757774,0.000057643883],"category_scores_gemma":[0.00009286737,0.0004671801,0.000085388165,0.001095434,0.00023751003,0.00044415126,0.00018390946,0.0012779677,0.0000049823357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059077103,0.00094499043,0.97889525,0.00025650839,0.00034615962,0.00020181258,0.006187837,0.0000045462484,0.0017098848,0.00032895894,0.0024293675,0.008103907],"study_design_scores_gemma":[0.008751936,0.0014299217,0.9850881,0.0002850238,0.00028553169,0.0004130027,0.001288461,0.0001051092,0.00047332325,0.00019273892,0.0011676246,0.0005192125],"about_ca_topic_score_codex":0.036413454,"about_ca_topic_score_gemma":0.0016461259,"teacher_disagreement_score":0.034767326,"about_ca_system_score_codex":0.00032268948,"about_ca_system_score_gemma":0.00028514577,"threshold_uncertainty_score":0.999778},"labels":[],"label_agreement":null},{"id":"W2149440394","doi":"10.1530/erc-10-0162","title":"A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer","year":2011,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Aromatase; Adjuvant; Breast cancer; Oncology; Adjuvant therapy; Internal medicine; Disease; Aromatase inhibitor; Postmenopausal women; Hormone therapy; Medical prescription; Cancer; Gynecology; Pharmacology","score_opus":0.01308848153215701,"score_gpt":0.32818383722372046,"score_spread":0.31509535569156344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149440394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038003933,0.9590147,4.9156785e-7,0.000031807893,0.0002604127,0.001674981,0.0007401426,0.000008805535,0.00026471374],"genre_scores_gemma":[0.047472388,0.9503081,0.000013378935,0.000016287513,0.00015241293,0.0016804907,0.00016469315,0.0000843276,0.00010792117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998105,0.00026493878,0.0005193668,0.0004292723,0.0003111708,0.00037025128],"domain_scores_gemma":[0.9985254,0.000039836214,0.00045537818,0.00047714118,0.00040402997,0.000098263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675941,0.00038477717,0.0007865392,0.00006891431,0.000058878624,0.000006687252,0.00027320904,0.00033018418,0.00016052264],"category_scores_gemma":[0.00005789697,0.00021863324,0.0002571495,0.00022471148,0.00020280667,0.0000065731774,0.00007818288,0.00029471744,0.0000023433763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007486587,0.00027108478,0.00004820096,0.0016418584,0.0021870947,0.0000027201083,0.00011101365,0.00003019185,0.008550928,0.00017953655,0.000350229,0.98587847],"study_design_scores_gemma":[0.005312429,0.003747068,0.00012477444,0.011509542,0.0058398554,0.0006304592,0.0001010711,0.000040767478,0.0940375,0.00050841767,0.87704617,0.0011019243],"about_ca_topic_score_codex":0.00023878139,"about_ca_topic_score_gemma":0.000009689749,"teacher_disagreement_score":0.98477656,"about_ca_system_score_codex":0.00012362334,"about_ca_system_score_gemma":0.0013202535,"threshold_uncertainty_score":0.8915605},"labels":[],"label_agreement":null},{"id":"W2151378093","doi":"10.1677/erc-10-0073","title":"Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis","year":2010,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pregnancy-related medical research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; China Scholarship Council; University of Texas Health Science Center at Houston; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Prostate cancer; LNCaP; Cancer research; Downregulation and upregulation; Metastasis; Small interfering RNA; Cell growth; Prostate; Medicine; Cancer cell; Cancer; Gene silencing; Androgen receptor; Internal medicine; Endocrinology; Biology; Cell culture; Transfection","score_opus":0.011766659951580157,"score_gpt":0.3315982691057275,"score_spread":0.3198316091541473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151378093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94206053,0.047256537,0.000005975115,0.005459352,0.0007656397,0.0009799948,0.00013175329,0.00015232468,0.0031878625],"genre_scores_gemma":[0.9130534,0.08060701,0.00079524453,0.00012811564,0.00013457774,0.00032313724,0.000054998163,0.0000803894,0.0048231157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732304,0.00010434505,0.00058502256,0.0005473446,0.0007809801,0.0006592713],"domain_scores_gemma":[0.9980609,0.0002673373,0.00019967642,0.0004587663,0.00031017148,0.00070315856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025875273,0.00029139902,0.0006048439,0.00026463348,0.00009369745,0.00001407361,0.00017585649,0.00022071219,0.0051260795],"category_scores_gemma":[0.0018616567,0.00021950538,0.00013052006,0.0006380223,0.00042277842,0.00017891916,0.00017786784,0.0015986022,0.000028170625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015382714,0.00045720255,0.05785741,0.001022464,0.00096650945,0.00028098683,0.0005877896,0.000006791566,0.712206,0.0010561136,0.013562673,0.21045777],"study_design_scores_gemma":[0.009752813,0.00061113125,0.0161462,0.0076579466,0.0008624584,0.00022916088,0.00011583232,0.00027973083,0.91744584,0.00065893354,0.04569705,0.0005428935],"about_ca_topic_score_codex":0.0023951358,"about_ca_topic_score_gemma":0.00010770869,"teacher_disagreement_score":0.20991488,"about_ca_system_score_codex":0.000087649176,"about_ca_system_score_gemma":0.0006456325,"threshold_uncertainty_score":0.9957834},"labels":[],"label_agreement":null},{"id":"W2151995827","doi":"10.1677/erc-10-0070","title":"Clinical significance of estrogen receptor phosphorylation","year":2010,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; Estrogen receptor; Estrogen; Estrogen receptor beta; Chemistry; Cancer research; Cell biology; Medicine; Biology; Internal medicine; Breast cancer; Cancer","score_opus":0.02065479380838157,"score_gpt":0.3631965065155283,"score_spread":0.34254171270714673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151995827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001567053,0.99433196,0.000010204001,0.000016667911,0.0020402516,0.00088412495,0.00011574307,0.000034441095,0.0009995763],"genre_scores_gemma":[0.00013446237,0.9947607,0.00028519903,0.000012849864,0.00077084574,0.00021960273,0.000754447,0.000121520105,0.0029403667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719775,0.00028327698,0.0011885974,0.0007283202,0.0002083312,0.00039375568],"domain_scores_gemma":[0.99804217,0.000074707306,0.00088100333,0.00070314476,0.00012372706,0.00017527795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030115864,0.0004954251,0.0013104584,0.00009070306,0.000056859844,0.000011590537,0.0004004796,0.0012360817,0.00021344618],"category_scores_gemma":[0.00014563701,0.00040810675,0.00097564055,0.00030150785,0.00021115322,0.00000428919,0.00012841684,0.0013080206,0.00010078257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042131,0.000098376855,0.00011331535,0.001296338,0.00081693486,0.00000978077,0.0000048037246,0.000008081462,0.0018933353,0.00009455685,0.0038646022,0.99175775],"study_design_scores_gemma":[0.00046238746,0.0002418455,0.0000040397094,0.0015576682,0.00074768474,0.000040415343,0.00000162813,0.000003888912,0.0040210714,0.000008860447,0.99250245,0.0004080443],"about_ca_topic_score_codex":0.000038989663,"about_ca_topic_score_gemma":0.0000029456903,"teacher_disagreement_score":0.9913497,"about_ca_system_score_codex":0.000041505555,"about_ca_system_score_gemma":0.00067272177,"threshold_uncertainty_score":0.9998371},"labels":[],"label_agreement":null},{"id":"W2154021120","doi":"10.1530/erc-15-0243","title":"Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; University of Calgary; Alberta Health Services","funders":"Alberta Innovates; Canada Research Chairs; Alberta Cancer Foundation; Eli Lilly and Company","keywords":"Medicine; Estrone; Sex hormone-binding globulin; Breast cancer; Randomized controlled trial; Internal medicine; Quartile; Biomarker; Aerobic exercise; Endocrinology; Estrogen; Cancer; Hormone; Androgen; Confidence interval; Biology","score_opus":0.020789948027370313,"score_gpt":0.2969840270326952,"score_spread":0.2761940790053249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154021120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617435,0.00797209,0.0000011404729,0.00016058594,0.00090455165,0.0029694485,0.000015588404,0.00007488895,0.0017273645],"genre_scores_gemma":[0.9951056,0.0025841969,0.00002650657,0.00009059092,0.00014884326,0.0010068959,0.00001416447,0.00004810532,0.000975072],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980082,0.00013352584,0.000608382,0.0003309585,0.0004208469,0.0004981006],"domain_scores_gemma":[0.9988533,0.0002471001,0.0002001916,0.0002851644,0.000089097106,0.0003250991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031344758,0.0002669223,0.0012587806,0.00028427492,0.000019064773,0.0000073266046,0.000088720415,0.00009897558,0.00021452799],"category_scores_gemma":[0.0003086161,0.00020434042,0.00018465116,0.00041517193,0.00010864881,0.00004969522,0.000034799243,0.00039041066,0.000027773174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98273766,0.00085414085,0.0007337107,0.00016760333,0.0003533714,0.0007724129,0.0023725554,0.00018946528,0.0043507176,0.00009910323,0.00031855665,0.007050703],"study_design_scores_gemma":[0.981169,0.0026087854,0.00023100068,0.0004519682,0.0003689501,0.00007175545,0.00010756013,0.000055992958,0.013471024,0.0002540052,0.0009994745,0.00021051228],"about_ca_topic_score_codex":0.0026997218,"about_ca_topic_score_gemma":0.000020954409,"teacher_disagreement_score":0.009120306,"about_ca_system_score_codex":0.000699416,"about_ca_system_score_gemma":0.00048352737,"threshold_uncertainty_score":0.8332761},"labels":[],"label_agreement":null},{"id":"W2156010365","doi":"10.1677/erc-06-0045","title":"Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model","year":2007,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Raloxifene; Tamoxifen; Family history; Gynecology; Risk factor; Oncology; Prospective cohort study; Risk assessment; Menopause; Obstetrics; Cancer; Internal medicine","score_opus":0.08700715479760872,"score_gpt":0.44594959239450804,"score_spread":0.3589424375968993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156010365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022409207,0.9359726,0.025607098,0.00006646201,0.0011829416,0.00560221,0.029126229,0.00012455121,0.00007700265],"genre_scores_gemma":[0.0039197155,0.97298867,0.0204248,0.000011618744,0.00034262848,0.0011173886,0.00068760506,0.00013972202,0.0003678715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964977,0.00005737353,0.0018999373,0.0006540653,0.0003681939,0.00052272715],"domain_scores_gemma":[0.99672866,0.00067255984,0.0011336716,0.00043784187,0.000650729,0.00037653925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032000252,0.00055974786,0.0021645601,0.0003510082,0.00019027713,0.000017031305,0.00011491539,0.00036967878,0.00031256213],"category_scores_gemma":[0.00029000477,0.0004477139,0.00072512456,0.0002690846,0.00011081139,0.00013691679,0.000037913822,0.00069654564,2.7773333e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016348656,0.00030029472,0.001112579,0.009710519,0.0020311421,0.0000014551835,0.00033527083,0.0010879419,0.000020676078,0.00019373327,0.00086856226,0.9841743],"study_design_scores_gemma":[0.01330992,0.00179153,0.005695763,0.023825277,0.038368005,0.00016856917,0.00024155159,0.08414766,0.0006097014,0.0010823628,0.82880926,0.001950416],"about_ca_topic_score_codex":0.0034839336,"about_ca_topic_score_gemma":0.0010841116,"teacher_disagreement_score":0.9822239,"about_ca_system_score_codex":0.001165083,"about_ca_system_score_gemma":0.007083203,"threshold_uncertainty_score":0.99979746},"labels":[],"label_agreement":null},{"id":"W2157523573","doi":"10.1530/erc-12-0211","title":"Case–control study of markers of insulin resistance and endometrial cancer risk","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"Canadian Institutes of Health Research; National Cancer Institute; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Canada Research Chairs","keywords":"Endometrial cancer; Insulin resistance; Medicine; Adiponectin; Internal medicine; Hyperinsulinemia; Leptin; Endocrinology; Population; Homeostatic model assessment; Insulin; Obesity; Cancer","score_opus":0.017544530778491357,"score_gpt":0.30623233527043286,"score_spread":0.28868780449194154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157523573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360561,0.060250968,0.0000047836616,0.0001237601,0.00060012576,0.0011241643,0.00034490804,0.00003144199,0.0014637843],"genre_scores_gemma":[0.9920061,0.006445909,0.00007942612,0.00003348032,0.00029142923,0.00020641525,0.0000036556808,0.00003497237,0.0008986111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979199,0.00020460202,0.0007213005,0.00030556976,0.00042763428,0.0004210031],"domain_scores_gemma":[0.9983289,0.00045971767,0.0004588377,0.00031803976,0.0001692993,0.00026515409],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033319398,0.00024791737,0.00085217727,0.00033318967,0.00006479838,0.0000044471954,0.000072045514,0.00008200629,0.0013051444],"category_scores_gemma":[0.00041993518,0.00019115544,0.00013885922,0.0011321742,0.00010257072,0.00011521341,0.000046592802,0.00032552372,0.0000029003277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012683992,0.0016947938,0.9093435,0.0002854843,0.0037565615,0.00043598027,0.00084019295,0.00004717731,0.00067451864,0.000057756202,0.00029347537,0.06988659],"study_design_scores_gemma":[0.16402923,0.004996752,0.8023622,0.0005821888,0.009456877,0.00060554984,0.0015201767,0.00005820775,0.009130792,0.000108319924,0.006465712,0.00068397186],"about_ca_topic_score_codex":0.0076557836,"about_ca_topic_score_gemma":0.00067806157,"teacher_disagreement_score":0.15134522,"about_ca_system_score_codex":0.00019474623,"about_ca_system_score_gemma":0.00009735467,"threshold_uncertainty_score":0.9996078},"labels":[],"label_agreement":null},{"id":"W2158435543","doi":"10.1530/erc-10-0235","title":"Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Institute of Gender and Health; Canadian Institutes of Health Research; University Health Network; U.S. Department of Defense","keywords":"Luteal phase; Follicular phase; Progesterone receptor; Serous carcinoma; Fallopian tube; Biology; Immunohistochemistry; Internal medicine; Andrology; Endocrinology; Molecular biology; Medicine; Estrogen receptor; Cancer; Ovarian cancer","score_opus":0.02399009151892472,"score_gpt":0.2851806287602314,"score_spread":0.2611905372413067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158435543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072665,0.0052436753,0.000007634246,0.001727768,0.00035093894,0.00095831294,0.00006659721,0.000098238204,0.00082018226],"genre_scores_gemma":[0.9946701,0.002276608,0.0011283006,0.00022144869,0.00013067768,0.0005518302,0.00009043786,0.00006058058,0.0008700219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982379,0.000055638673,0.00043236907,0.0005366492,0.00022714962,0.0005102686],"domain_scores_gemma":[0.99909526,0.00003066545,0.00011924036,0.0003597018,0.00005285824,0.00034228148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007508708,0.00031416802,0.0004824359,0.00017446766,0.000065753055,0.0000143394755,0.00008116014,0.00011620902,0.0012464299],"category_scores_gemma":[0.000017596934,0.00024900975,0.000073498166,0.0002530418,0.00007337876,0.00015093469,0.00005620927,0.0003248757,0.000028015962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029487985,0.004960883,0.86040044,0.00037630586,0.00056600594,0.0022173868,0.0036589347,0.0000076906235,0.020008393,0.0005778427,0.003302576,0.10097476],"study_design_scores_gemma":[0.053579643,0.0027033538,0.7065565,0.0014329669,0.00054647384,0.00040445026,0.00025448648,0.00018359863,0.21725251,0.00020649015,0.016179483,0.00070004445],"about_ca_topic_score_codex":0.005688839,"about_ca_topic_score_gemma":0.0003852336,"teacher_disagreement_score":0.19724411,"about_ca_system_score_codex":0.0003969846,"about_ca_system_score_gemma":0.0001753243,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W2159816324","doi":"10.1677/erc-07-0238","title":"Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway","year":2008,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Child and Family Research Institute","keywords":"Epidermal growth factor; Internal medicine; Endocrinology; Cell biology; Receptor; Protein expression; Epidermal growth factor receptor; Chemistry; Biology; Medicine; Gene; Biochemistry","score_opus":0.01980460408551053,"score_gpt":0.2522318952140281,"score_spread":0.2324272911285176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159816324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828533,0.01348869,0.0000412133,0.00015285198,0.00094678084,0.0015812756,0.00053127215,0.00012893391,0.00027566205],"genre_scores_gemma":[0.98750114,0.00083977456,0.000054861786,0.000018261404,0.000056171008,0.00021093905,0.00037694658,0.00006758994,0.0108743245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635464,0.00091933116,0.0009803543,0.0008603581,0.0001578387,0.0007274913],"domain_scores_gemma":[0.99856234,0.00006590558,0.0005495872,0.00056802377,0.00018151011,0.000072639225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001899608,0.00046500444,0.0007559547,0.00018718465,0.00023152636,0.0000075492035,0.0003266908,0.00036979304,0.003643425],"category_scores_gemma":[0.00005818303,0.00040389155,0.0001491264,0.00038749326,0.00020695238,0.00020679993,0.0001538093,0.0007388239,0.00016912898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024686608,0.00037518836,0.005831554,0.00014650033,0.00023049185,0.00003143947,0.0018341403,0.00013663876,0.9892099,0.000028538168,0.0015868737,0.00034185473],"study_design_scores_gemma":[0.004336165,0.00020888443,0.0045228917,0.00052205776,0.000017267335,0.000025960384,0.000064603046,9.3452536e-7,0.9816804,0.000033300912,0.008163009,0.00042451016],"about_ca_topic_score_codex":0.004434779,"about_ca_topic_score_gemma":0.000112399146,"teacher_disagreement_score":0.012648916,"about_ca_system_score_codex":0.00030750406,"about_ca_system_score_gemma":0.00013831336,"threshold_uncertainty_score":0.9998413},"labels":[],"label_agreement":null},{"id":"W2161615846","doi":"10.1530/erc-13-0165","title":"GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université du Québec","funders":"","keywords":"Enzalutamide; Prostate cancer; Antiandrogen; Blockade; Medicine; Androgen; Bicalutamide; Castration; Oncology; Prostate; Internal medicine; Metastasis; Androgen receptor; Cancer; Endocrinology; Hormone; Receptor","score_opus":0.039029580951642,"score_gpt":0.366636645280232,"score_spread":0.32760706432859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161615846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008321924,0.9866593,2.1182177e-7,0.0010089995,0.00022451676,0.003300819,0.00014900345,0.000045013767,0.00029023932],"genre_scores_gemma":[0.0030102897,0.99091667,0.00003022678,0.000055777353,0.0001186041,0.0011602837,0.00018538606,0.00011308967,0.0044097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966511,0.0006089157,0.0010494067,0.0005997635,0.0004404697,0.0006503023],"domain_scores_gemma":[0.99791497,0.0006527844,0.0005306886,0.00054386875,0.00015648022,0.00020123027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052092003,0.0005658016,0.002772926,0.00037897477,0.00010172422,0.00004942158,0.0001819178,0.0001981379,0.0001774662],"category_scores_gemma":[0.00019042421,0.00031906296,0.00037882084,0.00082887703,0.00058191665,0.000095220115,0.00017608728,0.0010806829,0.0000073395368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033585855,0.00019739622,0.006641437,0.025254246,0.0029404748,0.00053748867,0.00042146994,0.00001631117,0.000018936,0.00017496897,0.00090111495,0.95953757],"study_design_scores_gemma":[0.015025156,0.00020601843,0.00030672993,0.031810638,0.0027340073,0.00037803006,0.0000145952545,0.000093912,0.00010888406,0.000054505137,0.94886845,0.00039908252],"about_ca_topic_score_codex":0.0063709947,"about_ca_topic_score_gemma":0.00023695342,"teacher_disagreement_score":0.9591385,"about_ca_system_score_codex":0.00050775456,"about_ca_system_score_gemma":0.0010687024,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null},{"id":"W2165778677","doi":"10.1677/erc-09-0113","title":"VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo","year":2009,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ferrocene Chemistry and Applications","field":"Chemistry","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Fonds Québécois de la Recherche sur la Nature et les Technologies; Canadian Institutes of Health Research; Cancer Research Society","keywords":"In vivo; Cisplatin; Apoptosis; In vitro; Cancer research; Cancer cell; Breast cancer; Chemistry; Cancer; Biology; Internal medicine; Medicine; Chemotherapy; Biochemistry","score_opus":0.007695355261116825,"score_gpt":0.24644652225702884,"score_spread":0.238751166995912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165778677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98458076,0.0006017758,0.00003732619,0.0018797821,0.000057369856,0.00023355531,0.001045622,0.00023174276,0.011332066],"genre_scores_gemma":[0.9951668,0.0008796206,0.00007745232,0.00007899536,0.0002468189,0.00027839723,0.000030504914,0.000061041654,0.0031803763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975994,0.000013839303,0.00040460806,0.0008360635,0.0003938961,0.00075214537],"domain_scores_gemma":[0.99889916,0.00003142809,0.0002666815,0.00044368856,0.00014058607,0.00021843419],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000057638103,0.0005003296,0.00050109014,0.00007336323,0.00019479345,0.000039668445,0.00035280734,0.00014204557,0.0011606335],"category_scores_gemma":[0.000009325725,0.00046638213,0.00011131057,0.00053508015,0.00008373775,0.0002489604,0.00006220925,0.0010159932,0.000008971667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025219112,0.0005844037,0.0010361349,0.00004939755,0.00014435122,0.000100713136,0.00019480004,0.0049653766,0.98751765,0.000020251995,0.0015134412,0.0036212842],"study_design_scores_gemma":[0.0027822354,0.000049591512,0.011241974,0.00019407275,0.000108439206,0.0004979427,0.00007247914,0.0009860903,0.9824065,0.000058940244,0.0009865462,0.0006151873],"about_ca_topic_score_codex":0.0027385205,"about_ca_topic_score_gemma":0.00016621243,"teacher_disagreement_score":0.010586033,"about_ca_system_score_codex":0.00080693944,"about_ca_system_score_gemma":0.0004858406,"threshold_uncertainty_score":0.9997788},"labels":[],"label_agreement":null},{"id":"W2165922343","doi":"10.1530/erc-15-0038","title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute","keywords":"Gigantism; Somatostatin; Medicine; Acromegaly; Internal medicine; Endocrinology; Gastroenterology; Hypopituitarism; Prolactin; Pathology; Hormone; Growth hormone","score_opus":0.05922207547736815,"score_gpt":0.3823451828277266,"score_spread":0.3231231073503585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165922343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96758723,0.0255553,0.0000025789168,0.0025499465,0.00036665695,0.00039099986,0.000020032268,0.00011074935,0.0034164863],"genre_scores_gemma":[0.9863692,0.002661917,0.00012026726,0.0004221106,0.00005005474,0.00005792996,0.000029327897,0.000026001406,0.010263208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886686,0.00007886736,0.00030191411,0.00029456717,0.00018282619,0.00027497055],"domain_scores_gemma":[0.99929905,0.000068993395,0.00006451748,0.00022555659,0.00006170841,0.000280182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014374564,0.00016024018,0.00034807497,0.000063419626,0.000052021933,0.000011505095,0.000046440564,0.00008497294,0.00028786526],"category_scores_gemma":[0.00008169468,0.000114355826,0.000075470765,0.00015310792,0.000102182756,0.000053415846,0.00003833199,0.00024976247,0.00010699427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015512432,0.0005611916,0.9232949,0.00004411348,0.0009809387,0.0028320476,0.00025934327,0.000004831217,0.00009265612,0.00027745747,0.0049788984,0.06512239],"study_design_scores_gemma":[0.022030655,0.0020320022,0.91717356,0.00020556152,0.0007219792,0.0032995753,0.00018945707,0.00043354125,0.000205038,0.0018186182,0.051543035,0.000346952],"about_ca_topic_score_codex":0.00019550296,"about_ca_topic_score_gemma":0.000013472308,"teacher_disagreement_score":0.06477543,"about_ca_system_score_codex":0.00004681817,"about_ca_system_score_gemma":0.000215307,"threshold_uncertainty_score":0.46632951},"labels":[],"label_agreement":null},{"id":"W2169734442","doi":"10.1530/erc-11-0326","title":"Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer","year":2012,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Manitoba; University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Office of Defense Programs; BC Cancer Foundation; U.S. Department of Defense","keywords":"Oncostatin M; Breast cancer; Cancer research; Signal transduction; Cancer; Estrogen receptor; Internal medicine; Receptor; Cytokine; Biology; Medicine; Endocrinology; Interleukin 6; Cell biology","score_opus":0.023930661185169445,"score_gpt":0.33280238368534665,"score_spread":0.3088717225001772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169734442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937522,0.0021055168,0.0000025691515,0.002152364,0.00023861304,0.0002989161,0.0002751741,0.00008435307,0.0010902864],"genre_scores_gemma":[0.9962942,0.0003635197,0.0000680553,0.00034651687,0.00017885696,0.00013879468,0.000086299566,0.00005102519,0.0024727322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861914,0.000054038377,0.00037402767,0.00026851086,0.00023476988,0.0004495058],"domain_scores_gemma":[0.99928504,0.000070042624,0.0001640537,0.00016743936,0.000107397165,0.00020600684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009066332,0.0002205867,0.00037360436,0.00014451765,0.00010089609,0.000018673209,0.000053592415,0.000079137,0.0048750327],"category_scores_gemma":[0.000046177982,0.00016490046,0.000058330068,0.00026971006,0.000055648845,0.00023910071,0.000039804207,0.00048441542,0.000011852478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018712977,0.00027108248,0.7673839,0.00004200806,0.00017953226,0.000028441655,0.0006805836,0.000030225434,0.22147532,0.00003367912,0.008375717,0.001312379],"study_design_scores_gemma":[0.011209985,0.00043769748,0.54157627,0.0035372232,0.0005176713,0.00048484228,0.00061509165,0.00013214051,0.3991149,0.000024951172,0.041579805,0.000769384],"about_ca_topic_score_codex":0.002515081,"about_ca_topic_score_gemma":0.0001982093,"teacher_disagreement_score":0.2258076,"about_ca_system_score_codex":0.00033946097,"about_ca_system_score_gemma":0.00008443376,"threshold_uncertainty_score":0.9960346},"labels":[],"label_agreement":null},{"id":"W2171347556","doi":"10.1677/erc.0.0100561","title":"Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.","year":2003,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Insulin-like growth factor-binding protein; Prostate cancer; Cancer; Cell growth; Biology; Prostate; Receptor; Apoptosis; PI3K/AKT/mTOR pathway; Growth factor; Endocrinology; Internal medicine; Medicine; Signal transduction; Immunology; Cell biology; Insulin-like growth factor; Biochemistry","score_opus":0.13604043471661362,"score_gpt":0.4208137108266259,"score_spread":0.28477327611001224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171347556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026035812,0.9948113,0.000016885846,0.00057730114,0.0005611322,0.0012058669,0.000022298136,0.000025752155,0.00017588474],"genre_scores_gemma":[0.033950523,0.9646255,0.000025465075,0.00010297505,0.00007434358,0.00026241175,0.000018378438,0.000040145223,0.0009002841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969869,0.0005629692,0.0013492312,0.00048341413,0.00025747652,0.00035997393],"domain_scores_gemma":[0.99847806,0.00025778083,0.0006586331,0.00041345664,0.0000954615,0.00009664138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003703911,0.00040340045,0.0017412859,0.00022861463,0.000060847233,0.000009167959,0.00018925141,0.0003286306,0.00053551525],"category_scores_gemma":[0.00030001573,0.00023668897,0.00080814504,0.0007554262,0.00019877245,0.00009923047,0.000094789095,0.0009751571,0.000005850546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004436364,0.0001399011,0.009304879,0.011852016,0.0005693244,0.000025833142,0.0000461845,0.000037176746,0.00001554141,0.00027258342,0.00058432453,0.9771079],"study_design_scores_gemma":[0.0027848247,0.00059549743,0.06822527,0.16257486,0.0087626865,0.0006759387,0.000033617976,0.00021958933,0.00009221783,0.0009479884,0.7541024,0.0009851299],"about_ca_topic_score_codex":0.0006381271,"about_ca_topic_score_gemma":0.000042401218,"teacher_disagreement_score":0.97612274,"about_ca_system_score_codex":0.00035150914,"about_ca_system_score_gemma":0.00041171105,"threshold_uncertainty_score":0.96518964},"labels":[],"label_agreement":null},{"id":"W2172078107","doi":"10.1530/erc-14-0267","title":"Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Studies on Chitinases and Chitosanases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Queensland Government; Australian Government","keywords":"LNCaP; Prostate cancer; Gene knockdown; Cancer research; Metastasis; Androgen receptor; Angiogenesis; Biology; Prostate; Cancer; Cell culture; Medicine; Internal medicine","score_opus":0.004080062653689674,"score_gpt":0.22755207254140666,"score_spread":0.22347200988771698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172078107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900936,0.008734618,0.0000061057845,0.0005792845,0.00005677583,0.0002328799,0.00012028566,0.00001702295,0.0001594672],"genre_scores_gemma":[0.9849198,0.013945057,0.00007244126,0.00018755918,0.00003681315,0.000050760493,0.0000936127,0.000027457181,0.0006665026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990238,0.000049478276,0.00021615482,0.00036192616,0.00012025244,0.00022838717],"domain_scores_gemma":[0.99941707,0.000028695153,0.00020422235,0.0001376271,0.00014696694,0.00006539754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047562113,0.00019594407,0.00023891953,0.00003625646,0.0000949449,0.000012730126,0.000049325972,0.000074648386,0.000023351666],"category_scores_gemma":[0.000039179315,0.00015829942,0.00003433707,0.00013299272,0.00012880632,0.000009154977,0.00006123137,0.000089705565,3.1062316e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041860706,0.000055324537,0.029031642,0.000062609455,0.00038618318,0.000004520919,0.00022222956,0.00019016549,0.9570556,0.000028847675,0.0012636085,0.011280641],"study_design_scores_gemma":[0.001992617,0.000646995,0.054131776,0.00026485187,0.00011294175,0.000009702463,0.00009075929,0.00019551023,0.9391346,0.000046881825,0.003130041,0.00024329594],"about_ca_topic_score_codex":0.00041410732,"about_ca_topic_score_gemma":0.0014508347,"teacher_disagreement_score":0.025100134,"about_ca_system_score_codex":0.000017962524,"about_ca_system_score_gemma":0.00004154598,"threshold_uncertainty_score":0.64552623},"labels":[],"label_agreement":null},{"id":"W2173456805","doi":"10.1530/erc-15-0460","title":"Functional characterization of multiple DICER1 mutations in an adolescent","year":2015,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; University of Exeter; National Institute of General Medical Sciences; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Characterization (materials science); Genetics; Biology; Computer science; Nanotechnology; Materials science","score_opus":0.03718770911554439,"score_gpt":0.29822312635986026,"score_spread":0.2610354172443159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173456805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6616633,0.0022422122,0.00004763953,0.32921627,0.0018486948,0.0020326755,0.0008087193,0.00019976242,0.0019407094],"genre_scores_gemma":[0.8421962,0.0010963042,0.00014446388,0.109610535,0.004081998,0.0011061606,0.018344795,0.0003105168,0.023108985],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980935,0.00008649654,0.0006424844,0.0003515815,0.00052396255,0.00030197515],"domain_scores_gemma":[0.9988619,0.00006554851,0.00026695075,0.0003068068,0.00041394605,0.00008484926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007903999,0.00027397551,0.00059456076,0.0003624847,0.00002869172,0.000008785653,0.00007696187,0.00025494202,0.0008764765],"category_scores_gemma":[0.00016608354,0.00025616548,0.0001055205,0.0003735426,0.000085810556,0.000112866204,0.000047040652,0.001144398,0.000064286556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057544635,0.0010165768,0.23405099,0.0030341398,0.0016754958,0.0019101221,0.0022976769,0.00026344782,0.023965813,0.000016024038,0.69839597,0.032798264],"study_design_scores_gemma":[0.006028234,0.00023694424,0.47382402,0.0016632003,0.00076801935,0.000114947485,0.00009603115,0.0014196276,0.00070250075,0.0000616368,0.51452416,0.0005606795],"about_ca_topic_score_codex":0.000266142,"about_ca_topic_score_gemma":0.00020999137,"teacher_disagreement_score":0.23977304,"about_ca_system_score_codex":0.00043927986,"about_ca_system_score_gemma":0.0004006182,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W2175151668","doi":"10.1530/erc-15-0386","title":"CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; U.S. Public Health Service; Helse Vest; Hunter Medical Research Institute; National Health and Medical Research Council; Vincent Fairfax Family Foundation; Norges Forskningsråd; Kreftforeningen; Wellcome Trust; Cancer Research UK; Universitetet i Bergen; National Institute for Health and Care Research; Cancer Council Queensland; Haukeland Universitetssjukehus; Fred C. and Katherine B. Andersen Foundation; QIMR Berghofer Medical Research Institute; Francis Crick Institute; Mayo Foundation for Medical Education and Research; Cancer Council Tasmania; National Institutes of Health; Ovarian Cancer Research Fund; Breast Cancer Research Foundation","keywords":"Mendelian randomization; Endometrial cancer; Cancer; Randomization; Gynecology; Medicine; Oncology; Biology; Clinical trial; Internal medicine; Genetics; Gene","score_opus":0.02217251667561125,"score_gpt":0.30153985889802,"score_spread":0.2793673422224087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175151668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212668,0.06990813,0.0013681373,0.0020806654,0.0019365284,0.0014597853,0.00018412978,0.000078231744,0.0017176202],"genre_scores_gemma":[0.9844015,0.007666559,0.000603454,0.00026779872,0.0012208499,0.0005469494,0.00022114685,0.0000752,0.0049964953],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863213,0.00006534749,0.00031877396,0.00044487813,0.00015606706,0.00038281814],"domain_scores_gemma":[0.99924505,0.00004118849,0.00012878337,0.00020457944,0.00014694943,0.00023343315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018749993,0.0002462406,0.0003046992,0.00010961152,0.00010403481,0.000031903495,0.000114298025,0.00020132097,0.00006063567],"category_scores_gemma":[0.00016390966,0.00021511686,0.0001225616,0.0002613014,0.0000715599,0.000010839385,0.00005913657,0.00018233505,0.0000052000432],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009471112,0.0002848808,0.013063154,0.00029975202,0.004785848,0.00012040381,0.0016832147,0.00950144,0.65872735,0.00075607275,0.19248696,0.10881983],"study_design_scores_gemma":[0.057490107,0.0009253306,0.0001454458,0.0001501163,0.00045805864,0.00022625682,0.00013349266,0.00423744,0.3781268,0.00031306164,0.5568234,0.00097054255],"about_ca_topic_score_codex":0.00019880274,"about_ca_topic_score_gemma":0.000022435699,"teacher_disagreement_score":0.36433637,"about_ca_system_score_codex":0.000059803504,"about_ca_system_score_gemma":0.00024582003,"threshold_uncertainty_score":0.8772211},"labels":[],"label_agreement":null},{"id":"W2202874374","doi":"10.1530/erc-15-0045","title":"Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Autotaxin; Mediator; Thyroid cancer; Thyroid; Medicine; Inflammation; Cancer research; Cancer; Internal medicine; Neuroscience; Oncology; Biology; Lysophosphatidic acid; Receptor","score_opus":0.01588283169369096,"score_gpt":0.2840353588239547,"score_spread":0.2681525271302637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202874374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274738,0.071237676,0.000011863447,0.0003726119,0.00044059314,0.00013714247,0.000022086424,0.000023635803,0.0002806308],"genre_scores_gemma":[0.9930748,0.0048232162,0.000102913276,0.00063412613,0.00048054935,0.00009798002,0.000026855867,0.000038631155,0.0007209496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887097,0.00007268832,0.000236455,0.0003571578,0.00014924219,0.00031348213],"domain_scores_gemma":[0.99943334,0.0000060866973,0.00007466351,0.00023213257,0.000064518754,0.0001892783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001741651,0.0001778912,0.00019121767,0.000067271365,0.000035419736,0.000018857694,0.00013092723,0.00011444729,0.00014494764],"category_scores_gemma":[0.000029743276,0.00016167056,0.0000369064,0.00012232157,0.000058030986,0.000010827812,0.00006331789,0.00018096225,0.0000054086836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031463857,0.00010091093,0.15898047,0.000053945114,0.00026370768,0.000046963003,0.0026361565,0.0026652045,0.8165423,0.00032695086,0.004460992,0.0136077525],"study_design_scores_gemma":[0.0072127082,0.0002843753,0.01959767,0.000089631336,0.00010551384,0.000050719733,0.0005698725,0.0028311189,0.529859,0.00092663185,0.4375134,0.000959347],"about_ca_topic_score_codex":0.0005114952,"about_ca_topic_score_gemma":0.00022956898,"teacher_disagreement_score":0.43305242,"about_ca_system_score_codex":0.00003662118,"about_ca_system_score_gemma":0.0002469302,"threshold_uncertainty_score":0.6592734},"labels":[],"label_agreement":null},{"id":"W2231391297","doi":"10.1530/erc-15-0541","title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","year":2016,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Adrenalectomy; Bilateral adrenalectomy; Therapeutic approach; Surgery; Cushing syndrome; Internal medicine; Disease","score_opus":0.04791771087209198,"score_gpt":0.3570622790869505,"score_spread":0.30914456821485853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231391297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017854599,0.9918063,0.0000019964798,0.0018581618,0.00047721024,0.0032334651,0.00049616414,0.000045084482,0.0019030644],"genre_scores_gemma":[0.00020780838,0.99204797,0.00006959191,0.00079273427,0.00022048192,0.0018513938,0.0005314599,0.000085528736,0.0041930364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979284,0.00008705145,0.0006090707,0.0005287039,0.00023596252,0.0006108224],"domain_scores_gemma":[0.99890906,0.00021340369,0.00015023263,0.0005083442,0.00005069396,0.00016825327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069085065,0.00048686258,0.0013190296,0.00027556604,0.00006784646,0.000035270266,0.00022140818,0.00016613277,0.0005945843],"category_scores_gemma":[0.000070069385,0.00023807988,0.0004434235,0.00032633208,0.00002893287,0.000104415776,0.00005090178,0.00035368645,0.00017423635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010407796,0.00018051003,0.0004734223,0.0017309152,0.00063908886,0.00032612027,0.0001956961,4.3607662e-7,3.9563096e-7,0.00014000619,0.016732473,0.97947687],"study_design_scores_gemma":[0.0028847042,0.00021963962,0.00012920299,0.010583349,0.0012239848,0.00029039645,0.000019455354,7.861587e-7,4.6186574e-7,0.000090477406,0.9842724,0.00028510529],"about_ca_topic_score_codex":0.000820857,"about_ca_topic_score_gemma":0.00025414213,"teacher_disagreement_score":0.9791918,"about_ca_system_score_codex":0.00028163832,"about_ca_system_score_gemma":0.00029927885,"threshold_uncertainty_score":0.9708616},"labels":[],"label_agreement":null},{"id":"W2264528830","doi":"10.1530/erc-15-0383","title":"TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"London Health Sciences Foundation; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Cancer research; Epithelial–mesenchymal transition; Spheroid; Ovarian cancer; Metastasis; Mesenchymal stem cell; Cancer cell; Cell migration; Biology; Signal transduction; Cell; Cell biology; Chemistry; Cancer; Cell culture","score_opus":0.03015247300578474,"score_gpt":0.30358537831464427,"score_spread":0.27343290530885955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264528830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808278,0.010563454,0.00011002881,0.0027089948,0.0013013076,0.0006337947,0.000086412096,0.00015317321,0.0036150243],"genre_scores_gemma":[0.99086607,0.0019463917,0.00085751957,0.0003865886,0.0006594223,0.0001912688,0.000031221894,0.000091807364,0.0049696993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972096,0.000102537524,0.00067446526,0.00064652134,0.0005585578,0.00080833596],"domain_scores_gemma":[0.9986145,0.00009331129,0.00019775098,0.00033488398,0.00024028444,0.00051927473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023366061,0.00040129368,0.00076551945,0.00023516036,0.00007387835,0.00003557394,0.00016394502,0.00014750304,0.0033614766],"category_scores_gemma":[0.00018310963,0.00035333147,0.00018926864,0.0008861001,0.00013315724,0.00017745195,0.00009314417,0.0006873421,0.00007061941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031710828,0.0006305457,0.07198491,0.000401855,0.0013140391,0.001723536,0.0028253475,0.033189736,0.821914,0.00043913085,0.010374234,0.052031565],"study_design_scores_gemma":[0.02430451,0.00060895126,0.022987932,0.001771063,0.0010323891,0.00032777822,0.00070420234,0.0031722828,0.85091555,0.0008131404,0.09208425,0.0012779464],"about_ca_topic_score_codex":0.012884575,"about_ca_topic_score_gemma":0.0016260663,"teacher_disagreement_score":0.08171002,"about_ca_system_score_codex":0.0008411564,"about_ca_system_score_gemma":0.0009215643,"threshold_uncertainty_score":0.9998919},"labels":[],"label_agreement":null},{"id":"W2279025682","doi":"10.1530/erc-15-0502","title":"Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Caprion (Canada)","funders":"Conseil Régional d'Alsace; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Ligue Contre le Cancer; Québec Consortium for Drug Discovery","keywords":"RAC1; CDC42; GTPase; Guanine nucleotide exchange factor; Gene knockdown; GTP'; Cell biology; Chemistry; Biology; Biochemistry; Signal transduction; Enzyme; Gene","score_opus":0.0048107735937042715,"score_gpt":0.24989023913491476,"score_spread":0.2450794655412105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279025682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545723,0.0035807574,0.00003747024,0.00038963655,0.00003717782,0.00016940862,0.0000207147,0.000012734852,0.00029486962],"genre_scores_gemma":[0.9915514,0.006865981,0.00005682882,0.000056080975,0.000043844782,0.000033146476,0.000008078529,0.000023410807,0.0013612185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915093,0.000036657988,0.00012873812,0.00040635245,0.000059368984,0.00021792969],"domain_scores_gemma":[0.999639,0.000013227733,0.00007028542,0.00017597832,0.000024653315,0.000076866614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045063098,0.00016990751,0.00016747082,0.000044789165,0.00007724906,0.000015723983,0.000047231006,0.00011143882,0.00004000609],"category_scores_gemma":[0.000009769106,0.00011561019,0.00001749917,0.00005233336,0.00012592784,0.00001267923,0.000102772414,0.00011415667,6.2577703e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001386523,0.000025082947,0.012441532,0.000018555736,0.000038410304,0.0000155197,0.00008329505,8.6638494e-7,0.9713359,0.000022381775,0.00020272179,0.015677124],"study_design_scores_gemma":[0.0026032722,0.00025158073,0.013591942,0.00019186753,0.000029731145,0.00015170156,0.000025733745,0.00003967046,0.9790301,0.00007623808,0.0037561338,0.0002520549],"about_ca_topic_score_codex":0.000114639566,"about_ca_topic_score_gemma":0.00011031024,"teacher_disagreement_score":0.015425068,"about_ca_system_score_codex":0.000019716912,"about_ca_system_score_gemma":0.000027940017,"threshold_uncertainty_score":0.47144467},"labels":[],"label_agreement":null},{"id":"W2291987540","doi":"10.1530/erc-16-0082","title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"Baylor-Hopkins Center for Mendelian Genomics; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; Johns Hopkins University","keywords":"Gigantism; Biology; Comparative genomic hybridization; Genetics; Gene duplication; Loss of heterozygosity; Somatic cell; Cytogenetics; Chromosome; Gene; Allele","score_opus":0.007570864529437352,"score_gpt":0.23462486353359419,"score_spread":0.22705399900415685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291987540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943425,0.0026370268,0.00006269491,0.0010271969,0.00028080272,0.00017471139,0.000040105544,0.00002763366,0.0014072944],"genre_scores_gemma":[0.9820525,0.0015506735,0.000095849726,0.000070277674,0.00006194655,0.00007156957,0.00003973765,0.00003053032,0.016026888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998835,0.00004536028,0.00031929306,0.00031218925,0.00010738165,0.0003807433],"domain_scores_gemma":[0.9994954,0.000016054704,0.00009575771,0.0002936109,0.00003243868,0.0000667215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007259912,0.00018217413,0.0001970577,0.00007597183,0.000058841535,0.000016197175,0.0001668921,0.00011061721,0.0005996669],"category_scores_gemma":[0.000025210666,0.00013913204,0.00007525002,0.00013664918,0.000070726855,0.000011667062,0.00007801928,0.00009405669,0.000077061304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014052108,0.0002800846,0.17599376,0.00017664519,0.0005599428,0.00081553456,0.00063624856,0.00068147824,0.8039025,0.0051337094,0.0016860557,0.009993524],"study_design_scores_gemma":[0.016043577,0.0011078242,0.4196741,0.0011868443,0.0002398997,0.0062792255,0.0010596819,0.00019113334,0.48030362,0.012078406,0.059126362,0.002709347],"about_ca_topic_score_codex":0.00024080272,"about_ca_topic_score_gemma":0.00022493786,"teacher_disagreement_score":0.3235989,"about_ca_system_score_codex":0.0000710842,"about_ca_system_score_gemma":0.00011341061,"threshold_uncertainty_score":0.6565932},"labels":[],"label_agreement":null},{"id":"W2298325430","doi":"10.1530/erc-15-0105","title":"Estrogen regulates luminal progenitor cell differentiation through H19 gene expression","year":2015,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Cancer Society Research Institute; Cure Brain Cancer Foundation; CancerCare Manitoba Foundation; University of Manitoba; Manitoba Health Research Council","keywords":"Progenitor cell; Estrogen receptor; Estrogen; Matrigel; Biology; Progenitor; Estrogen receptor alpha; Signal transduction; Cell biology; Estrogen receptor beta; Cancer research; Cellular differentiation; Endocrinology; Internal medicine; Stem cell; Breast cancer; Cancer; Angiogenesis; Medicine; Gene; Genetics","score_opus":0.010119038642521581,"score_gpt":0.2596078442966456,"score_spread":0.24948880565412399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298325430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97256994,0.024484055,0.0001278229,0.00013424401,0.0008031071,0.0003564054,0.000016956781,0.000070354356,0.0014371139],"genre_scores_gemma":[0.9924107,0.0013376337,0.0009771347,0.000044382003,0.0006710044,0.00012194617,0.0003882563,0.00006448928,0.003984442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844927,0.00010565807,0.00029457046,0.00047858193,0.00025176164,0.00042018757],"domain_scores_gemma":[0.999143,0.0000075914495,0.00015910818,0.00037040497,0.00012541715,0.00019449474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075482145,0.00027785014,0.00020458722,0.00004176537,0.00009850847,0.000027928967,0.00018864844,0.00024793847,0.000048698712],"category_scores_gemma":[0.00002881898,0.00023475807,0.00014092466,0.00015221548,0.00006465812,0.000015973126,0.00012786848,0.00024088124,0.000059007143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020159647,0.00012059113,0.0041358555,0.000021154214,0.0001265103,0.000028441451,0.000119454395,0.0004905461,0.9862433,0.00003730386,0.0077529782,0.0007222481],"study_design_scores_gemma":[0.0017999924,0.00030981662,0.00023666384,0.0000337739,0.000095466625,0.00008087524,0.000043749435,0.0001163482,0.9757624,0.00012076597,0.021107092,0.00029301122],"about_ca_topic_score_codex":0.00006311025,"about_ca_topic_score_gemma":0.0000021958544,"teacher_disagreement_score":0.023146423,"about_ca_system_score_codex":0.000065625005,"about_ca_system_score_gemma":0.00014750594,"threshold_uncertainty_score":0.9573156},"labels":[],"label_agreement":null},{"id":"W2310360756","doi":"10.1530/erc-15-0042","title":"Autophagy in endocrine tumors","year":2015,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Autophagy; Endocrine system; Biology; Context (archaeology); Cancer research; Cancer; Pancreas; Cell biology; Endocrinology; Hormone; Apoptosis; Biochemistry; Genetics","score_opus":0.059445931346016626,"score_gpt":0.42773020507760057,"score_spread":0.36828427373158396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310360756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001738297,0.9857892,5.9293683e-7,0.00014011857,0.0007940229,0.0015710426,0.00009262048,0.0002828478,0.011155728],"genre_scores_gemma":[0.00014318753,0.9770355,0.000034891284,0.00016984293,0.0005188041,0.000793613,0.00039369724,0.00022053889,0.020689892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996257,0.00018844896,0.0013009809,0.00082404143,0.0005562212,0.0008732749],"domain_scores_gemma":[0.99801326,0.00008280121,0.00042272848,0.00086252356,0.00012100704,0.0004976859],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018641858,0.0008296074,0.0033210577,0.00067039917,0.000042700965,0.000020823847,0.0003266562,0.00023261797,0.0036710093],"category_scores_gemma":[0.000080496764,0.00065490283,0.0007535249,0.0011985826,0.00010593518,0.00010227613,0.00012269072,0.0015454348,0.0007265416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066932116,0.00026718553,0.0000372005,0.0074771754,0.0009757163,0.008988553,0.00004877392,0.000007921839,0.0000011544143,0.0003998654,0.0065576853,0.97517186],"study_design_scores_gemma":[0.0027692653,0.00014112111,0.00003685834,0.016878542,0.0017014667,0.0017078057,0.000007833323,0.000018460294,0.000024545307,0.00021419919,0.97595227,0.0005476562],"about_ca_topic_score_codex":0.00035044755,"about_ca_topic_score_gemma":0.000018511824,"teacher_disagreement_score":0.97462416,"about_ca_system_score_codex":0.0010942974,"about_ca_system_score_gemma":0.0022177536,"threshold_uncertainty_score":0.9995902},"labels":[],"label_agreement":null},{"id":"W2313448551","doi":"10.1530/erc-12-0324","title":"Insulin resistance and cancer: the role of insulin and IGFs","year":2012,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Insulin resistance; Insulin; Insulin receptor; Carcinogenesis; Cancer; Biology; Immune system; Cell growth; Cancer research; Bioinformatics; Endocrinology; Immunology; Genetics","score_opus":0.013489286838058426,"score_gpt":0.2885564802797654,"score_spread":0.27506719344170694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313448551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009685813,0.99686176,6.9592255e-7,0.000028605702,0.00039518106,0.00048872293,0.00032998013,0.000012319942,0.0009141561],"genre_scores_gemma":[0.0009226144,0.99640584,0.000025111369,0.00006702746,0.00061326334,0.0004131425,0.0000922078,0.000076793185,0.0013840073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981111,0.0001787041,0.00057663955,0.0005220744,0.00017780981,0.0004336537],"domain_scores_gemma":[0.99874926,0.0000391611,0.00046725533,0.0005203617,0.00008906625,0.000134895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019066271,0.00043664276,0.0009883983,0.000065330336,0.00009048599,0.000020562738,0.00027829187,0.00030266223,0.00014319136],"category_scores_gemma":[0.000040044713,0.00030225643,0.00019037165,0.00022899952,0.0002431328,0.0000075334187,0.00020659021,0.00041954368,0.0000039965557],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022784392,0.00001890184,0.000054106764,0.0018678408,0.0004045608,8.99208e-7,0.000046221285,0.0000010783876,0.000082911836,0.00019855089,0.0006812969,0.99662083],"study_design_scores_gemma":[0.00044421467,0.000025628175,0.000028490871,0.001438957,0.0009305091,0.000012882344,0.000017038354,0.0000011891656,0.00089372596,0.00009262994,0.99577564,0.00033907284],"about_ca_topic_score_codex":0.00028403493,"about_ca_topic_score_gemma":0.00023788976,"teacher_disagreement_score":0.9962818,"about_ca_system_score_codex":0.000040365176,"about_ca_system_score_gemma":0.00031387038,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W2314780368","doi":"10.1530/erc-16-0013","title":"NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Corticotropic cell; Biology; Immunohistochemistry; Internal medicine; Endocrinology; Anterior pituitary; Pituitary gland; Pituitary tumors; Prolactin; Cancer research; Hormone; Immunology; Medicine","score_opus":0.008880662768574877,"score_gpt":0.2697453911216173,"score_spread":0.2608647283530424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314780368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845407,0.00583401,0.000054143107,0.0020472168,0.00050542183,0.0004907673,0.000031891246,0.000106896274,0.0063889446],"genre_scores_gemma":[0.9890283,0.0032938002,0.00007915641,0.00020750289,0.00011585747,0.000100215584,0.000045544188,0.000034976456,0.0070947004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864215,0.000036133933,0.00033644188,0.00035738037,0.00020726793,0.000420636],"domain_scores_gemma":[0.99942064,0.000053331587,0.00008243455,0.00026145662,0.000047470025,0.00013463975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005675376,0.00021776532,0.00032083478,0.000187312,0.000048096048,0.0000050966187,0.0000670914,0.000068835296,0.0015206493],"category_scores_gemma":[0.00003321523,0.00013969939,0.00009709852,0.0003037214,0.000037969145,0.0001842898,0.00003049098,0.0001879322,0.00020441765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018766663,0.0023464286,0.7292298,0.00020408505,0.0010664839,0.0040425346,0.00066146627,0.00016556881,0.13970223,0.0007915832,0.017460974,0.10245216],"study_design_scores_gemma":[0.047554284,0.0014133861,0.57524186,0.0013761537,0.0005173286,0.0002942442,0.00017039476,0.00035315115,0.2957783,0.0029357804,0.07319226,0.0011728399],"about_ca_topic_score_codex":0.0011118083,"about_ca_topic_score_gemma":0.0001925692,"teacher_disagreement_score":0.15607606,"about_ca_system_score_codex":0.00036083034,"about_ca_system_score_gemma":0.00014386569,"threshold_uncertainty_score":0.9993921},"labels":[],"label_agreement":null},{"id":"W2324898736","doi":"10.1530/erc-14-0423","title":"The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy","year":2014,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Prostate Cancer Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Single-nucleotide polymorphism; Prostate cancer; Internal medicine; Haplotype; Proportional hazards model; Locus (genetics); Hazard ratio; Medicine; Oncology; Endocrinology; Biochemical recurrence; Allele; Glucuronosyltransferase; Prostatectomy; Genotype; Genetics; Biology; Cancer; Gene","score_opus":0.0027862196196356053,"score_gpt":0.250667759555955,"score_spread":0.2478815399363194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324898736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96053493,0.03719001,0.000013193394,0.00064803776,0.00042712135,0.00047377264,0.000043578497,0.000020613852,0.0006487178],"genre_scores_gemma":[0.9783285,0.01679331,0.000029922945,0.00011720317,0.00011082495,0.0004703061,0.000014151749,0.000040056824,0.0040956684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851894,0.00010320424,0.00034261282,0.00039291056,0.00018255963,0.00045977757],"domain_scores_gemma":[0.99911004,0.000027843857,0.0001943987,0.00043101012,0.00013827854,0.0000984008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015423179,0.00023538098,0.00020702154,0.00003548,0.00012029443,0.000021750016,0.00022055177,0.00012773152,0.000056785215],"category_scores_gemma":[0.000048910828,0.00015263096,0.0001324371,0.00019333253,0.0002024139,0.0000066210882,0.000114378876,0.00027861787,0.000016157606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024933647,0.00020818556,0.056713413,0.00034509323,0.0010788895,0.00007621156,0.0009851526,0.0005099821,0.5008475,0.0001731533,0.017726272,0.41884276],"study_design_scores_gemma":[0.0015247228,0.00049428566,0.002029563,0.0002333358,0.000106021085,0.000060058366,0.000020444888,0.00036046683,0.8179877,0.00012785305,0.17669223,0.0003633555],"about_ca_topic_score_codex":0.00026134463,"about_ca_topic_score_gemma":0.00007520642,"teacher_disagreement_score":0.4184794,"about_ca_system_score_codex":0.000030053567,"about_ca_system_score_gemma":0.00013514161,"threshold_uncertainty_score":0.62241095},"labels":[],"label_agreement":null},{"id":"W2325704466","doi":"10.1530/erc-14-0232","title":"The kinome associated with estrogen receptor-positive status in human breast cancer","year":2014,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cure Brain Cancer Foundation","keywords":"Kinome; Breast cancer; Kinase; Estrogen receptor; Bioinformatics; Computational biology; Estrogen receptor alpha; Biology; Cancer research; Medicine; Cancer; Oncology; Internal medicine; Genetics","score_opus":0.007334814083471788,"score_gpt":0.2987326748477516,"score_spread":0.2913978607642798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325704466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065126875,0.9906409,0.0000010466852,0.00009191713,0.0003828278,0.0010297125,0.00043335257,0.000044362838,0.00086320884],"genre_scores_gemma":[0.0028250392,0.99106574,0.0000045830225,0.000034031877,0.0003158526,0.000789449,0.0014071111,0.00018699057,0.0033712247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965452,0.0005674458,0.0007153149,0.0008307385,0.00028843034,0.0010528956],"domain_scores_gemma":[0.99832696,0.000100049794,0.000637818,0.00057827326,0.00014030904,0.00021658436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002466574,0.00074927567,0.0011959344,0.00012570048,0.00028863564,0.00006377737,0.00044982688,0.00066186854,0.00008899908],"category_scores_gemma":[0.000045474713,0.00046995864,0.00041783278,0.00055837166,0.00024037328,0.000007179646,0.00016395393,0.0012252652,0.000026071599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034435606,0.0003425915,0.0028766,0.0018394805,0.010450642,0.00021981749,0.000093964,0.00039098406,0.0014781981,0.00060363347,0.007701867,0.97365785],"study_design_scores_gemma":[0.0015108126,0.0003298063,0.00021425665,0.0076187765,0.0009843861,0.0001339066,0.000009908422,0.000008021535,0.00038098366,0.000008746285,0.9879303,0.0008701044],"about_ca_topic_score_codex":0.00076774834,"about_ca_topic_score_gemma":0.00032553132,"teacher_disagreement_score":0.9802284,"about_ca_system_score_codex":0.0005105588,"about_ca_system_score_gemma":0.0007494074,"threshold_uncertainty_score":0.99977523},"labels":[],"label_agreement":null},{"id":"W2509895884","doi":"10.1530/erc-16-0297","title":"BRCA2 functions: from DNA repair to replication fork stabilization","year":2016,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université Laval; Hôtel-Dieu de Québec","funders":"Natural Sciences and Engineering Research Council of Canada; Jewish General Hospital; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Genome instability; Biology; Fanconi anemia; DNA repair; RAD51; Homologous recombination; Genetics; Chromosome instability; Telomere; BRCA2 Protein; DNA replication; Cancer research; DNA re-replication; DNA damage; Gene; Mutation; DNA; Chromosome; Eukaryotic DNA replication; Germline mutation","score_opus":0.02034789958555874,"score_gpt":0.3258856017428809,"score_spread":0.3055377021573222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509895884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019801772,0.9945893,0.001026766,0.00010131538,0.0010201258,0.001281373,0.00045276052,0.00023155894,0.001098756],"genre_scores_gemma":[0.000057098754,0.9801276,0.00040007598,0.00009797105,0.00069194566,0.0013977586,0.0022178253,0.00014700994,0.0148627255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972523,0.00016166367,0.000695194,0.0013148556,0.00020964659,0.00036633026],"domain_scores_gemma":[0.99744827,0.000037137073,0.00036465251,0.0018380393,0.00015384045,0.00015808849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016002361,0.00042285392,0.0006701699,0.00012458867,0.00008542376,0.000021707414,0.00030215312,0.0004043514,0.0005163791],"category_scores_gemma":[0.00030441865,0.00035749492,0.00050887,0.00034493627,0.000028328024,0.000007694994,0.00020416423,0.00020062449,0.00043301348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025235284,0.000038110982,0.000009805677,0.0005687823,0.00056776317,0.0000048867278,0.000009609928,0.000009228927,0.0035167008,0.00013219763,0.017786022,0.97733164],"study_design_scores_gemma":[0.000256011,0.00011771156,0.0000038903277,0.0027483606,0.0003944062,0.00001955732,0.000004146195,0.0000037008995,0.0026673002,0.000091294656,0.9932605,0.00043310024],"about_ca_topic_score_codex":0.0000890125,"about_ca_topic_score_gemma":0.000058432463,"teacher_disagreement_score":0.97689855,"about_ca_system_score_codex":0.00027080212,"about_ca_system_score_gemma":0.00033647937,"threshold_uncertainty_score":0.9998877},"labels":[],"label_agreement":null},{"id":"W2522136113","doi":"10.1530/erc-16-0354","title":"BRCA2: a grown-up cancer susceptibility gene","year":2016,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer; Gene; Biology; Genetics; Oncology; Medicine; Computational biology; Cancer research","score_opus":0.007848481268727153,"score_gpt":0.30912316152798375,"score_spread":0.3012746802592566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522136113","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00785981,0.04507253,0.000104862454,0.000994089,0.9394992,0.00073101965,0.0037680222,0.00012894919,0.0018415248],"genre_scores_gemma":[0.009387934,0.048339598,0.00015599292,0.0001761618,0.84631515,0.0015648225,0.0021967113,0.00035584962,0.0915078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553305,0.00018942835,0.0008030097,0.0017384122,0.0007844454,0.0009516395],"domain_scores_gemma":[0.9968518,0.000108253575,0.00050760957,0.0014959015,0.00079140894,0.00024504904],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026797096,0.00079396385,0.0006795814,0.00014966467,0.00018517567,0.00005791392,0.00082234835,0.0013659922,0.0028331554],"category_scores_gemma":[0.00050323724,0.000697324,0.00042186276,0.00030837554,0.0003100715,0.000012416695,0.00042221628,0.0010114567,0.00014254989],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020064728,0.000041484393,0.00022804967,0.000100076024,0.0008239406,0.000017284534,0.000039289065,0.00011975052,0.057132784,0.000008101911,0.9317038,0.009584794],"study_design_scores_gemma":[0.0020004057,0.0001291921,0.000055128665,0.00019276352,0.00026304583,0.000011138714,0.000008650021,0.0000061182104,0.07639193,0.00011972332,0.91997296,0.0008489595],"about_ca_topic_score_codex":0.0013735208,"about_ca_topic_score_gemma":0.0019263607,"teacher_disagreement_score":0.09318406,"about_ca_system_score_codex":0.0013046104,"about_ca_system_score_gemma":0.0034844526,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2528213995","doi":"10.1530/erc-16-0329","title":"mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Everolimus; PI3K/AKT/mTOR pathway; Protein kinase B; Neuroendocrine tumors; Immunohistochemistry; Medicine; In vivo; Cancer research; Internal medicine; Pharmacology; Apoptosis; Oncology; Biology; Biotechnology; Biochemistry","score_opus":0.01351555454926406,"score_gpt":0.2978357769380235,"score_spread":0.2843202223887594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528213995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777065,0.0036856043,0.0000019940371,0.0161926,0.00033869903,0.0009985795,0.00004425855,0.00025681342,0.00077496044],"genre_scores_gemma":[0.979054,0.002761377,0.0001047692,0.0003384102,0.00018159187,0.0003550593,0.000005356056,0.00012635936,0.017073117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960688,0.0003668837,0.00079447654,0.00090335595,0.00065506366,0.0012114184],"domain_scores_gemma":[0.9978398,0.00064367004,0.00017210301,0.0006334327,0.000120444245,0.00059055776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002175318,0.00047112606,0.00075525756,0.00066124013,0.00008805283,0.000029513703,0.00019394593,0.000016991542,0.0008577193],"category_scores_gemma":[0.0017470556,0.0003243667,0.00013306385,0.000830075,0.0003254547,0.00036621018,0.00022041373,0.000647661,0.00012361935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013528441,0.0005673485,0.33216318,0.00046072772,0.00022563104,0.08817342,0.000173212,0.000023842033,0.508401,0.0005223669,0.0049254065,0.050835453],"study_design_scores_gemma":[0.02919624,0.003496709,0.27657396,0.0034867793,0.0001455877,0.022754043,0.00021056121,0.00011002029,0.39777154,0.0008434271,0.26407588,0.0013352716],"about_ca_topic_score_codex":0.00032600207,"about_ca_topic_score_gemma":0.000104697756,"teacher_disagreement_score":0.25915048,"about_ca_system_score_codex":0.00041471582,"about_ca_system_score_gemma":0.00037609803,"threshold_uncertainty_score":0.99992085},"labels":[],"label_agreement":null},{"id":"W2552944256","doi":"10.1530/erc-16-0393","title":"Differential roles of RET isoforms in medullary and papillary thyroid carcinomas","year":2016,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Queen's University","funders":"Queen's University; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Thyroid carcinoma; Biology; Anoikis; Receptor tyrosine kinase; Proto-Oncogene Proteins c-ret; Tyrosine kinase; Cell biology; Cancer cell; Endocrinology; Thyroid; Cancer; Signal transduction; Receptor","score_opus":0.007796352522564408,"score_gpt":0.2553965774551967,"score_spread":0.2476002249326323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552944256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630956,0.03108323,0.0000028792185,0.0043363683,0.00015984687,0.00029682458,0.00004174683,0.000034978955,0.000948544],"genre_scores_gemma":[0.96565616,0.03308461,0.000025572275,0.00008685701,0.00008013033,0.00010051923,0.000011926135,0.000028484028,0.00092576724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987875,0.00002718287,0.00036523747,0.0003037088,0.00021004511,0.00030631156],"domain_scores_gemma":[0.99942654,0.00006034051,0.00010419622,0.00023903981,0.000043679658,0.0001262145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037578717,0.00019258141,0.00042819005,0.00013593015,0.000025228066,0.00000405523,0.00005581075,0.00007242736,0.0006370051],"category_scores_gemma":[0.000021900407,0.000112078495,0.000086317,0.0001556995,0.00010992166,0.000075561475,0.00006106886,0.00013264669,0.000007073029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058233726,0.00034250657,0.856512,0.00015962706,0.00043377932,0.00035401745,0.0003765254,0.0000047101817,0.061712198,0.00081314245,0.0026806865,0.076028466],"study_design_scores_gemma":[0.014196363,0.0009218309,0.8148588,0.0011274139,0.00034194393,0.00018796154,0.00008825688,0.000023717002,0.15973924,0.00062554807,0.0075715915,0.00031736243],"about_ca_topic_score_codex":0.00047693722,"about_ca_topic_score_gemma":0.00028146122,"teacher_disagreement_score":0.098027036,"about_ca_system_score_codex":0.00018343543,"about_ca_system_score_gemma":0.000093514376,"threshold_uncertainty_score":0.6974759},"labels":[],"label_agreement":null},{"id":"W2564132902","doi":"10.1530/erc-16-0419","title":"Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases","year":2017,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Epigenetics; Neuroendocrine carcinoma; Neuroendocrine tumour; Medicine; Cancer research; Oncology; Internal medicine; Biology; Pathology; Carcinoma; Genetics; Gene","score_opus":0.029450846015961395,"score_gpt":0.3454542594050315,"score_spread":0.3160034133890701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564132902","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06627134,0.0684988,0.0000040731247,0.8490183,0.0024214128,0.0066390173,0.0005034909,0.00068037346,0.0059632096],"genre_scores_gemma":[0.505158,0.033335395,0.0012189291,0.20322093,0.015194136,0.007296512,0.0052023293,0.0022476753,0.22712609],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929275,0.00048021518,0.0011827516,0.0017170762,0.0016292243,0.0020632425],"domain_scores_gemma":[0.99631137,0.00030048305,0.0009104017,0.0017486213,0.00038485983,0.00034427884],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012604117,0.0011049189,0.0017258783,0.0012152283,0.00022994979,0.0001578003,0.00081353396,0.00009108567,0.0029187626],"category_scores_gemma":[0.0008629273,0.0009970282,0.00047820198,0.00060702534,0.0004992468,0.000428916,0.0004297221,0.0057323333,0.00032035157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027674067,0.00016567315,0.002120589,0.0010494472,0.00034245633,0.5220037,0.000017599226,0.0001286698,0.00055547827,0.000015212369,0.46638858,0.0069358572],"study_design_scores_gemma":[0.005567646,0.00076407654,0.007574285,0.0020228273,0.0007279121,0.034402393,0.000010861157,0.0003631888,0.0117671965,0.00030840808,0.93544704,0.0010441935],"about_ca_topic_score_codex":0.0011144673,"about_ca_topic_score_gemma":0.00015053767,"teacher_disagreement_score":0.6457974,"about_ca_system_score_codex":0.0006342128,"about_ca_system_score_gemma":0.0007480414,"threshold_uncertainty_score":0.999248},"labels":[],"label_agreement":null},{"id":"W2583082560","doi":"10.1530/erc-16-0496","title":"Pituitary acromegaly: not one disease","year":2017,"lang":"en","type":"letter","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Acromegaly; Risk stratification; Pituitary tumors; Epigenetics; Pituitary adenoma; Disease; Medicine; Bioinformatics; Broad spectrum; Adenoma; Pathology; Neuroscience; Biology; Internal medicine; Genetics; Growth hormone; Gene","score_opus":0.02703821333650549,"score_gpt":0.3045985027313428,"score_spread":0.27756028939483735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583082560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009397403,0.027660936,0.0000020173477,0.934765,0.001634291,0.0010641732,0.00097284035,0.0002915142,0.024211818],"genre_scores_gemma":[0.10731911,0.014558121,0.00009716775,0.5592387,0.0069831153,0.00071123976,0.007706418,0.00038266447,0.3030035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717516,0.000044507284,0.0004432499,0.00085064716,0.0006381998,0.0008482509],"domain_scores_gemma":[0.99777406,0.000045766246,0.0002870474,0.0014151849,0.00010368231,0.00037422992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004211733,0.00062990515,0.0009794732,0.00021813637,0.00026711472,0.000052404634,0.00031297494,0.00042466575,0.0032775253],"category_scores_gemma":[0.000071618546,0.0005265079,0.0004801401,0.000104258725,0.00015159587,0.00015683033,0.0001285822,0.0020891505,0.0006692142],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032280647,0.0002295044,0.007348529,0.00043967573,0.001992549,0.027159346,0.00002418975,0.0000036672807,0.000011873814,0.000013127912,0.9575053,0.0049494244],"study_design_scores_gemma":[0.0055458974,0.0001657315,0.018892396,0.0009334996,0.0026369556,0.00017397142,0.0000022813945,0.000021029418,0.000045243563,0.0005134911,0.9704977,0.0005717978],"about_ca_topic_score_codex":0.0014441916,"about_ca_topic_score_gemma":0.000029089299,"teacher_disagreement_score":0.37552634,"about_ca_system_score_codex":0.00029783163,"about_ca_system_score_gemma":0.00054919964,"threshold_uncertainty_score":0.99971867},"labels":[],"label_agreement":null},{"id":"W2592270240","doi":"10.1530/erc-17-0004","title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ipsen; Università degli Studi di Torino; Kanazawa Medical University; Università degli Studi dell'Aquila; Université de Lyon; Hospices Civils de Lyon","keywords":"Pituitary tumors; Pituitary adenoma; Neuroendocrine tumors; Adenoma; Pathology; Anterior pituitary; Medicine; Hormone; Internal medicine","score_opus":0.014553462301906121,"score_gpt":0.3212345771739681,"score_spread":0.30668111487206196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592270240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95694184,0.0024312083,0.000023586585,0.026924513,0.0031557684,0.0011511788,0.00057345955,0.00031208096,0.008486332],"genre_scores_gemma":[0.98875666,0.0009968249,0.0011631453,0.0036412338,0.0013072272,0.00031058796,0.0010042471,0.00013099455,0.0026890945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963593,0.00010528948,0.00070897344,0.0012617003,0.0006000626,0.0009647093],"domain_scores_gemma":[0.99704844,0.000050310024,0.0002852805,0.0016785403,0.00017683092,0.0007606114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008454168,0.0006292799,0.00080770795,0.0003055901,0.0005125378,0.000101244215,0.000863274,0.00007540205,0.0027803823],"category_scores_gemma":[0.00016953368,0.00054529204,0.00026005445,0.00014600901,0.00021581053,0.0008280036,0.00046607392,0.00068976835,0.00044878578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005122912,0.00402462,0.7485182,0.0001254853,0.0030239308,0.11512835,0.0010365804,0.00035372007,0.007449504,0.0013109089,0.045757785,0.068147995],"study_design_scores_gemma":[0.020290473,0.0032112617,0.8766697,0.00039758222,0.0010657993,0.0049851383,0.00029443923,0.00096682674,0.004030076,0.0050476394,0.08171411,0.001326931],"about_ca_topic_score_codex":0.008006147,"about_ca_topic_score_gemma":0.0006642944,"teacher_disagreement_score":0.12815152,"about_ca_system_score_codex":0.00025617983,"about_ca_system_score_gemma":0.00035071824,"threshold_uncertainty_score":0.99969983},"labels":[],"label_agreement":null},{"id":"W2618996609","doi":"10.1530/erc-17-0131","title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; National Institutes of Health; Université Paris Descartes","keywords":"Germline; Biology; Missense mutation; Germline mutation; Cancer research; Pituitary tumors; Mutation; Gene; Cell cycle; Copy-number variation; Cyclin E; Genetics; Endocrinology; Internal medicine; Molecular biology; Cyclin D1; Medicine; Genome","score_opus":0.030825204639808222,"score_gpt":0.3205431530728196,"score_spread":0.2897179484330114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618996609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931164,0.0030239257,0.000030150437,0.0019633418,0.00015764043,0.00029802413,0.000113480535,0.000010484026,0.0012865916],"genre_scores_gemma":[0.9985268,0.0005867133,0.000028806993,0.00006677123,0.000029962419,0.00005945856,0.000062939194,0.000010139589,0.00062840316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993571,0.000013973049,0.0001994792,0.00013469327,0.00015932458,0.00013542631],"domain_scores_gemma":[0.9992856,0.000024878242,0.00018395395,0.00038871358,0.000059322454,0.000057546953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041185576,0.0000919791,0.00018154757,0.000065171356,0.00009270238,0.000007583794,0.00008780944,0.000024197978,0.000102408485],"category_scores_gemma":[0.00009246108,0.00005991304,0.00006729559,0.000090937334,0.00007351065,0.00009318727,0.00001993688,0.00011021673,0.000004168173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035581074,0.00061768445,0.9954179,0.000081277976,0.0002681661,0.00030593362,0.00032907748,0.0005252182,0.00030541274,0.00040305784,0.00030362845,0.00108685],"study_design_scores_gemma":[0.005127687,0.000086642845,0.99203104,0.00020765848,0.00049249246,0.00002553769,0.0001232919,0.00027504473,0.00033095182,0.000597721,0.0006342917,0.00006762943],"about_ca_topic_score_codex":0.0034501841,"about_ca_topic_score_gemma":0.0006005133,"teacher_disagreement_score":0.0054104445,"about_ca_system_score_codex":0.000039130173,"about_ca_system_score_gemma":0.00010825239,"threshold_uncertainty_score":0.5215669},"labels":[],"label_agreement":null},{"id":"W2735522662","doi":"10.1530/erc-17-0209","title":"A comprehensive review on MEN2B","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Computer science","score_opus":0.09907016582732375,"score_gpt":0.4699450566218236,"score_spread":0.37087489079449987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735522662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.902579e-7,0.9747062,0.0000016008378,0.0031986427,0.0010677984,0.0014663747,0.00002461907,0.0001405354,0.019393642],"genre_scores_gemma":[5.4521064e-7,0.9798164,0.000076948614,0.0022309578,0.0005606974,0.00033350827,0.00022661328,0.00015019465,0.016604142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973256,0.00017037858,0.00084872014,0.0006725442,0.00047560796,0.0005071345],"domain_scores_gemma":[0.9974939,0.0001818381,0.00074620463,0.0011391212,0.00011052257,0.00032839968],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018689068,0.00061965594,0.0035077473,0.00020850814,0.00016751727,0.000033875334,0.00037820585,0.00019736601,0.0015131285],"category_scores_gemma":[0.00048124284,0.00042532015,0.0009299857,0.00021811273,0.00014659754,0.000040747127,0.000117201795,0.0026624396,0.0006251035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059350214,0.000036062476,0.0000017659656,0.08545897,0.0006550256,0.00069297676,0.000004550432,8.3617437e-7,1.526565e-7,0.000070231596,0.05149796,0.86157554],"study_design_scores_gemma":[0.0005373299,0.000075801654,0.0000026854846,0.27638558,0.0028338756,0.00085310475,5.1600006e-7,0.000017308514,1.9070556e-7,0.000010311704,0.7190147,0.00026855877],"about_ca_topic_score_codex":0.000096281794,"about_ca_topic_score_gemma":4.8310744e-7,"teacher_disagreement_score":0.86130697,"about_ca_system_score_codex":0.00033110668,"about_ca_system_score_gemma":0.00056911353,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W2748863347","doi":"10.1530/erc-17-0251","title":"Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"ArcelorMittal","keywords":"Medicine; Breast cancer; Internal medicine; Androgen receptor; Estrogen; Testosterone (patch); Endocrinology; Androgen; Oncology; Estrogen receptor; Cancer; Hormone; Prostate cancer","score_opus":0.008230355450572038,"score_gpt":0.26481141155503457,"score_spread":0.2565810561044625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748863347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918253,0.0041739587,0.000012063702,0.0025584756,0.00040465232,0.00046829387,0.00008674577,0.0000320509,0.00043847616],"genre_scores_gemma":[0.9962156,0.0022573492,0.000053945212,0.00024993613,0.00021421925,0.0002075962,0.00008425401,0.00007754636,0.0006395941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980803,0.000090958616,0.00030582576,0.00056212995,0.00041443924,0.0005463177],"domain_scores_gemma":[0.99888676,0.000013046946,0.00021968594,0.0005478399,0.00012313943,0.00020953431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010883181,0.00034425975,0.00032972518,0.00006664747,0.00015201354,0.00005327445,0.0004456061,0.00029853638,0.0005683922],"category_scores_gemma":[0.0000342323,0.00024832363,0.000045721794,0.00010931495,0.00021447489,0.000021641852,0.00016053226,0.00047605287,0.00001667128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004587336,0.0013659978,0.760168,0.00008319726,0.0025961776,0.00051661656,0.0004517251,0.0003291622,0.121323,0.00011351431,0.004293423,0.10417184],"study_design_scores_gemma":[0.028409937,0.0020760687,0.9045956,0.0004374015,0.00013804581,0.00013494704,0.000027797865,0.00011580911,0.050682202,0.000045652476,0.012166315,0.0011702304],"about_ca_topic_score_codex":0.0021311198,"about_ca_topic_score_gemma":0.00032837348,"teacher_disagreement_score":0.14442758,"about_ca_system_score_codex":0.00008246174,"about_ca_system_score_gemma":0.0003042385,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W2750836859","doi":"10.1530/erc-17-0266","title":"Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Penetrance; Pheochromocytoma; Multiple endocrine neoplasia type 2; Medicine; Parathyroidectomy; Disease; Phenotype; Mutation; Germline mutation; Internal medicine; Genetics; Biology; Gene","score_opus":0.04421730752026238,"score_gpt":0.36869530282173,"score_spread":0.32447799530146765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750836859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013448083,0.9800405,0.000005238537,0.00015113791,0.00012678298,0.00093460345,0.000039580984,0.0000071011154,0.005246984],"genre_scores_gemma":[0.17281075,0.82681376,0.00001089314,0.000025216683,0.00007428055,0.000071178045,0.000016357597,0.000026364945,0.00015121547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982181,0.000110190515,0.00073449133,0.00033022361,0.00028862193,0.00031837562],"domain_scores_gemma":[0.9985989,0.0003485662,0.00059758633,0.00038015452,0.000025737669,0.000049055012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040908266,0.0003449841,0.0014297509,0.00022570362,0.00011012623,0.00001603385,0.000244776,0.00012920417,0.000018286031],"category_scores_gemma":[0.00006245258,0.00017204639,0.00014928148,0.00033592296,0.00038636875,0.00014630088,0.000100656434,0.0007168914,0.0000010130931],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047081546,0.00021511229,0.0008995774,0.01639928,0.000721022,0.0025244874,0.0061421874,0.00004272835,0.000046559657,0.008486716,0.00035390287,0.9636976],"study_design_scores_gemma":[0.026939902,0.0030902708,0.004144531,0.12626478,0.008827895,0.020870453,0.012567186,0.00059822696,0.0005320362,0.023162166,0.77005047,0.0029520849],"about_ca_topic_score_codex":0.00037775692,"about_ca_topic_score_gemma":0.00047534995,"teacher_disagreement_score":0.9607455,"about_ca_system_score_codex":0.00014782672,"about_ca_system_score_gemma":0.00023945035,"threshold_uncertainty_score":0.7015848},"labels":[],"label_agreement":null},{"id":"W2755822411","doi":"10.1530/erc-17-0316","title":"Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission","year":2017,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust; Canadian Institutes of Health Research; Terry Fox Research Institute; Ministry of Agriculture, Food and Rural Affairs; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Agriculture, Food and Rural Affairs","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Cancer immunotherapy; Thyroid cancer; Cancer; Medicine; Immunology; Internal medicine","score_opus":0.050254521916592194,"score_gpt":0.3710253973340803,"score_spread":0.3207708754174881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755822411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008115536,0.99339193,0.0000013644291,0.0006565771,0.0020922206,0.0017915101,0.00021949036,0.00009897035,0.0009363588],"genre_scores_gemma":[0.00058762834,0.9508202,0.000009005027,0.00020224214,0.00009632115,0.0007756547,0.00019056258,0.00019855837,0.047119815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99310464,0.0028040987,0.0016896878,0.0009482813,0.00016417811,0.0012891421],"domain_scores_gemma":[0.9955841,0.00074760575,0.0014986789,0.0021035664,0.000042208896,0.0000238707],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010439241,0.001159385,0.0025793274,0.00062510074,0.0010218665,0.00015976194,0.0023156307,0.0008888444,0.0041907816],"category_scores_gemma":[0.0001244364,0.0007565038,0.0011316802,0.00046230675,0.0005781485,0.00024671038,0.0002659179,0.0027544594,0.0005906443],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011154641,0.00023367489,0.00004210622,0.0011177029,0.0018166879,0.0001594534,0.0008799922,0.0000056777153,0.007616102,0.00005987441,0.0020841912,0.98486906],"study_design_scores_gemma":[0.0024466864,0.00017545951,0.00029150664,0.017907092,0.00052527833,0.0008268478,0.00008560859,4.3271874e-7,0.00087831257,0.000031646887,0.97599065,0.00084046624],"about_ca_topic_score_codex":0.001401522,"about_ca_topic_score_gemma":0.00004775125,"teacher_disagreement_score":0.9840286,"about_ca_system_score_codex":0.0006212235,"about_ca_system_score_gemma":0.00082223216,"threshold_uncertainty_score":0.99954623},"labels":[],"label_agreement":null},{"id":"W2763295416","doi":"10.1530/erc-17-0377","title":"Dose–response effects of exercise on insulin among colon cancer survivors","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; University of Pennsylvania","keywords":"Medicine; Insulin resistance; Aerobic exercise; Colorectal cancer; Insulin; Internal medicine; Cancer; Endocrinology; Gastroenterology","score_opus":0.010464477358873792,"score_gpt":0.30381474723005564,"score_spread":0.29335026987118185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763295416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236185,0.009568964,0.0000016435073,0.001352777,0.002876303,0.00086230674,0.00005313232,0.0001091852,0.0028138363],"genre_scores_gemma":[0.98147607,0.0070494944,0.000006753432,0.00013048667,0.00017397938,0.00043027528,0.000012131654,0.00007671084,0.010644091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979575,0.00012396034,0.00042247522,0.0004915428,0.00050938805,0.00049513153],"domain_scores_gemma":[0.9978153,0.00023682383,0.0004071366,0.001068167,0.00020639617,0.0002661649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000226158,0.00033777626,0.000709149,0.00019944091,0.000223326,0.00003394662,0.00031466354,0.00017325486,0.00073065],"category_scores_gemma":[0.00032095955,0.0002951146,0.00024527774,0.00023605353,0.00027393352,0.00014429378,0.00010885641,0.00055799534,0.000039813254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040432144,0.0010915837,0.69337404,0.003524699,0.0015436241,0.00241541,0.006285566,0.00072313653,0.037659425,0.00032885748,0.006893923,0.2057276],"study_design_scores_gemma":[0.009089193,0.0009936744,0.81043726,0.0053842375,0.000715019,0.000017822254,0.00014895553,0.00018088742,0.14709496,0.000066652196,0.025293516,0.0005778156],"about_ca_topic_score_codex":0.054491565,"about_ca_topic_score_gemma":0.011382533,"teacher_disagreement_score":0.20514978,"about_ca_system_score_codex":0.00032925265,"about_ca_system_score_gemma":0.00032271128,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W2774064635","doi":"10.1530/erc-17-0366","title":"Receptor activities of persistent pollutant serum mixtures and breast cancer risk","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Per- and polyfluoroalkyl substances research","field":"Environmental Science","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Aryl hydrocarbon receptor; Internal medicine; Estrogen receptor; Androgen receptor; Cancer; Pollutant; Receptor; Hormone; Medicine; Physiology; Endocrinology; Oncology; Chemistry; Gene; Transcription factor; Biochemistry; Organic chemistry","score_opus":0.00932906123112882,"score_gpt":0.27697832576651116,"score_spread":0.26764926453538235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774064635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681774,0.02036075,6.3533713e-7,0.002129847,0.0003030921,0.0001602289,0.00079872226,0.0000223941,0.008046977],"genre_scores_gemma":[0.9650674,0.026106492,0.00003191335,0.000028773395,0.00007110997,0.000026471838,0.0000018588286,0.00001957129,0.008646438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860144,0.00006240735,0.00019212684,0.00033474664,0.0003739901,0.00043530422],"domain_scores_gemma":[0.9991804,0.000030982093,0.00021094756,0.0004059057,0.000012230653,0.00015954622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010617484,0.00017805278,0.00023344788,0.000036512633,0.00037211293,0.000053399097,0.0003420795,0.00006253835,0.01415367],"category_scores_gemma":[0.000021507247,0.00014320755,0.00012426332,0.0000849953,0.0005852155,0.00032534136,0.00025158425,0.00030892965,0.00004749452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015830193,0.000049634396,0.60778046,0.000030038278,0.00022853559,0.000011768738,0.00081644295,0.00060896407,0.02994608,0.000019283958,0.003778019,0.35657248],"study_design_scores_gemma":[0.0014823482,0.000113431095,0.90669936,0.0001569475,0.00013028798,0.000055445907,0.0003186893,0.0010815361,0.04406295,0.00010160029,0.04533742,0.0004599901],"about_ca_topic_score_codex":0.019856501,"about_ca_topic_score_gemma":0.0022005253,"teacher_disagreement_score":0.35611248,"about_ca_system_score_codex":0.00022325949,"about_ca_system_score_gemma":0.000037986323,"threshold_uncertainty_score":0.9867475},"labels":[],"label_agreement":null},{"id":"W2782939356","doi":"10.1530/erc-17-0509","title":"DICER1 gene mutations in endocrine tumors","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; St. Michael's Hospital","funders":"","keywords":"Endocrine system; Pancreas; Endocrine gland; Gene mutation; Gene; Cancer research; Biology; Thyroid; Mutation; Medicine; Internal medicine; Endocrinology; Hormone; Genetics","score_opus":0.0442906480848622,"score_gpt":0.3826765592906455,"score_spread":0.33838591120578326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782939356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004237576,0.9816866,0.000001875043,0.0003564836,0.00067581265,0.002025901,0.00017998194,0.0002134163,0.014436161],"genre_scores_gemma":[0.00029757433,0.9822544,0.00018641035,0.00007978827,0.00050086423,0.0015179132,0.0003802152,0.00019621335,0.014586606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600667,0.0001683711,0.0016367438,0.00083461415,0.00049457175,0.0008590047],"domain_scores_gemma":[0.9980325,0.00030757385,0.00045053402,0.0007463428,0.00019020353,0.0002728624],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016032335,0.0008008982,0.0029912002,0.00079144177,0.00009741007,0.000025786268,0.00026401566,0.0001594592,0.0028698056],"category_scores_gemma":[0.00048999407,0.0006531285,0.0006738583,0.0015016552,0.00023453367,0.00008978139,0.00022988184,0.0011471193,0.0013269084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025442694,0.00022478847,0.0003029046,0.015031285,0.0020390314,0.0035634106,0.00024897954,0.0000034764619,0.0000032967278,0.000102994694,0.0048035323,0.9736509],"study_design_scores_gemma":[0.0014766672,0.00011387629,0.00020543732,0.019944368,0.0027651591,0.0016554391,0.000031755615,0.00002060912,0.000011348197,0.00008140632,0.97312856,0.00056538504],"about_ca_topic_score_codex":0.00075741793,"about_ca_topic_score_gemma":0.0005070077,"teacher_disagreement_score":0.97308546,"about_ca_system_score_codex":0.0009566435,"about_ca_system_score_gemma":0.0009775553,"threshold_uncertainty_score":0.999592},"labels":[],"label_agreement":null},{"id":"W2783442236","doi":"10.1530/erc-17-0493","title":"Sex steroids in the tumor microenvironment and prostate cancer progression","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Prostate Cancer Canada; Movember Foundation","keywords":"Prostate cancer; Tumor microenvironment; Prostate; Context (archaeology); Medicine; Cancer; Tumor progression; Androgen; Sex steroid; Oncology; Testosterone (patch); Cancer research; Internal medicine; Biology; Steroid; Hormone","score_opus":0.03428621551525527,"score_gpt":0.3960438199909786,"score_spread":0.3617576044757233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783442236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022631227,0.9918986,8.904678e-8,0.0009221845,0.0002356073,0.0039319713,0.00011618414,0.000040408184,0.00059181295],"genre_scores_gemma":[0.00011853256,0.98592144,0.000025165762,0.00013109807,0.00028894635,0.0036214131,0.00016009802,0.00009891589,0.0096344035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713904,0.0002617987,0.0006324039,0.00073939277,0.0005071732,0.0007202079],"domain_scores_gemma":[0.9989496,0.00008018351,0.00026057803,0.0005058579,0.000036890575,0.0001669257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028176766,0.00055478734,0.0012859217,0.00023732569,0.00012348816,0.000051144954,0.00021941683,0.0001440394,0.0004434618],"category_scores_gemma":[0.000014196676,0.00028712404,0.00021103749,0.0004791684,0.0003211554,0.000069808346,0.0001694237,0.0010436934,0.00005356986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012650668,0.00018459858,0.0016513135,0.009820741,0.00049468165,0.0010559079,0.000569971,4.0958167e-7,0.000012131102,0.000003803992,0.008439593,0.97764033],"study_design_scores_gemma":[0.002109702,0.0003516999,0.0001527751,0.024607042,0.00092381553,0.00048867654,0.00005777196,0.0000050909916,0.00008692314,0.000011443197,0.97091573,0.0002892992],"about_ca_topic_score_codex":0.00025016302,"about_ca_topic_score_gemma":0.000050217543,"teacher_disagreement_score":0.97735107,"about_ca_system_score_codex":0.0008177462,"about_ca_system_score_gemma":0.0005596221,"threshold_uncertainty_score":0.9999581},"labels":[],"label_agreement":null},{"id":"W2784118723","doi":"10.1530/erc-17-0488","title":"The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2","year":2018,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Multiple endocrine neoplasia; Endocrine system; Biology; Evolutionary biology; Computational biology; Medicine; Genetics; Internal medicine; Mutation; Gene; Hormone; Germline mutation","score_opus":0.020021790533924017,"score_gpt":0.36836582583155236,"score_spread":0.34834403529762836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784118723","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08569619,0.19751318,0.000003024639,0.0016494388,0.709304,0.0024576152,0.0002132204,0.00030354044,0.0028598316],"genre_scores_gemma":[0.14683418,0.2837091,0.0005042366,0.00014107524,0.53418154,0.00035021768,0.0002311843,0.0005408149,0.03350765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99488586,0.0003536415,0.0013953748,0.0009830034,0.0013213746,0.0010607543],"domain_scores_gemma":[0.9925013,0.0040466837,0.0006820119,0.0011728562,0.0012095632,0.00038755944],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034669958,0.0006204108,0.0012580163,0.00024036021,0.00026337057,0.000074245654,0.00053173484,0.00012608455,0.00067090365],"category_scores_gemma":[0.0053421254,0.00042065728,0.0002897918,0.0006129999,0.00087858975,0.000079948775,0.0003919948,0.0024558445,0.00007171227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013470681,0.00014340959,0.022507723,0.0004983049,0.001033942,0.0011927786,0.000031280877,0.000010931028,0.00034427326,0.00000874654,0.9582973,0.014584244],"study_design_scores_gemma":[0.004616087,0.0017518898,0.0034808428,0.0005794416,0.00058203377,0.00051448215,0.000043091066,0.00048302088,0.0006179353,0.00012566369,0.9868413,0.0003642195],"about_ca_topic_score_codex":0.00037708355,"about_ca_topic_score_gemma":0.0003526069,"teacher_disagreement_score":0.17512242,"about_ca_system_score_codex":0.00012338032,"about_ca_system_score_gemma":0.0011405649,"threshold_uncertainty_score":0.9998455},"labels":[],"label_agreement":null},{"id":"W2790570326","doi":"10.1530/erc-18-0015","title":"65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Temozolomide; Medicine; Pituitary tumors; Anaplastic astrocytoma; Oncology; Internal medicine; Glioblastoma; Adjuvant; Adjuvant therapy; Pituitary adenoma; Astrocytoma; Melanoma; Cancer research; Chemotherapy; Adenoma","score_opus":0.03173571722439277,"score_gpt":0.338364168976728,"score_spread":0.3066284517523352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790570326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016874438,0.9798578,2.8806315e-7,0.00006778405,0.00023763099,0.0014637194,0.00021485875,0.0000354186,0.0012480338],"genre_scores_gemma":[0.00545324,0.9913669,0.000056196033,0.000019660736,0.00010322569,0.00020336137,0.00031950572,0.000081111,0.0023967612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815595,0.000072799965,0.0006656214,0.00044821535,0.00031250317,0.00034488642],"domain_scores_gemma":[0.9983454,0.00003041417,0.0005225773,0.00087167136,0.00008889324,0.00014104047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004233074,0.00045321457,0.0018086205,0.00015043658,0.00004909446,0.0000046921587,0.00019437644,0.00013146999,0.00037563583],"category_scores_gemma":[0.000005060085,0.00023516655,0.00048613278,0.00046472467,0.00020332864,0.00006418144,0.000045993198,0.00018777317,0.00003022247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011473887,0.0026668683,0.006574643,0.008171687,0.008745838,0.001022154,0.00031877967,0.000021930335,0.0000041310045,0.00016621564,0.0017928226,0.96936756],"study_design_scores_gemma":[0.010071024,0.0031245071,0.0012498739,0.013010455,0.008688481,0.00063958473,0.000034482302,0.0000042810943,0.00015177134,0.000053064796,0.96256274,0.00040974212],"about_ca_topic_score_codex":0.001962339,"about_ca_topic_score_gemma":0.00018290593,"teacher_disagreement_score":0.9689578,"about_ca_system_score_codex":0.00024167822,"about_ca_system_score_gemma":0.000724868,"threshold_uncertainty_score":0.95898134},"labels":[],"label_agreement":null},{"id":"W2800029808","doi":"10.1530/erc-18-0141","title":"65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Disease; Cancer; Precision medicine; Receptor tyrosine kinase; Repurposing; Cancer research; Bioinformatics; Targeted therapy; Personalized medicine; Multiple endocrine neoplasia type 2; Medullary thyroid cancer; Thyroid cancer; Internal medicine; Receptor; Mutation; Biology; Gene; Pathology; Genetics; Germline mutation","score_opus":0.11340842744004513,"score_gpt":0.42436261938153297,"score_spread":0.3109541919414878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800029808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009689029,0.9844474,9.3523494e-7,0.0053315656,0.001924474,0.0050389827,0.00018365226,0.000097585624,0.002006491],"genre_scores_gemma":[0.00018553493,0.9633789,0.00003485312,0.00041700242,0.00161816,0.0033981611,0.00007485461,0.00023141401,0.030661127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542356,0.00036980936,0.001225721,0.0008925446,0.0012079806,0.00088040996],"domain_scores_gemma":[0.99576294,0.0012427658,0.0010465274,0.0012424936,0.00047128217,0.00023399689],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032342883,0.0006901492,0.002276191,0.00030531388,0.00024699242,0.000020175734,0.00086670695,0.00007558686,0.0026545208],"category_scores_gemma":[0.0010838908,0.00034658294,0.00089917216,0.0012521176,0.00091179105,0.000088697416,0.00024679126,0.0015571702,0.000067270346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029313678,0.0004279615,0.00005517064,0.04721842,0.0054071313,0.00079278654,0.0013799883,0.000017100516,0.0006940036,0.010056827,0.36481544,0.5662038],"study_design_scores_gemma":[0.0031473932,0.00048577102,0.0000035803546,0.03959589,0.001212305,0.0002631707,0.00010100141,0.0000060760526,0.00087119534,0.0001087489,0.9539061,0.00029872652],"about_ca_topic_score_codex":0.000544676,"about_ca_topic_score_gemma":0.00007500429,"teacher_disagreement_score":0.5890907,"about_ca_system_score_codex":0.00062995305,"about_ca_system_score_gemma":0.0010509288,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W2802716398","doi":"10.1530/erc-18-0100","title":"Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Cleveland Clinic","keywords":"Von Hippel–Lindau disease; Neuroendocrine tumors; Medicine; Disease; Internal medicine; Pathology","score_opus":0.017657227347211223,"score_gpt":0.33661801883928955,"score_spread":0.31896079149207834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802716398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97721934,0.0048914202,0.000010934491,0.006851427,0.0007170076,0.0015973584,0.00010431142,0.00036792344,0.008240303],"genre_scores_gemma":[0.97578764,0.0021119944,0.00006523589,0.00044950517,0.0004700944,0.00019804115,0.00010440705,0.00014687434,0.020666204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99508476,0.00031722692,0.0011771158,0.0009021936,0.0012704466,0.0012482525],"domain_scores_gemma":[0.9966106,0.00032522457,0.000568684,0.0009036567,0.0007679063,0.0008239709],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017851479,0.00056374824,0.0012257296,0.00055480836,0.00016613015,0.0000134032525,0.0003902739,0.000017312537,0.0045519606],"category_scores_gemma":[0.0024278818,0.00046139487,0.00028617133,0.0015748184,0.0011485963,0.00025172406,0.0002305606,0.00081616646,0.00013914368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01360017,0.004252119,0.7643393,0.0031559195,0.0045149312,0.05534837,0.0011816776,0.00019066528,0.06641983,0.004725889,0.061250195,0.021020891],"study_design_scores_gemma":[0.046941396,0.018204194,0.59485304,0.012883802,0.0049643135,0.0073200455,0.00079128484,0.0038702397,0.20419998,0.007992665,0.095387034,0.0025919946],"about_ca_topic_score_codex":0.00068774505,"about_ca_topic_score_gemma":0.00013121993,"teacher_disagreement_score":0.16948628,"about_ca_system_score_codex":0.00033421075,"about_ca_system_score_gemma":0.00047851808,"threshold_uncertainty_score":0.99978375},"labels":[],"label_agreement":null},{"id":"W2848247105","doi":"10.1530/erc-18-0283","title":"65 YEARS OF THE DOUBLE HELIX: It’s all in the DNA: understanding and managing endocrine neoplasms","year":2018,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endocrine system; Helix (gastropod); DNA; Computational biology; Cancer research; Medicine; Computer science; Biology; Internal medicine; Genetics; Paleontology; Hormone","score_opus":0.02583665657043695,"score_gpt":0.3223109654274844,"score_spread":0.29647430885704745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2848247105","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045595072,0.04309403,0.00086669973,0.01125325,0.8772364,0.0056966287,0.0007978393,0.000110719804,0.015349314],"genre_scores_gemma":[0.53021574,0.10202145,0.00017560263,0.0012251042,0.33922124,0.0010503923,0.0014308044,0.0007688807,0.023890765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969426,0.00022716909,0.00051097665,0.0007487315,0.00087805226,0.0006924666],"domain_scores_gemma":[0.998458,0.00012212683,0.00028644231,0.000911096,0.00013910295,0.000083201136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045658593,0.00038632957,0.0003995278,0.0001773996,0.00011469823,0.0000674569,0.0008568356,0.00048408823,0.000095516356],"category_scores_gemma":[0.00020291594,0.00029792212,0.00019821613,0.00044350536,0.00029440777,0.00000887195,0.00063709304,0.0012863172,0.000006309947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040852933,0.000056137178,0.000015465363,0.00019873094,0.0006029124,0.00012975176,0.00036243998,0.0003845493,0.040595487,0.00035461228,0.9561468,0.00074458926],"study_design_scores_gemma":[0.003123931,0.00023848352,0.00001676268,0.00039122716,0.00017409537,0.00006701101,0.000281526,0.000073889554,0.037747778,0.00045208127,0.95704156,0.0003916427],"about_ca_topic_score_codex":0.001315325,"about_ca_topic_score_gemma":0.0018306202,"teacher_disagreement_score":0.5380152,"about_ca_system_score_codex":0.00031038676,"about_ca_system_score_gemma":0.00050572626,"threshold_uncertainty_score":0.9999473},"labels":[],"label_agreement":null},{"id":"W2870052481","doi":"10.1530/erc-18-0160","title":"65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents","year":2018,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Fondation du cancer des Cèdres; Children's Hospital Foundation; Fondation de l'Hôpital de Montréal pour enfants; National Institutes of Health; Pediatric Oncology Group of Ontario","keywords":"GNAS complex locus; Medullary thyroid cancer; Endocrine system; Medicine; Disease; MEN1; Bioinformatics; Genetic testing; Cancer; Precision medicine; Thyroid cancer; Biology; Genetics; Internal medicine; Gene; Pathology; Hormone","score_opus":0.02644096254670851,"score_gpt":0.35937220213488075,"score_spread":0.3329312395881722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2870052481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03293025,0.9630881,7.139624e-8,0.00018840525,0.00040301177,0.0028910984,0.00011670873,0.00007049228,0.00031184586],"genre_scores_gemma":[0.017217828,0.9784766,0.000023596433,0.00003809815,0.00020669252,0.00027126836,0.000049493858,0.00016574722,0.0035507134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959583,0.00023636475,0.0011547299,0.0009025287,0.0007927995,0.00095522444],"domain_scores_gemma":[0.99802417,0.00008940225,0.00055394793,0.000934259,0.00012456678,0.00027363427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001387473,0.0006367211,0.0022385414,0.000591932,0.00006103661,0.000025820375,0.0006058653,0.000054233515,0.0002695336],"category_scores_gemma":[0.00019423287,0.00045515265,0.0004970777,0.0013303874,0.00044573555,0.00012944345,0.00065242546,0.001654562,0.00006795553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008098604,0.0013377212,0.07439052,0.0628823,0.003079812,0.0119451145,0.000112182664,0.0000147117335,0.00012899605,0.0002526168,0.008803798,0.8362424],"study_design_scores_gemma":[0.009265496,0.00050278555,0.03267631,0.08031103,0.0018315928,0.035049714,0.000013544065,0.0000045074557,0.0005239875,0.000070208625,0.8388514,0.00089941785],"about_ca_topic_score_codex":0.00093400065,"about_ca_topic_score_gemma":0.00008783926,"teacher_disagreement_score":0.83534294,"about_ca_system_score_codex":0.00031282875,"about_ca_system_score_gemma":0.0006071225,"threshold_uncertainty_score":0.99979},"labels":[],"label_agreement":null},{"id":"W2883001605","doi":"10.1530/erc-18-0244","title":"Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization","keywords":"microRNA; Neuroendocrine tumors; Biology; Classifier (UML); Preprocessor; Computational biology; Artificial intelligence; Computer science; Genetics","score_opus":0.05979104104869274,"score_gpt":0.4035878385768374,"score_spread":0.3437967975281446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883001605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818538,0.001891251,0.00004942736,0.0040197247,0.0006701121,0.0011181353,0.000023786051,0.0005283201,0.009845463],"genre_scores_gemma":[0.98201245,0.00080636214,0.0041265124,0.0014269933,0.00081029604,0.00024001802,0.00003109371,0.0001832494,0.010363044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99513257,0.00023670043,0.00092427514,0.0010363426,0.0010004562,0.0016696884],"domain_scores_gemma":[0.99773496,0.00013899697,0.00031002436,0.00089938566,0.00047127224,0.00044533712],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001525717,0.00055302697,0.0008117327,0.0002815442,0.00031135292,0.00006246634,0.00036017495,0.000011694219,0.0029803775],"category_scores_gemma":[0.00074525835,0.0004910906,0.00025422848,0.000944014,0.00051384047,0.0004675516,0.00028156248,0.0010057418,0.00053776195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031150603,0.00051274,0.07060147,0.0010106484,0.0010270615,0.042222716,0.0006958201,0.0005735628,0.846633,0.00076756516,0.013311145,0.019529171],"study_design_scores_gemma":[0.017209997,0.009412315,0.00918997,0.0027778777,0.0008715845,0.08111564,0.0006359653,0.005858589,0.81736493,0.0015402484,0.052719988,0.0013028856],"about_ca_topic_score_codex":0.0007434994,"about_ca_topic_score_gemma":0.000076722645,"teacher_disagreement_score":0.061411496,"about_ca_system_score_codex":0.000675018,"about_ca_system_score_gemma":0.00048811853,"threshold_uncertainty_score":0.9997541},"labels":[],"label_agreement":null},{"id":"W2896060946","doi":"10.1530/erc-18-0226","title":"Neuroendocrine differentiation of prostate cancer leads to PSMA suppression","year":2018,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Windsor","funders":"Academy of Medical Sciences; Korea Health Industry Development Institute; National Institute for Health and Care Research; Cancer Research UK; Government of Ontario","keywords":"Somatostatin receptor 2; Prostate cancer; Cancer research; Enzalutamide; Somatostatin receptor; Neuroendocrine differentiation; Biology; Neuroendocrine tumors; Cell biology; Cancer; Molecular biology; Medicine; Internal medicine; Endocrinology; Somatostatin; Androgen receptor","score_opus":0.019242059246432963,"score_gpt":0.34537987315157886,"score_spread":0.3261378139051459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896060946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849,0.0029429048,0.000009397742,0.0080438135,0.0008601582,0.0010403983,0.000088883695,0.00011041996,0.0020040413],"genre_scores_gemma":[0.9699094,0.003821953,0.00008069511,0.0002238985,0.0003341349,0.00033460796,0.00007232525,0.000058083235,0.025164854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798614,0.000056035242,0.00042745477,0.00045593097,0.000490086,0.0005843696],"domain_scores_gemma":[0.9987701,0.000032256183,0.00013231256,0.00038745406,0.00039702616,0.00028085642],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000051707797,0.00024835503,0.00041771337,0.00027567797,0.000105596235,0.000015254794,0.00012842122,0.00003922419,0.0027973026],"category_scores_gemma":[0.000053620875,0.00018305899,0.00011269197,0.0006840044,0.0001487107,0.00011721689,0.000119047,0.00029016053,0.0000870369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004478259,0.0004977811,0.43411744,0.00048526088,0.0005187358,0.00029760247,0.0010461698,0.00011961371,0.45805407,0.00015200401,0.032859523,0.067373574],"study_design_scores_gemma":[0.0059031793,0.001342979,0.11041382,0.0007204599,0.00025316246,0.00007153172,0.000035201807,0.00037807558,0.84573686,0.000071867704,0.03482043,0.00025245693],"about_ca_topic_score_codex":0.00072786765,"about_ca_topic_score_gemma":0.000112484006,"teacher_disagreement_score":0.38768277,"about_ca_system_score_codex":0.00025216735,"about_ca_system_score_gemma":0.00023578126,"threshold_uncertainty_score":0.9981143},"labels":[],"label_agreement":null},{"id":"W2908714764","doi":"10.1530/erc-18-0523","title":"Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Limiting; Carcinogenesis; Prolactin; Phenotype; Cancer research; Medicine; Biology; Internal medicine; Cancer; Genetics; Gene; Hormone; Engineering","score_opus":0.009550721519378361,"score_gpt":0.2621290981097536,"score_spread":0.25257837659037524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908714764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785613,0.0067259967,0.0000043083533,0.0011936609,0.00092739274,0.0007257757,0.000011901217,0.00027445142,0.011575231],"genre_scores_gemma":[0.98925894,0.0011956047,0.00014127408,0.00037812348,0.00032708872,0.000079163896,0.000048536574,0.00009485221,0.0084764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784756,0.000045905832,0.00051456207,0.00054292293,0.00039201663,0.00065706274],"domain_scores_gemma":[0.998662,0.00008201004,0.0003518928,0.00045508763,0.00020927588,0.00023973978],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000935674,0.00034124317,0.0005490226,0.0002013616,0.000101645506,0.00002590878,0.00014227342,0.00013161908,0.0021189086],"category_scores_gemma":[0.00016150733,0.0002850337,0.0001935762,0.0005440054,0.000049562776,0.00021233353,0.000075173564,0.00059683545,0.0008823342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029256165,0.0005328479,0.76431847,0.0007238089,0.0016253375,0.0015908616,0.001503803,0.0007008634,0.15670943,0.0010079929,0.00777588,0.06058507],"study_design_scores_gemma":[0.011698283,0.0015048257,0.6925435,0.0016709317,0.0010261605,0.00065635436,0.0006000941,0.0046316744,0.2231218,0.0006167935,0.060298216,0.0016313829],"about_ca_topic_score_codex":0.00022229989,"about_ca_topic_score_gemma":0.0000054777215,"teacher_disagreement_score":0.071775,"about_ca_system_score_codex":0.00021562474,"about_ca_system_score_gemma":0.00020621618,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W2910743083","doi":"10.1530/erc-18-0465","title":"Roles of the HOXA10 gene during castrate-resistant prostate cancer progression","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Downregulation and upregulation; Biology; Transcriptome; Transcription factor; Cancer research; LNCaP; Gene expression; Androgen receptor; Gene; Prostate; Cancer; Genetics","score_opus":0.010206905508999772,"score_gpt":0.31775176286825046,"score_spread":0.3075448573592507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910743083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710331,0.022695927,1.124082e-7,0.002593218,0.00040234072,0.0014102957,0.00008042715,0.00005872104,0.0017258832],"genre_scores_gemma":[0.9652613,0.0057635535,0.000031517884,0.000030662075,0.00008824027,0.00027734714,0.00001803203,0.000048458085,0.02848093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981337,0.000056116714,0.00036710766,0.0003726691,0.00054889976,0.00052150374],"domain_scores_gemma":[0.99902,0.000019851459,0.00018766685,0.00044991952,0.00019015418,0.00013244597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008103257,0.00022730039,0.0003672036,0.000098774755,0.00010891661,0.000015426065,0.00015724234,0.00007053098,0.00099426],"category_scores_gemma":[0.000013162657,0.00012886034,0.00015734196,0.00048678683,0.00013413912,0.000090586516,0.0001166654,0.00042254353,0.000027521557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020885216,0.00016669995,0.2509274,0.00060650276,0.00048408474,0.00015867352,0.00052819756,0.00038480447,0.73696,0.000043869106,0.00037292158,0.007278352],"study_design_scores_gemma":[0.005986323,0.0002640153,0.14432248,0.0014133588,0.00017676876,0.00006627473,0.00012866463,0.00011509091,0.84283996,0.000034268367,0.004466047,0.00018675154],"about_ca_topic_score_codex":0.00058331556,"about_ca_topic_score_gemma":0.00012628578,"teacher_disagreement_score":0.106604904,"about_ca_system_score_codex":0.00036044314,"about_ca_system_score_gemma":0.0005328227,"threshold_uncertainty_score":0.99991894},"labels":[],"label_agreement":null},{"id":"W2915015126","doi":"10.1530/erc-18-0332","title":"Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Chromosome instability; Internal medicine; Oncology; Genome instability; Clinical trial; Biomarker; Medicine; Neuroendocrine tumors; Multivariate analysis; Biology; Genetics; Chromosome; Gene","score_opus":0.03917875316243985,"score_gpt":0.3686049822565779,"score_spread":0.32942622909413805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915015126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943114,0.0064683207,0.0000028022016,0.0011425961,0.0002794841,0.0013544197,0.000083011604,0.000026411839,0.001211817],"genre_scores_gemma":[0.9961826,0.0014294457,0.0001770155,0.000120263816,0.000033697117,0.000049735223,0.000017497774,0.000029456152,0.0019602412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976602,0.0002811283,0.0008909751,0.00031775632,0.00048453076,0.00036536937],"domain_scores_gemma":[0.9979844,0.00043693153,0.0005534034,0.0006631145,0.00025678013,0.00010535118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001890447,0.00017728955,0.0012804604,0.0004256054,0.000027881872,0.000004897635,0.00023226975,0.000013043067,0.0012415437],"category_scores_gemma":[0.00039745064,0.00011239081,0.0005927276,0.001670633,0.00014135738,0.000056894914,0.00011989201,0.00037478443,0.000016941338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008260155,0.00014009423,0.25347528,0.00038120226,0.005975622,0.00018734117,0.00011417721,0.013495913,0.72238636,0.0004940667,0.00040497386,0.0021189349],"study_design_scores_gemma":[0.008813405,0.0006367706,0.19554766,0.00051375304,0.0058839247,0.00030159715,0.00038436285,0.0054302197,0.7652055,0.00015889092,0.016801342,0.00032259547],"about_ca_topic_score_codex":0.00052665034,"about_ca_topic_score_gemma":0.000034464207,"teacher_disagreement_score":0.057927635,"about_ca_system_score_codex":0.00011904661,"about_ca_system_score_gemma":0.00028063325,"threshold_uncertainty_score":0.99967146},"labels":[],"label_agreement":null},{"id":"W2991511894","doi":"10.1530/erc-19-0258","title":"Photodynamic therapy enables tumor-specific ablation in preclinical models of thyroid cancer","year":2019,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute; Terry Fox Research Institute; Princess Margaret Cancer Foundation","keywords":"Medicine; Thyroid cancer; Photodynamic therapy; Thyroid; Cancer; Malignancy; Thyroid carcinoma; Ablation; Pathology; Cancer research; Oncology; Internal medicine; Surgery; Chemistry","score_opus":0.027580300683800515,"score_gpt":0.32287675943587335,"score_spread":0.29529645875207283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991511894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9221642,0.07185469,0.0000043754594,0.000836045,0.00042768283,0.0010606372,0.000042273972,0.00005599248,0.0035540818],"genre_scores_gemma":[0.9200626,0.07768294,0.000059420257,0.00016609204,0.000084932064,0.00045581465,0.00003403246,0.00005073379,0.00140344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980768,0.00005659285,0.00065089035,0.0004946055,0.00033751543,0.00038358822],"domain_scores_gemma":[0.9990305,0.00010087191,0.00022996387,0.00043209866,0.000105770785,0.00010084844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000115783325,0.00025399617,0.0006260878,0.00018090042,0.000023466195,0.00000903519,0.00010743849,0.000086984575,0.0022498737],"category_scores_gemma":[0.0000074098766,0.00020444834,0.00017813042,0.00042353358,0.000056074867,0.00015603314,0.000030242427,0.0003400096,0.000036398567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047620507,0.002985857,0.6956238,0.00042616602,0.0015989378,0.00026860007,0.0014915845,0.1037954,0.09772791,0.003824009,0.0044443444,0.0830513],"study_design_scores_gemma":[0.07105522,0.003466623,0.632389,0.004433265,0.00048490576,0.00013396748,0.00036569865,0.026748735,0.20142779,0.0043654568,0.053560928,0.0015684073],"about_ca_topic_score_codex":0.0028342956,"about_ca_topic_score_gemma":0.00030725257,"teacher_disagreement_score":0.103699885,"about_ca_system_score_codex":0.00051926094,"about_ca_system_score_gemma":0.00026097178,"threshold_uncertainty_score":0.99866223},"labels":[],"label_agreement":null},{"id":"W2994033895","doi":"10.1530/erc-19-0420","title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","year":2019,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Medical Research Council; Prostate Cancer Foundation","keywords":"Epigenetics; Reprogramming; Biology; Prostate cancer; Epigenome; Lineage (genetic); Cancer research; DNA methylation; Phenotype; Cancer; Transcription factor; Genetics; Gene; Gene expression","score_opus":0.043541312039840095,"score_gpt":0.37492675142322535,"score_spread":0.33138543938338527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994033895","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029527783,0.99392647,3.6202368e-7,0.0013106237,0.00067865744,0.002331235,0.00044074265,0.00004333617,0.0009732933],"genre_scores_gemma":[0.0003123564,0.9621072,0.000008401373,0.00002792192,0.00016999246,0.0008469115,0.00021135015,0.00010792481,0.036207948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973422,0.00013786857,0.00078921847,0.00057858526,0.00050278706,0.00064930646],"domain_scores_gemma":[0.9986238,0.0002072187,0.00032683864,0.00048001294,0.00016582361,0.00019634671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010606429,0.00050266803,0.001581636,0.00021648516,0.00013864499,0.000031982607,0.00019998958,0.00009150501,0.00059833145],"category_scores_gemma":[0.000027932472,0.00027884782,0.0004411564,0.0005327656,0.0002646719,0.000054089858,0.000088913854,0.0008576951,0.000029402443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023619819,0.00006897627,0.00061748736,0.015050978,0.0015533157,0.00015419656,0.00005899914,0.000007916264,0.000021918702,0.00021865245,0.0014924088,0.98051894],"study_design_scores_gemma":[0.0023228338,0.0002685198,0.00029790064,0.008399187,0.0025951902,0.00040250085,0.000014561171,0.00002527853,0.000050303068,0.000034197426,0.9853394,0.0002501202],"about_ca_topic_score_codex":0.00025229764,"about_ca_topic_score_gemma":0.000042110263,"teacher_disagreement_score":0.983847,"about_ca_system_score_codex":0.00019061341,"about_ca_system_score_gemma":0.0012232331,"threshold_uncertainty_score":0.9999664},"labels":[],"label_agreement":null},{"id":"W29986924","doi":"10.1530/erc-18-0160","title":"Reply to Todres, Stephenson and Jones","year":2017,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"History","score_opus":0.01701823401570567,"score_gpt":0.3198969860869099,"score_spread":0.30287875207120424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29986924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95125014,0.0067938617,0.0000030897443,0.015485963,0.00023023834,0.00030402464,0.000016088592,0.000055847697,0.025860744],"genre_scores_gemma":[0.9781879,0.0018565952,0.00012991038,0.0011155788,0.00008064649,0.00003973509,0.000010505996,0.000017321821,0.018561818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993126,0.000007243183,0.00012268523,0.00023760412,0.00011040207,0.00020951522],"domain_scores_gemma":[0.99932903,0.000009979565,0.00005079062,0.00040334498,0.000032780456,0.0001740611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024594363,0.000115633105,0.00019629991,0.000043256347,0.00019100134,0.000028805955,0.000057913676,0.00002544148,0.00030271348],"category_scores_gemma":[0.000054964905,0.00008714099,0.000036839298,0.000034004177,0.000035081404,0.00007939971,0.000058013506,0.00009263303,0.000057357254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065077114,0.00021785327,0.8192446,0.0000907065,0.0004631513,0.0011234203,0.00037330706,0.000012195499,0.0007568885,0.0006364562,0.047752474,0.12867816],"study_design_scores_gemma":[0.006699281,0.000415661,0.7025903,0.00021433026,0.00025535497,0.00021554327,0.000054647782,0.00004348511,0.0014860071,0.00055850815,0.28724864,0.00021826742],"about_ca_topic_score_codex":0.0035542212,"about_ca_topic_score_gemma":0.0001082579,"teacher_disagreement_score":0.23949619,"about_ca_system_score_codex":0.00003533976,"about_ca_system_score_gemma":0.000034275115,"threshold_uncertainty_score":0.5372943},"labels":[],"label_agreement":null},{"id":"W2998813768","doi":"10.1530/erc-19-0448","title":"Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Ministry of Economic Development and Innovation; Medical Research Council; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Novartis Pharma; Wellcome Trust; Genome Canada; Ontario Genomics; Pfizer","keywords":"Somatostatin receptor 2; Propidium iodide; Corticotropic cell; Apoptosis; Molecular biology; Cell cycle; Flow cytometry; Somatostatin; Adrenocorticotropic hormone; Cancer research; Biology; Somatostatin receptor; Chemistry; Endocrinology; Biochemistry; Hormone; Anterior pituitary","score_opus":0.005619348997792304,"score_gpt":0.22123994661301688,"score_spread":0.21562059761522456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998813768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358225,0.0037744523,0.00011558798,0.000799774,0.0005214755,0.0003941963,0.000019709893,0.00003357641,0.0007590062],"genre_scores_gemma":[0.9970326,0.0012156096,0.00007188605,0.00053487497,0.00030246342,0.000049772756,0.00002931009,0.000035505644,0.0007279743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886376,0.000069078334,0.00031175374,0.00034271044,0.00017839932,0.0002342967],"domain_scores_gemma":[0.99944705,0.000015745554,0.00015356267,0.00017458036,0.000058655234,0.00015043588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026564807,0.00018333836,0.0001978219,0.000035719142,0.000036297555,0.00000768109,0.00013748097,0.00008831782,0.00008602347],"category_scores_gemma":[0.000094208815,0.00016798946,0.00012203911,0.0001710486,0.000056391043,0.0000033104288,0.00006828915,0.00016453186,0.00004817929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008010424,0.00005377009,0.0001663546,0.00006145288,0.00005889797,0.000028436381,0.00003411632,0.0003224734,0.99158204,0.00004704334,0.003959143,0.0036061548],"study_design_scores_gemma":[0.00094355486,0.00059474836,0.0004424007,0.000050505998,0.000025071373,0.0000036429594,0.0000085406,0.00005868439,0.95407104,0.000012432395,0.04361514,0.00017423905],"about_ca_topic_score_codex":0.000032442837,"about_ca_topic_score_gemma":0.0000026843309,"teacher_disagreement_score":0.039656,"about_ca_system_score_codex":0.000020695688,"about_ca_system_score_gemma":0.000084244966,"threshold_uncertainty_score":0.6850411},"labels":[],"label_agreement":null},{"id":"W3005995778","doi":"10.1530/erc-19-0417","title":"Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thyroid cancer; Meta-analysis; Internal medicine; Cochrane Library; Incidence (geometry); Relative risk; Prostate cancer; Oncology; Breast cancer; Publication bias; Cancer; Confounding; Gynecology; Confidence interval","score_opus":0.051508940819235995,"score_gpt":0.3708871010082483,"score_spread":0.3193781601890123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005995778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015955144,0.99130833,0.0000025991576,0.003249407,0.000100279285,0.0047725225,0.00030611735,0.000105212595,0.00015396233],"genre_scores_gemma":[0.000039979397,0.9856035,0.000025394214,0.0011008733,0.00008305829,0.00991934,0.00013164777,0.00009716007,0.0029990159],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962954,0.00030554793,0.0014406728,0.0010865311,0.00047745707,0.00039441738],"domain_scores_gemma":[0.9976115,0.00019498802,0.000977837,0.00067480217,0.00014558081,0.00039528622],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021299146,0.00089071447,0.01218278,0.00032437796,0.00010118621,0.00005088518,0.00012841205,0.00019912054,0.001818009],"category_scores_gemma":[0.00011034647,0.0005386562,0.002255816,0.001621087,0.00008125675,0.000102805214,0.00012967031,0.0006965885,0.00004158518],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005850546,0.00003753782,0.000013511309,0.646247,0.33277786,0.00018987046,0.000027623617,0.0000011839404,8.620937e-8,0.000032928296,0.0015382958,0.019128203],"study_design_scores_gemma":[0.00036380682,0.00010329593,0.000004677101,0.056724038,0.7132317,0.00028573227,0.0000047352146,0.0000046948658,6.2211365e-7,0.0000050769527,0.22896037,0.00031125365],"about_ca_topic_score_codex":0.0009093189,"about_ca_topic_score_gemma":0.000131475,"teacher_disagreement_score":0.589523,"about_ca_system_score_codex":0.0005980391,"about_ca_system_score_gemma":0.00041168323,"threshold_uncertainty_score":0.9997065},"labels":[],"label_agreement":null},{"id":"W3014356214","doi":"10.1530/erc-19-0463","title":"Pulmonary and overall healthcare utilization after childhood and young adult thyroid cancer","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; The Scarborough Hospital; Public Health Ontario; University of Toronto; Pediatric Oncology Group","funders":"Pediatric Oncology Group of Ontario; Government of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Childhood cancer; Medicine; Thyroid cancer; Health care; Pediatrics; Cancer; Intensive care medicine; Oncology; Internal medicine; Political science","score_opus":0.015543057188599545,"score_gpt":0.28242053054796673,"score_spread":0.2668774733593672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014356214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7862731,0.1743012,0.0000028934232,0.037629236,0.00021200928,0.0006085512,0.000117246236,0.00011310653,0.00074263586],"genre_scores_gemma":[0.8846933,0.11017666,0.000037243968,0.003912462,0.00025141434,0.00043445372,0.00004794406,0.000046020206,0.00040050133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986374,0.00003144418,0.0002773864,0.0005129912,0.00021605905,0.00032475637],"domain_scores_gemma":[0.9992805,0.000015251074,0.000085736436,0.00015884568,0.00010030092,0.00035936612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019576584,0.00025335688,0.00035144723,0.00005089653,0.0000796988,0.000023002965,0.000036120007,0.000076737946,0.00047595066],"category_scores_gemma":[0.000018590195,0.00021277477,0.000060956387,0.0001873739,0.000052917945,0.00012431579,0.000058983293,0.00027369705,0.000010312379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007370184,0.00022894236,0.9066211,0.0004957984,0.0005411613,0.00069672236,0.002239924,0.000029060791,0.00065337657,0.0005204355,0.0031748984,0.08406158],"study_design_scores_gemma":[0.005592835,0.0006280161,0.9785508,0.00069696835,0.00053005695,0.00041121437,0.00014583941,0.0007394941,0.0017923245,0.00014571293,0.010373295,0.00039343062],"about_ca_topic_score_codex":0.0027061915,"about_ca_topic_score_gemma":0.00028981554,"teacher_disagreement_score":0.09842018,"about_ca_system_score_codex":0.0001647352,"about_ca_system_score_gemma":0.00012298672,"threshold_uncertainty_score":0.86767036},"labels":[],"label_agreement":null},{"id":"W3032997756","doi":"10.1530/erc-20-0201","title":"HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: History of the multiple endocrine neoplasia workshops and overview of MEN2019","year":2020,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pheochromocytoma; Multiple endocrine neoplasia; MEN1; Medicine; Multiple endocrine neoplasia type 2; Thyroid carcinoma; Endocrine system; Cancer; Thyroid cancer; Thyroid; Internal medicine; Hormone; Biology; Gene; Germline mutation; Genetics","score_opus":0.09646010021006984,"score_gpt":0.38087666160831646,"score_spread":0.2844165613982466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032997756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051783707,0.5464888,0.0000017974698,0.009506262,0.38027233,0.006414556,0.002940201,0.00016290085,0.002429434],"genre_scores_gemma":[0.1267544,0.6692964,0.00026923322,0.00022041822,0.11381918,0.0014114068,0.0007758406,0.0009881036,0.086465016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909864,0.0010010584,0.0018802858,0.0011755467,0.0036740683,0.0012826256],"domain_scores_gemma":[0.9923308,0.0028228941,0.0012229042,0.0015491002,0.001484872,0.000589412],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005301787,0.00085683994,0.0021335406,0.0005726297,0.00013748615,0.000021269709,0.0010457214,0.0000759805,0.00035789245],"category_scores_gemma":[0.0045374753,0.0006015752,0.000478886,0.0010410311,0.0023037186,0.00025786224,0.0019848177,0.005147171,0.000005577954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011429131,0.00030864018,0.002582194,0.007886862,0.0005361844,0.001147323,0.0003510333,0.000027545902,0.0010691207,0.0000517311,0.96569794,0.019198494],"study_design_scores_gemma":[0.004724233,0.0007626885,0.0010477818,0.005816559,0.0004903764,0.00058238406,0.00017166721,0.000082585655,0.0048448048,0.00021686901,0.9808456,0.00041448502],"about_ca_topic_score_codex":0.0012261183,"about_ca_topic_score_gemma":0.0004286182,"teacher_disagreement_score":0.26645315,"about_ca_system_score_codex":0.00095649675,"about_ca_system_score_gemma":0.0044312933,"threshold_uncertainty_score":0.99964356},"labels":[],"label_agreement":null},{"id":"W3037336826","doi":"10.1530/erc-20-0135","title":"Tyrosine kinase inhibitor therapy and metabolic remodelling in papillary thyroid cancer","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Papillary thyroid cancer; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Thyroid cancer; Medicine; Tyrosine; Cancer; Oncology; Internal medicine; Biology; Endocrinology; Receptor; Biochemistry","score_opus":0.030049953456722983,"score_gpt":0.287824498911565,"score_spread":0.257774545454842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037336826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6487143,0.3349392,0.000003628521,0.015251528,0.00017159482,0.00046316374,0.000028435388,0.000083360785,0.0003447867],"genre_scores_gemma":[0.7256069,0.27123824,0.00011369,0.0021051578,0.000355755,0.00026668992,0.000017553517,0.00005296794,0.00024304395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983044,0.00004646489,0.00040932477,0.00055534637,0.00025782496,0.0004266379],"domain_scores_gemma":[0.9992691,0.000036577523,0.00010154335,0.00022255415,0.00006426024,0.00030592992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000056958368,0.00031274415,0.00058494054,0.00010807247,0.000061351806,0.000021911788,0.00006866517,0.000082779974,0.00048811766],"category_scores_gemma":[0.000019353196,0.0002511985,0.00010746803,0.00053096697,0.00006059494,0.00011788759,0.000048286296,0.0004016767,0.000015552214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032747367,0.0011305468,0.40965596,0.00045626846,0.0019975307,0.0026012182,0.0053025265,0.0059891352,0.10666753,0.0017958485,0.014534872,0.44659382],"study_design_scores_gemma":[0.050150104,0.002009065,0.18791947,0.0020217358,0.0010696361,0.00019764522,0.00031866462,0.0076932516,0.32469904,0.00038552342,0.4218555,0.0016803308],"about_ca_topic_score_codex":0.0018637545,"about_ca_topic_score_gemma":0.00012801346,"teacher_disagreement_score":0.4449135,"about_ca_system_score_codex":0.0001672615,"about_ca_system_score_gemma":0.00017464146,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W3091526633","doi":"10.1530/erc-20-0297","title":"Adiponectin receptor activation inhibits prostate cancer xenograft growth","year":2020,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; State Government of Victoria; Prostate Cancer Foundation of Australia; Society for Endocrinology; Movember Foundation; Australian Government; Prostate Cancer Foundation","keywords":"Adiponectin; Adiponectin receptor 1; LNCaP; Prostate cancer; Adipokine; Cancer research; Endocrinology; Internal medicine; Medicine; Cancer; Biology; Insulin resistance; Insulin","score_opus":0.014645533151671823,"score_gpt":0.27615078193587606,"score_spread":0.2615052487842042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091526633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95441407,0.006496493,0.000035910565,0.03242843,0.000592303,0.0011173384,0.00009581315,0.00051574706,0.0043038903],"genre_scores_gemma":[0.980408,0.008184484,0.0001635923,0.0026599967,0.0013105212,0.00046576216,0.00023962192,0.00008942362,0.0064785727],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982677,0.000052284588,0.00045921994,0.00043603848,0.00037364845,0.00041112542],"domain_scores_gemma":[0.9988169,0.00003544838,0.00021312734,0.00018494426,0.00033651912,0.0004130736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000585637,0.00027314146,0.00039603765,0.00012008637,0.00011166629,0.00002348062,0.000086170054,0.00007843893,0.003003307],"category_scores_gemma":[0.00032077814,0.00023816439,0.0001322592,0.000772257,0.00006331778,0.00029163185,0.000037308633,0.0003480066,0.00015015868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005510602,0.0007217022,0.17714012,0.0023580624,0.003090205,0.00013498735,0.011231891,0.001785723,0.3291133,0.003104037,0.2032606,0.26254877],"study_design_scores_gemma":[0.0068648392,0.00025482042,0.034188684,0.0006748728,0.00077045575,0.000021999042,0.00019643102,0.00047323387,0.3142309,0.0001449858,0.6415798,0.00059899513],"about_ca_topic_score_codex":0.0007648923,"about_ca_topic_score_gemma":0.000025405187,"teacher_disagreement_score":0.4383192,"about_ca_system_score_codex":0.00015088683,"about_ca_system_score_gemma":0.00040875835,"threshold_uncertainty_score":0.99790806},"labels":[],"label_agreement":null},{"id":"W3126018719","doi":"10.1530/erc-20-0382","title":"Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nausea; Neuroendocrine tumors; Internal medicine; Clinical endpoint; Gastroenterology; Confidence interval; Oncology; Clinical trial","score_opus":0.02156480544578787,"score_gpt":0.3332527958309429,"score_spread":0.31168799038515504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126018719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700032,0.008991053,0.000015444044,0.008885121,0.00081621564,0.00085660134,0.00004790942,0.00034910414,0.010035369],"genre_scores_gemma":[0.9672185,0.007688084,0.00040959645,0.0006606556,0.000111109286,0.0002805234,0.00017805898,0.00015700237,0.023296429],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99542433,0.0003040768,0.0009308826,0.00103687,0.00088592886,0.0014179377],"domain_scores_gemma":[0.99796844,0.00021372047,0.00017413544,0.00084325083,0.00027564928,0.0005248318],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006845692,0.0005287703,0.000981659,0.0004863826,0.00009638498,0.00006683863,0.00024783472,0.0000135559,0.007017438],"category_scores_gemma":[0.00049445016,0.00049028365,0.00027277108,0.0018297771,0.00015814841,0.00029959215,0.00025845136,0.0012765832,0.00040244067],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027571982,0.003535689,0.20031077,0.0012500886,0.0015924741,0.6547133,0.00018474992,0.002115286,0.08709141,0.003129497,0.017415842,0.025903707],"study_design_scores_gemma":[0.033133466,0.0011981238,0.078812376,0.0010003716,0.000755165,0.04054114,0.00036986984,0.0031964916,0.54475033,0.0016026918,0.29314682,0.0014931444],"about_ca_topic_score_codex":0.0006477407,"about_ca_topic_score_gemma":0.0011376153,"teacher_disagreement_score":0.61417216,"about_ca_system_score_codex":0.00029067494,"about_ca_system_score_gemma":0.000537433,"threshold_uncertainty_score":0.9997549},"labels":[],"label_agreement":null},{"id":"W3134335774","doi":"10.1530/erc-20-0504","title":"KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Gene knockdown; Biology; Cell growth; Prostate cancer; Transcription factor; Cancer research; Cell; Androgen receptor; Cell biology; Gene; Cancer; Genetics","score_opus":0.008863425710436808,"score_gpt":0.28919489979411445,"score_spread":0.28033147408367765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134335774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630889,0.03421519,0.000005809614,0.00031952723,0.00032753425,0.00021017538,0.00020760107,0.000016268888,0.001608953],"genre_scores_gemma":[0.9683814,0.0154821435,0.0000772472,0.00005568466,0.000092880546,0.00004901962,0.0001227087,0.00005464366,0.015684295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837625,0.00005933244,0.00031444433,0.0005229134,0.00028464888,0.0004424245],"domain_scores_gemma":[0.99894714,0.000018017432,0.00013051998,0.0004082387,0.000319269,0.00017678516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067382505,0.0002408052,0.00030238004,0.000051366027,0.000062994404,0.000021517044,0.00015530366,0.00014199207,0.00075969135],"category_scores_gemma":[0.000090371606,0.00021633996,0.00011215845,0.00024521272,0.00013254599,0.000012129639,0.00024263763,0.00022715851,0.0000044444846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069829584,0.000085557156,0.033051737,0.000080281374,0.0002581554,0.000014640431,0.00017720165,0.00015309788,0.9633994,0.000111391375,0.001245812,0.0013528623],"study_design_scores_gemma":[0.0011826422,0.00006255016,0.0145409955,0.000033209395,0.000061630744,0.000019103334,0.00017510919,0.0000204934,0.91055197,0.000036444697,0.073081456,0.00023441487],"about_ca_topic_score_codex":0.0029442043,"about_ca_topic_score_gemma":0.00044614394,"teacher_disagreement_score":0.071835645,"about_ca_system_score_codex":0.000060159044,"about_ca_system_score_gemma":0.0004968599,"threshold_uncertainty_score":0.88220876},"labels":[],"label_agreement":null},{"id":"W3149820296","doi":"10.1530/erc-20-0496","title":"Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Atrial fibrillation; Thyroid cancer; Meta-analysis; Medicine; Internal medicine; Thyroid; Cancer; Oncology; Cardiology","score_opus":0.047142731222190336,"score_gpt":0.3537511047315806,"score_spread":0.3066083735093903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149820296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037935697,0.9926239,0.000001668385,0.00021225326,0.00032195396,0.0023269074,0.00056124333,0.00008124613,0.00007721486],"genre_scores_gemma":[0.0050782496,0.989045,0.000027061802,0.00003367324,0.00025131437,0.0009968941,0.0032270148,0.00013978432,0.0012009967],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955312,0.0003270454,0.001430992,0.0012038826,0.00088213605,0.0006247594],"domain_scores_gemma":[0.99747384,0.0001534364,0.0009820233,0.0008487319,0.0002940178,0.00024796365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000100316276,0.0009587654,0.0073099965,0.0008734266,0.00007297979,0.00005653427,0.00015649754,0.00029474718,0.004391265],"category_scores_gemma":[0.000034764853,0.000610308,0.0047346847,0.0031427513,0.000047056536,0.00010097327,0.00011131557,0.00071716076,0.000024791369],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002286781,0.00030905235,0.059677925,0.0025165437,0.6593279,0.0003248313,0.00006489408,0.0018529203,5.2624507e-8,0.00002503179,0.00056300306,0.27510917],"study_design_scores_gemma":[0.0048082513,0.00026670878,0.009055842,0.002623096,0.7048791,0.000011144636,0.0000034729492,0.000014998632,0.000002033066,0.00000204959,0.27777374,0.0005595662],"about_ca_topic_score_codex":0.0039581424,"about_ca_topic_score_gemma":0.0021065322,"teacher_disagreement_score":0.2772107,"about_ca_system_score_codex":0.0020231039,"about_ca_system_score_gemma":0.000959729,"threshold_uncertainty_score":0.9996348},"labels":[],"label_agreement":null},{"id":"W3162319908","doi":"10.1530/erc-21-0030","title":"A pilot study of everolimus and radiation for neuroendocrine liver metastases","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Everolimus; Medicine; Neuroendocrine tumors; Tolerability; Radiation therapy; Oncology; Internal medicine; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Urology; Phases of clinical research; Toxicity; Chemotherapy; Adverse effect","score_opus":0.03787095804094056,"score_gpt":0.34970388152816295,"score_spread":0.3118329234872224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162319908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808612,0.015554386,0.0000126499735,0.001283327,0.00027027368,0.0015541352,0.000074893454,0.00008473528,0.0003044093],"genre_scores_gemma":[0.9900833,0.005926697,0.0002719518,0.00016340178,0.00009870117,0.00036330445,0.000038212336,0.000057754332,0.0029966934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794185,0.0001540572,0.0004786445,0.000532615,0.0004254635,0.00046739748],"domain_scores_gemma":[0.99856335,0.00033779882,0.0001557592,0.0003915341,0.00034025218,0.00021128224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006654234,0.00023307794,0.0005471659,0.00020583053,0.00008048675,0.000018008104,0.00008562166,0.0000030729548,0.00035536083],"category_scores_gemma":[0.0007005418,0.00021207372,0.000081415936,0.0005073642,0.00007687203,0.00017126623,0.00012187258,0.00029493397,0.0000047339986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022173014,0.028195465,0.24609296,0.005935383,0.0070091654,0.10553327,0.0011260379,0.0023831765,0.31321216,0.0030041218,0.033618722,0.23171653],"study_design_scores_gemma":[0.09537863,0.063558966,0.14492649,0.00066838367,0.003897845,0.0288612,0.0021359737,0.0030400336,0.52050793,0.000811956,0.13482442,0.0013881667],"about_ca_topic_score_codex":0.0005437138,"about_ca_topic_score_gemma":0.00030885093,"teacher_disagreement_score":0.23032837,"about_ca_system_score_codex":0.00006703451,"about_ca_system_score_gemma":0.00018814323,"threshold_uncertainty_score":0.86481154},"labels":[],"label_agreement":null},{"id":"W3169559325","doi":"10.1530/erc-21-0116","title":"Targeting androgen receptor signaling: a historical perspective","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Prostate Cancer Canada; Prostate Cancer Foundation","keywords":"Prostate cancer; Medicine; Androgen deprivation therapy; Cancer; Disease; Hormonal therapy; Oncology; Prostate; Internal medicine; Androgen; Hormone","score_opus":0.05901755478858615,"score_gpt":0.3948831400957289,"score_spread":0.3358655853071427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169559325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008318857,0.99367344,0.0000029657645,0.0009481904,0.0009173811,0.0012432252,0.00007543784,0.00015613272,0.0029749272],"genre_scores_gemma":[0.000004786787,0.94504565,0.0001760472,0.000030813822,0.0008873211,0.00064648455,0.00058542745,0.0001560701,0.052467383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968196,0.0002261794,0.00073441176,0.0009240557,0.00055861135,0.00073714316],"domain_scores_gemma":[0.99834436,0.00015313533,0.0002872832,0.00040866263,0.0004382615,0.00036828185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015629771,0.00059130485,0.002466348,0.00031139608,0.00014482351,0.000034147015,0.00017047976,0.0003325464,0.0046657366],"category_scores_gemma":[0.00021873455,0.00043269468,0.0009408819,0.0010406513,0.00006962101,0.000060875405,0.00013269756,0.0015665332,0.00019869444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013647694,0.00045939945,0.00006451425,0.012586541,0.006868933,0.004634303,0.00046373182,0.0000055564064,0.00006660987,0.00034850714,0.11125836,0.8631071],"study_design_scores_gemma":[0.0012390495,0.00015895937,1.5134486e-7,0.013732565,0.0023623824,0.00033547194,0.000096222175,0.0000037820937,0.00007683339,0.000013894102,0.9815805,0.00040020706],"about_ca_topic_score_codex":0.00044504253,"about_ca_topic_score_gemma":0.0000024748615,"teacher_disagreement_score":0.8703221,"about_ca_system_score_codex":0.010113386,"about_ca_system_score_gemma":0.0025730717,"threshold_uncertainty_score":0.9998125},"labels":[],"label_agreement":null},{"id":"W3170594626","doi":"10.1530/erc-21-0098","title":"Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer","year":2021,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; National Cancer Institute; Dan L. Duncan Cancer Center, Baylor College of Medicine; Adrienne Helis Malvin Medical Research Foundation; Prostate Cancer Foundation","keywords":"Enzalutamide; Bicalutamide; Prostate cancer; Androgen receptor; Medicine; Flutamide; Abiraterone acetate; Cyproterone acetate; Androgen; Oncology; Internal medicine; Androgen deprivation therapy; Antiandrogen; Cancer; Pharmacology; Hormone","score_opus":0.02342480583172414,"score_gpt":0.3628771149748778,"score_spread":0.33945230914315366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170594626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011997151,0.9815074,5.578193e-7,0.002064161,0.00038120896,0.00335753,0.0003930867,0.00008648083,0.00021241758],"genre_scores_gemma":[0.00036343076,0.9871846,0.00012055381,0.00020635125,0.00048788387,0.0012523415,0.000921526,0.00021441649,0.009248886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963403,0.00025694043,0.0009805706,0.0010920367,0.0005074178,0.00082276633],"domain_scores_gemma":[0.99836123,0.00017017522,0.0003819661,0.0003942884,0.00038427775,0.00030803797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021498888,0.00079905294,0.0022770234,0.0004542486,0.000114480536,0.00008604772,0.00011184477,0.00039811613,0.0011076994],"category_scores_gemma":[0.000037191625,0.00062502525,0.00039542644,0.0010329974,0.000179634,0.00016392393,0.00007299555,0.0012862117,0.00002175629],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049886614,0.00022149437,0.0010298126,0.0069252304,0.002239763,0.0009967065,0.0013833249,0.000013146461,0.00069652783,0.000008731032,0.0021091024,0.9838773],"study_design_scores_gemma":[0.006530255,0.00043057202,0.00009374824,0.045392387,0.0009749259,0.00046375234,0.00018490723,0.000019647969,0.0045134095,0.000008960802,0.94056803,0.00081939093],"about_ca_topic_score_codex":0.0012591147,"about_ca_topic_score_gemma":0.0003461974,"teacher_disagreement_score":0.9830579,"about_ca_system_score_codex":0.0012593481,"about_ca_system_score_gemma":0.0024295396,"threshold_uncertainty_score":0.99980545},"labels":[],"label_agreement":null},{"id":"W3174319659","doi":"10.1530/erc-21-0192","title":"Celebrating the 80th anniversary of hormone ablation for prostate cancer","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Medicine; Androgen; Cancer; Disease; Radiation therapy; Prostate; Ablation; Oncology; Endocrine system; Internal medicine; Hormone; Cancer research; Bioinformatics; Biology","score_opus":0.020317115866904788,"score_gpt":0.3338556181193614,"score_spread":0.3135385022524566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174319659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84988785,0.12259574,0.00006638877,0.020611955,0.00042428865,0.0017110126,0.00024119591,0.000079867714,0.0043817074],"genre_scores_gemma":[0.95103055,0.017455041,0.000290489,0.00016993491,0.0002003753,0.00046132732,0.00017253325,0.000039883533,0.030179843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887013,0.000038161055,0.00026532062,0.00025188056,0.00025111137,0.00032338614],"domain_scores_gemma":[0.9991001,0.00009061138,0.00012073979,0.00021967414,0.0003942282,0.000074631804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009582031,0.00013252534,0.0002470278,0.00005836029,0.00013205725,0.000012496693,0.000060551713,0.000046025416,0.00031455097],"category_scores_gemma":[0.000048192243,0.00008705732,0.00011724352,0.0004320792,0.00008654733,0.00009251545,0.000040897896,0.0002257006,0.0000036595754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054036095,0.00073696696,0.11485158,0.0013426534,0.0044459,0.0007524669,0.007295585,0.0037965414,0.5702195,0.0019315192,0.10095701,0.18826665],"study_design_scores_gemma":[0.024300931,0.0011461722,0.060667597,0.0009421375,0.0013474616,0.0001626181,0.002180351,0.009684124,0.74196136,0.0010501721,0.15597844,0.00057864236],"about_ca_topic_score_codex":0.00045708413,"about_ca_topic_score_gemma":0.00008215368,"teacher_disagreement_score":0.18768801,"about_ca_system_score_codex":0.00021292036,"about_ca_system_score_gemma":0.00061215414,"threshold_uncertainty_score":0.35500947},"labels":[],"label_agreement":null},{"id":"W4200075526","doi":"10.1530/erc-21-0107","title":"Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial","year":2021,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Finasteride; Obesity; Prostate; Cancer; Testosterone (patch); Odds ratio; PCA3","score_opus":0.013507635379501035,"score_gpt":0.2949682247587653,"score_spread":0.2814605893792642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200075526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8904428,0.08066781,0.0000010542008,0.020494292,0.0014128403,0.0025149628,0.0038005922,0.00011645364,0.00054919935],"genre_scores_gemma":[0.71100765,0.27001756,0.000088760404,0.0005400039,0.0006227629,0.002133854,0.00047907623,0.000075137,0.015035185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688286,0.0002918379,0.0007308667,0.0009797761,0.0004719724,0.00064270117],"domain_scores_gemma":[0.9981116,0.00023969503,0.00045905102,0.0006245359,0.00030161033,0.0002634921],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027982544,0.00042748475,0.0006192695,0.00005205754,0.00033108506,0.00009063182,0.000109799614,0.00012136169,0.0012303258],"category_scores_gemma":[0.00017962238,0.00029702706,0.00021203265,0.0004856331,0.00014246292,0.00019558296,0.00015192418,0.00068127876,0.000017237444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052477416,0.0009979616,0.61821264,0.00019741847,0.004160517,0.00083525357,0.0031223202,0.00045829907,0.0005231803,0.00005690921,0.04351892,0.27543917],"study_design_scores_gemma":[0.17911991,0.0010876554,0.63167846,0.0028424405,0.0035471981,0.000061201834,0.0005620554,0.0003784836,0.018696608,0.0010415681,0.16018835,0.0007960759],"about_ca_topic_score_codex":0.01936028,"about_ca_topic_score_gemma":0.006186642,"teacher_disagreement_score":0.2746431,"about_ca_system_score_codex":0.0006965512,"about_ca_system_score_gemma":0.0010806682,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W4308699314","doi":"10.1530/erc-22-0229","title":"Mitochondrial dynamics and oxidative phosphorylation as critical targets in cancer","year":2022,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University","keywords":"Mitochondrion; Oxidative phosphorylation; Cancer cell; mitochondrial fusion; Biology; Cell biology; Mitochondrial fission; Cancer; Phosphorylation; Computational biology; Cancer research; Biochemistry; Mitochondrial DNA; Gene; Genetics","score_opus":0.007867019348182926,"score_gpt":0.2878778467394413,"score_spread":0.2800108273912584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308699314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741032,0.012175118,0.0005539735,0.0033303206,0.0047860574,0.0004795713,0.00028919018,0.000035433113,0.0042471355],"genre_scores_gemma":[0.9863119,0.0019487606,0.0002744667,0.00068514724,0.00038771582,0.0005632894,0.00040693532,0.000037852853,0.009383916],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988822,0.00014049756,0.00021116747,0.0003917218,0.00012747456,0.00024696218],"domain_scores_gemma":[0.9996603,0.000025500123,0.0000542845,0.00014388557,0.000046397538,0.000069594185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005966951,0.00013477623,0.00014645967,0.000068768575,0.00013103464,0.000010096658,0.00008169654,0.00007932936,0.0027537367],"category_scores_gemma":[0.00012155539,0.00014634528,0.00004419669,0.00016315815,0.00007203985,0.0000059534223,0.0001368077,0.00030517596,0.0000091890915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024875533,0.0003371483,0.024165286,0.000044645,0.00021865462,0.00020183231,0.0006244158,0.0077145044,0.91420394,0.011832343,0.023854224,0.014315432],"study_design_scores_gemma":[0.010193546,0.0022119735,0.00672581,0.000056097677,0.00017177427,0.00055057945,0.0010054143,0.008703007,0.2096461,0.0032567668,0.75600564,0.0014732858],"about_ca_topic_score_codex":0.0007458378,"about_ca_topic_score_gemma":0.0007294324,"teacher_disagreement_score":0.7321514,"about_ca_system_score_codex":0.00012350551,"about_ca_system_score_gemma":0.00012460469,"threshold_uncertainty_score":0.99815786},"labels":[],"label_agreement":null},{"id":"W4309886630","doi":"10.1530/erc-22-0293","title":"The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading","year":2022,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Thyroid; Pathology; Thyroid nodules; Thyroid carcinoma; Thyroid neoplasm; Medicine; Thyroid cancer; Internal medicine","score_opus":0.04526580672888172,"score_gpt":0.37450418120894097,"score_spread":0.32923837448005927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309886630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048333546,0.9958618,5.470243e-7,0.00051762734,0.00036495295,0.0013083721,0.00013228384,0.000027288712,0.0013037678],"genre_scores_gemma":[0.0012822272,0.994665,0.000014469238,0.000032389406,0.00010850831,0.0017017013,0.00016161178,0.0000672396,0.001966811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784243,0.00011040553,0.0008205535,0.0005197019,0.00035374056,0.00035315592],"domain_scores_gemma":[0.9984742,0.00033323068,0.0005894429,0.00046591964,0.000037759328,0.0000994642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019935762,0.00038315798,0.0014006362,0.0002094747,0.0001376684,0.000018044315,0.00017389006,0.00012292479,0.0003650126],"category_scores_gemma":[0.00006157771,0.0002519817,0.00027849403,0.0007781569,0.00012213721,0.00005109866,0.00011313136,0.0010437476,0.000002871323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004904684,0.00020168736,0.00062306575,0.003473881,0.0007411398,0.0000909147,0.00027688473,0.0000036159743,0.000021800823,0.0033578305,0.002741147,0.988419],"study_design_scores_gemma":[0.0016562596,0.00019782942,0.0009708427,0.007347134,0.00089833187,0.00017223219,0.00011259914,0.00001752366,0.000008700001,0.000043667867,0.98836136,0.00021352098],"about_ca_topic_score_codex":0.0002641403,"about_ca_topic_score_gemma":0.00009590738,"teacher_disagreement_score":0.9882055,"about_ca_system_score_codex":0.0009910279,"about_ca_system_score_gemma":0.00049212587,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W4313857372","doi":"10.1530/erc-22-0287","title":"Diagnosis and management of parathyroid carcinoma: a state-of-the-art review","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Parathyroid carcinoma; Medicine; Primary hyperparathyroidism; Internal medicine; General surgery; Intensive care medicine","score_opus":0.05336146601300389,"score_gpt":0.37879065425612735,"score_spread":0.32542918824312345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313857372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024383886,0.99505794,2.3804807e-7,0.00019502768,0.0001524204,0.0028634095,0.0001610758,0.000031885284,0.0012941655],"genre_scores_gemma":[0.00005330814,0.9870558,0.000022152799,0.0000386484,0.000014249808,0.0016379865,0.00008447392,0.00007409716,0.011019334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979129,0.00009129985,0.0009459178,0.00042424508,0.00032546395,0.00030018817],"domain_scores_gemma":[0.9985652,0.00007099494,0.00059285405,0.00060448627,0.000063177555,0.000103273596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009493262,0.00041178227,0.002127224,0.0001240975,0.00003735851,0.0000038060814,0.00015714916,0.00007286007,0.000051351013],"category_scores_gemma":[0.000021895357,0.0002586529,0.000574142,0.00088135694,0.000096529286,0.000027490505,0.00017877789,0.00029324854,0.000071738854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019441528,0.00029684,0.0010017297,0.18863413,0.004403578,0.00047503613,0.000029808321,0.000001268729,3.4325453e-7,0.0000873694,0.10093884,0.70411164],"study_design_scores_gemma":[0.0012635204,0.000087877204,0.0007529414,0.08416475,0.009060739,0.0000773689,0.000002980458,9.423199e-7,0.000007688379,0.000033713775,0.9043579,0.00018956226],"about_ca_topic_score_codex":0.00012860226,"about_ca_topic_score_gemma":0.000015999138,"teacher_disagreement_score":0.80341905,"about_ca_system_score_codex":0.00012168739,"about_ca_system_score_gemma":0.00018285676,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4360607662","doi":"10.1530/erc-22-0348","title":"Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thyroid carcinoma; Internal medicine; Odds ratio; Meta-analysis; Thyroid cancer; Thyroid; Oncology; Carcinoma; Papillary thyroid cancer; Gastroenterology","score_opus":0.16672749847227097,"score_gpt":0.3536910852552722,"score_spread":0.18696358678300123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360607662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016340029,0.98831123,0.0000079838255,0.001713913,0.0015864302,0.0034706097,0.001410702,0.00074032584,0.0011248299],"genre_scores_gemma":[0.021310246,0.96195114,0.000079290934,0.0002133082,0.0010453376,0.003186715,0.0021593391,0.00076050113,0.0092941355],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885131,0.0011097314,0.0031608995,0.0031133313,0.0018664987,0.0022364084],"domain_scores_gemma":[0.9925456,0.000898842,0.0017815017,0.003275666,0.0003616301,0.001136748],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00068725727,0.0027546682,0.013035158,0.0018936992,0.00065130746,0.00030639002,0.0008458289,0.00091074285,0.0019733254],"category_scores_gemma":[0.0001379952,0.001976222,0.011523579,0.0059363116,0.0003882706,0.00025168364,0.0006480702,0.0025255666,0.0005930311],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002818626,0.002163144,0.0047734194,0.016449288,0.8578981,0.023145938,0.00059485214,0.00018390456,0.000021026157,0.0004765043,0.021065436,0.07294652],"study_design_scores_gemma":[0.003648997,0.00047039855,0.0018167543,0.0023825604,0.61617935,0.00049043755,0.0000716073,0.000049781887,0.000022234852,0.000037263984,0.37326422,0.001566411],"about_ca_topic_score_codex":0.00674621,"about_ca_topic_score_gemma":0.0014681664,"teacher_disagreement_score":0.3521988,"about_ca_system_score_codex":0.0025537552,"about_ca_system_score_gemma":0.0023991195,"threshold_uncertainty_score":0.999868},"labels":[],"label_agreement":null},{"id":"W4362601741","doi":"10.1530/erc-22-0226","title":"Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care","year":2023,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Palliative care; Medicine; Context (archaeology); Multidisciplinary approach; Disease; Quality of life (healthcare); Disease management; Multidisciplinary team; Nursing; Hospice care; Family medicine; Intensive care medicine; Internal medicine","score_opus":0.07454472902699458,"score_gpt":0.41855732914249794,"score_spread":0.3440126001155034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362601741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037767892,0.96590066,0.000004013078,0.0059068734,0.00035589584,0.02202476,0.00095222145,0.00025823992,0.00082056347],"genre_scores_gemma":[0.02740944,0.96382403,0.0004414752,0.0004661422,0.00011672756,0.0055129286,0.00067185867,0.00028040988,0.0012770091],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468505,0.00054352987,0.001313234,0.0011018844,0.0013724258,0.0009838949],"domain_scores_gemma":[0.99627334,0.0010021749,0.0005783036,0.0010105534,0.000676603,0.00045903062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007891036,0.00079698506,0.001958691,0.00069738063,0.00015904811,0.00006522575,0.00032558307,0.0000193698,0.0001960917],"category_scores_gemma":[0.0015770218,0.00046640803,0.00031186113,0.0016044648,0.00017634734,0.00018590008,0.00037246925,0.0014372648,0.000055345245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006462444,0.0024159441,0.044365283,0.24491566,0.004721876,0.37205282,0.007626071,0.00031099175,6.185644e-7,0.0049273525,0.018310308,0.29389063],"study_design_scores_gemma":[0.009701505,0.0027460055,0.0058748364,0.06697377,0.005518275,0.00079521537,0.008188575,0.000010444163,0.000023865456,0.000048695914,0.8988767,0.0012420696],"about_ca_topic_score_codex":0.00044035836,"about_ca_topic_score_gemma":0.0014903265,"teacher_disagreement_score":0.8805664,"about_ca_system_score_codex":0.000771298,"about_ca_system_score_gemma":0.0013712876,"threshold_uncertainty_score":0.99977875},"labels":[],"label_agreement":null},{"id":"W4365135500","doi":"10.1530/erc-22-0249","title":"African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Demography; Poisson regression; Ethnic group; Internal medicine; Hazard ratio; Incidence (geometry); Epidemiology; Race (biology); Propensity score matching; Proportional hazards model; Oncology; Population; Confidence interval; Biology","score_opus":0.01270307319737803,"score_gpt":0.29984659443119366,"score_spread":0.28714352123381565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365135500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991027,0.00024248548,0.0000021064495,0.0036353038,0.00027448573,0.0004245079,0.000027660233,0.00021267941,0.004153786],"genre_scores_gemma":[0.99474025,0.00010002591,0.00003347999,0.00028276042,0.0001271092,0.00011023163,0.000088932,0.000046350622,0.004470855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980167,0.00007519044,0.000444164,0.00042064837,0.00036045062,0.00068284036],"domain_scores_gemma":[0.99913454,0.0000729186,0.0001146094,0.0002988283,0.00007621668,0.0003028684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008585834,0.00022884819,0.00050092157,0.00031625776,0.000059804308,0.000007854832,0.000112684684,0.00005296861,0.0006956313],"category_scores_gemma":[0.00013882006,0.00019348833,0.00012072677,0.002020871,0.00017416656,0.000057836984,0.00008345125,0.0005889044,0.00034311204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007413898,0.0002619416,0.9657041,0.00005726609,0.000093292954,0.0071725757,0.0010948832,0.00017221639,0.00007212136,0.0001651167,0.005759555,0.01870553],"study_design_scores_gemma":[0.0029031672,0.00039780454,0.988403,0.00009388613,0.00007751968,0.00023555645,0.00020361053,0.0007311154,0.0004587534,0.000070704955,0.0061919615,0.00023291219],"about_ca_topic_score_codex":0.00421185,"about_ca_topic_score_gemma":0.00051087094,"teacher_disagreement_score":0.022698896,"about_ca_system_score_codex":0.00029479785,"about_ca_system_score_gemma":0.00017596729,"threshold_uncertainty_score":0.78902256},"labels":[],"label_agreement":null},{"id":"W4376609289","doi":"10.1530/erc-22-0206","title":"Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa","funders":"","keywords":"Neuroendocrine tumors; Medicine; Pancreas; Disease; Neuroendocrine differentiation; Best practice; Pathology; Intensive care medicine; General surgery; Internal medicine; Oncology; Cancer; Management","score_opus":0.022998890176887065,"score_gpt":0.3362417012474677,"score_spread":0.31324281107058066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376609289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.885241,0.0012337024,0.0000112647895,0.109706506,0.000554814,0.0027835122,0.00019389587,0.00015585302,0.00011948563],"genre_scores_gemma":[0.9715108,0.020929541,0.0019697202,0.0013799256,0.000073225914,0.0010638055,0.00003893635,0.00009449868,0.0029395476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689686,0.00021301482,0.00083395845,0.00060079776,0.0005828302,0.0008725271],"domain_scores_gemma":[0.996132,0.0018851679,0.0006859403,0.00084498135,0.0002721665,0.00017975329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011798306,0.0003719201,0.0006902031,0.00014653576,0.00028520083,0.000021071397,0.00040736934,0.0000033143335,0.000044144672],"category_scores_gemma":[0.0005832889,0.00023599739,0.00037633436,0.0016637291,0.00081862794,0.000108290486,0.00048676762,0.0005597925,0.0000048587153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124557605,0.005249249,0.2534086,0.009138662,0.02139129,0.02332859,0.0012206818,0.01567326,0.010045883,0.0054861386,0.4999865,0.1426154],"study_design_scores_gemma":[0.03063035,0.0072750645,0.4051539,0.0012171709,0.0056903167,0.027538912,0.009738078,0.0118343765,0.031481665,0.00044747142,0.46782488,0.0011678018],"about_ca_topic_score_codex":0.0009908982,"about_ca_topic_score_gemma":0.00019190363,"teacher_disagreement_score":0.1517453,"about_ca_system_score_codex":0.000105766,"about_ca_system_score_gemma":0.000122567,"threshold_uncertainty_score":0.9623694},"labels":[],"label_agreement":null},{"id":"W4376619961","doi":"10.1530/erc-22-0337","title":"Second primary cancers and survival among neuroendocrine tumor patients","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Neuroendocrine tumors; Gastroenterology; Proportional hazards model; Cohort; Epidemiology; Pancreatic cancer; Cohort study; Population; Oncology; Cancer; Confidence interval","score_opus":0.012630497469520243,"score_gpt":0.29481861033033996,"score_spread":0.28218811286081974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376619961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839953,0.0009878135,3.2399373e-7,0.0016252119,0.0009332241,0.0010148933,0.0001048189,0.00062238553,0.01071603],"genre_scores_gemma":[0.97942716,0.0023964837,0.000036178844,0.0005333703,0.00016965423,0.00030186382,0.00015075454,0.00015042136,0.016834104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648625,0.00009629448,0.0005449985,0.00084104174,0.00082471425,0.0012066776],"domain_scores_gemma":[0.9984073,0.0001513896,0.00016500145,0.0004912981,0.00018837294,0.0005966126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000082830935,0.00042552364,0.00065426604,0.00047177266,0.00017117227,0.000044508684,0.0001999436,0.000009093826,0.0010838078],"category_scores_gemma":[0.0002636492,0.00038863366,0.00013714035,0.0012486106,0.00033935375,0.00034992542,0.00033160113,0.00085775496,0.00015647072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009118702,0.00024628354,0.92696255,0.0013372062,0.00047833854,0.037013683,0.0001040647,0.0005302761,0.0049136523,0.00035514298,0.01870894,0.008437963],"study_design_scores_gemma":[0.012115528,0.0008946496,0.90705585,0.00037192873,0.00016145287,0.0016649335,0.00009288205,0.00017776358,0.009119121,0.00044865644,0.067262515,0.00063468725],"about_ca_topic_score_codex":0.0006840464,"about_ca_topic_score_gemma":0.00039539757,"teacher_disagreement_score":0.04855358,"about_ca_system_score_codex":0.0005584693,"about_ca_system_score_gemma":0.00044160773,"threshold_uncertainty_score":0.99985653},"labels":[],"label_agreement":null},{"id":"W4386705026","doi":"10.1530/erc-22-0301","title":"A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Pfizer; Eli Lilly and Company","keywords":"Temsirolimus; Bevacizumab; Medicine; Discontinuation; Adverse effect; Internal medicine; Regimen; Phases of clinical research; Clinical endpoint; Gastroenterology; Progression-free survival; Oncology; Surgery; Toxicity; Chemotherapy; Clinical trial","score_opus":0.023715393067750237,"score_gpt":0.3639791544733013,"score_spread":0.3402637614055511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386705026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928772,0.0023792428,3.7822815e-7,0.0012348434,0.00017786876,0.0022563895,0.00003089466,0.00031926393,0.00072390377],"genre_scores_gemma":[0.99199516,0.0029695916,0.000040134666,0.000060104674,0.00005009533,0.00061331555,0.000023935556,0.00010703148,0.004140609],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962128,0.00017649302,0.0009797037,0.00083778775,0.00074833096,0.0010449048],"domain_scores_gemma":[0.99840105,0.0002334356,0.00022538877,0.00065762247,0.0001270426,0.00035547582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012524224,0.00042705168,0.0010322782,0.0010587249,0.00012579637,0.00001425622,0.00021799712,0.000010846898,0.00023945645],"category_scores_gemma":[0.0005144737,0.00038838215,0.0001011215,0.0024202236,0.00016877268,0.0002569349,0.00033006293,0.00079766434,0.000022059152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018350612,0.025602873,0.26053712,0.0029989516,0.0013425621,0.24980633,0.004505351,0.005062137,0.19583629,0.00041122444,0.002585531,0.23296103],"study_design_scores_gemma":[0.42451903,0.12656341,0.25866327,0.004119734,0.001553155,0.028685467,0.012888145,0.013962597,0.09711789,0.0015158311,0.027240865,0.0031705988],"about_ca_topic_score_codex":0.0007665619,"about_ca_topic_score_gemma":0.00033175846,"teacher_disagreement_score":0.4061684,"about_ca_system_score_codex":0.00014337074,"about_ca_system_score_gemma":0.00017262777,"threshold_uncertainty_score":0.9998568},"labels":[],"label_agreement":null},{"id":"W4387392976","doi":"10.1530/erc-23-0010","title":"Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells","year":2023,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada); Vancouver General Hospital; University of British Columbia","funders":"Terry Fox Research Institute; Terry Fox Foundation; Michael Smith Health Research BC; Prostate Cancer Canada; Cancer Research Society; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Prostate cancer; Semaphorin; Androgen; LNCaP; Androgen receptor; Androgen deprivation therapy; Endocrinology; Internal medicine; Cancer research; Biology; Enzalutamide; Downregulation and upregulation; Cancer; Medicine; Hormone; Receptor; Biochemistry; Gene","score_opus":0.02375680841031348,"score_gpt":0.34380338944090805,"score_spread":0.3200465810305946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387392976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98065025,0.009876923,7.2561437e-7,0.006254877,0.00040635915,0.001194723,0.00010011258,0.00028046797,0.001235557],"genre_scores_gemma":[0.9097947,0.033356734,0.00006569585,0.00015077686,0.00018493118,0.0014522705,0.00008042993,0.00010028537,0.05481421],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976133,0.000074021176,0.00038086055,0.00051094854,0.0003974955,0.0010233539],"domain_scores_gemma":[0.99918425,0.000061473125,0.000073619034,0.0003139702,0.00011106853,0.00025560625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020748856,0.00027646747,0.00041582074,0.000445382,0.000082459665,0.0000269598,0.00012971275,0.00008530224,0.00095047976],"category_scores_gemma":[0.000027926479,0.00022292182,0.00011306127,0.0016630731,0.00008921412,0.000106603125,0.000097566604,0.00045482384,0.00022080062],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015936864,0.00045199474,0.49364495,0.0010410567,0.000883048,0.008939618,0.0034420223,0.0017091298,0.41474217,0.000046575446,0.012053217,0.061452538],"study_design_scores_gemma":[0.013764536,0.00052380847,0.0866568,0.0014793877,0.00027237055,0.00021559825,0.00045547585,0.0017011159,0.8547172,0.00028173352,0.039260197,0.00067178666],"about_ca_topic_score_codex":0.0023806738,"about_ca_topic_score_gemma":0.000549225,"teacher_disagreement_score":0.43997502,"about_ca_system_score_codex":0.00087731035,"about_ca_system_score_gemma":0.0006828139,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W4391887860","doi":"10.1530/erc-23-0353","title":"Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Adrenocortical carcinoma; Oncology; Cancer; Medicine; Internal medicine","score_opus":0.03631211611585243,"score_gpt":0.3257969445742213,"score_spread":0.28948482845836887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391887860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9355317,0.029017316,0.001629747,0.0020306318,0.005781161,0.00090111326,0.00023950275,0.0007239334,0.0241449],"genre_scores_gemma":[0.9905078,0.0005217709,0.00013039766,0.000020198975,0.0004884399,0.00029334973,0.000049857015,0.000067093795,0.007921103],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99793035,0.000051970415,0.000513206,0.00055047806,0.0003568882,0.0005970986],"domain_scores_gemma":[0.9992277,0.00012087976,0.00004852414,0.0002895405,0.000075818905,0.00023751648],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011875078,0.00026550808,0.0004247296,0.00027625856,0.00009465925,0.000033863267,0.0001028007,0.00010034237,0.0010308501],"category_scores_gemma":[0.000023274579,0.0002283373,0.00013085663,0.0008713428,0.00007310852,0.00014269144,0.00005928101,0.0008302827,0.00009653806],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007888811,0.00090363034,0.081719324,0.0045876624,0.0026613886,0.04672556,0.005169966,0.6904827,0.0043468312,0.105923526,0.032018494,0.017572153],"study_design_scores_gemma":[0.007557219,0.0001812184,0.009339618,0.0022843187,0.0005030872,0.00083736295,0.00054306333,0.9679482,0.0010466888,0.00008551085,0.009186616,0.00048707332],"about_ca_topic_score_codex":0.0028958,"about_ca_topic_score_gemma":0.00018937532,"teacher_disagreement_score":0.27746558,"about_ca_system_score_codex":0.001114991,"about_ca_system_score_gemma":0.00061566406,"threshold_uncertainty_score":0.99988234},"labels":[],"label_agreement":null},{"id":"W4395038817","doi":"10.1530/erc-23-0349","title":"Patient-reported burden associated with pheochromocytoma/paraganglioma diagnosis","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Pheochromocytoma; Paraganglioma; Quality of life (healthcare); Disease burden; Disease; Neuroendocrine tumors; Intensive care medicine; Internal medicine; Pediatrics; Pathology; Nursing","score_opus":0.011350009008176983,"score_gpt":0.2763131222083702,"score_spread":0.26496311320019317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395038817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653962,0.020351052,0.0000037792724,0.0016910381,0.000374093,0.00049283064,0.000053732707,0.0005147807,0.011122478],"genre_scores_gemma":[0.9944608,0.0007551358,0.000023358194,0.0001272929,0.00008876895,0.00035848777,0.00025533055,0.00006350459,0.003867303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984497,0.00002916968,0.00031348466,0.00043670804,0.00035611718,0.00041480822],"domain_scores_gemma":[0.9993196,0.00007498266,0.00007544314,0.00025643077,0.000089198584,0.00018435523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000034808552,0.00026772445,0.00035767883,0.00017894358,0.0000802914,0.00003525375,0.00004536467,0.000081758044,0.0018082556],"category_scores_gemma":[0.000056500372,0.00018402601,0.0001320873,0.0007674259,0.00005569258,0.00012666278,0.000027215208,0.00025965009,0.000101868165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014454075,0.0024799847,0.4236264,0.00047086526,0.025804415,0.23083952,0.0029719046,0.00062402117,0.00073920854,0.0006419026,0.06854121,0.24181516],"study_design_scores_gemma":[0.07817866,0.013923113,0.49519104,0.019042494,0.02292688,0.022922568,0.0012318306,0.009609486,0.050390217,0.0038121648,0.27779764,0.0049739173],"about_ca_topic_score_codex":0.00081043097,"about_ca_topic_score_gemma":0.00010345311,"teacher_disagreement_score":0.23684125,"about_ca_system_score_codex":0.00024776818,"about_ca_system_score_gemma":0.00020944473,"threshold_uncertainty_score":0.9991042},"labels":[],"label_agreement":null},{"id":"W4399960956","doi":"10.1530/erc-23-0337","title":"Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study","year":2024,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Ipsen; Sanofi; Exelixis; Advanced Accelerator Applications; Gilead Sciences; Eisai; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Lanreotide; Medicine; Clinical endpoint; Placebo; Internal medicine; Gastroenterology; Neuroendocrine tumors; Phases of clinical research; Surgery; Randomized controlled trial; Clinical trial; Pathology","score_opus":0.018403431309836123,"score_gpt":0.37337252416386624,"score_spread":0.3549690928540301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399960956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751241,0.012335002,0.000009072294,0.0054909615,0.00039641312,0.003351863,0.00005984615,0.00037463405,0.0028581119],"genre_scores_gemma":[0.9788407,0.0025915361,0.000111964764,0.00008195776,0.00015037897,0.0009265644,0.000032882428,0.00010397341,0.017160026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718714,0.00013190719,0.0005617924,0.0006722361,0.0007459763,0.0007009605],"domain_scores_gemma":[0.99853176,0.00023266586,0.00012828593,0.00073186046,0.00013355464,0.00024186258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007957251,0.00042684417,0.000697495,0.0002417393,0.00010679978,0.000037926795,0.00020570443,0.000011698902,0.00079042517],"category_scores_gemma":[0.000060296392,0.00023485844,0.00015569494,0.0008796869,0.00020227699,0.00017217071,0.000068902955,0.00047901654,0.000057503814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09074453,0.023154743,0.056568604,0.002822711,0.016984615,0.32366377,0.008443309,0.014115702,0.07123152,0.002386636,0.022905707,0.36697817],"study_design_scores_gemma":[0.14297119,0.06220149,0.006429511,0.0020931885,0.0028871943,0.016528815,0.0032253573,0.0044765673,0.14384414,0.00019075336,0.6139105,0.0012413018],"about_ca_topic_score_codex":0.0009835865,"about_ca_topic_score_gemma":0.0003858176,"teacher_disagreement_score":0.5910048,"about_ca_system_score_codex":0.0003400382,"about_ca_system_score_gemma":0.00042439907,"threshold_uncertainty_score":0.9577249},"labels":[],"label_agreement":null},{"id":"W4402581350","doi":"10.1530/erc-24-0029","title":"Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Metanephrines; Medicine; Paraganglioma; Pheochromocytoma; Adrenocorticotropic hormone; Neuroendocrine tumors; Cushing syndrome; Adrenalectomy; Internal medicine; Surgery; Hormone","score_opus":0.048390927367971855,"score_gpt":0.3997501162510605,"score_spread":0.35135918888308865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402581350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026802665,0.9929325,3.9494378e-7,0.00014877698,0.0009285849,0.0016613703,0.0011086258,0.00019664085,0.00034285994],"genre_scores_gemma":[0.0016542022,0.9935611,0.00009068867,0.00011527652,0.00027804374,0.0002658976,0.0024615854,0.0001805852,0.0013926137],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965052,0.00016576258,0.0012641937,0.0010730008,0.00047587056,0.0005159803],"domain_scores_gemma":[0.9978985,0.00014338129,0.00054029253,0.001042283,0.00009614623,0.00027939476],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000111141,0.00085531996,0.003764649,0.00032552594,0.000074020754,0.000027802243,0.00025381785,0.00025381593,0.0031639761],"category_scores_gemma":[0.000201667,0.0005104331,0.0007714517,0.0010376626,0.000066775,0.00017582667,0.00012068131,0.00080861576,0.000096728385],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009708526,0.00023648622,0.000032915927,0.2235872,0.005147051,0.08504768,0.00009569878,9.201941e-7,0.0000013816609,0.000015272977,0.0044980342,0.68124026],"study_design_scores_gemma":[0.0017004359,0.0005871393,0.00005442554,0.49042222,0.02891079,0.032334395,0.000018952496,0.0000055831306,0.000019575253,0.00009959765,0.44518405,0.00066282233],"about_ca_topic_score_codex":0.0019286093,"about_ca_topic_score_gemma":0.00018053116,"teacher_disagreement_score":0.68057746,"about_ca_system_score_codex":0.0003451533,"about_ca_system_score_gemma":0.0009525233,"threshold_uncertainty_score":0.9997347},"labels":[],"label_agreement":null},{"id":"W4403632643","doi":"10.1530/erc-24-0282","title":"In memoriam: Charis Eng MD PhD (1962–2024)","year":2024,"lang":"en","type":"editorial","venue":"Endocrine Related Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Publishing; Associate editor; Editorial board; Library science; Medicine; Psychoanalysis; Psychology; Political science; Law; Computer science","score_opus":0.011688799290568132,"score_gpt":0.3285436245086093,"score_spread":0.31685482521804115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403632643","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018273026,0.10960509,0.000008227786,0.0025350968,0.8795527,0.0008140078,0.00040675883,0.0003863266,0.0065090284],"genre_scores_gemma":[0.0003342142,0.022590848,0.00013686012,0.00022373645,0.81579924,0.00073525996,0.00039831048,0.00040976837,0.15937178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513257,0.000083504885,0.0010239643,0.0013679941,0.0013015987,0.0010903908],"domain_scores_gemma":[0.9978693,0.0003437784,0.00030065447,0.000896837,0.00029666495,0.00029274976],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023561863,0.0009231574,0.0015281959,0.00077145733,0.000065440596,0.000055602035,0.00036894224,0.00093869056,0.006699004],"category_scores_gemma":[0.00036957927,0.0008442727,0.000373372,0.0012465927,0.00015800784,0.0002479449,0.00020709394,0.005309713,0.00083876663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005375747,0.000085090265,0.000035795325,0.0009627797,0.0007464297,0.002623309,0.0006985078,0.00007336947,0.00043431154,0.000065743065,0.9844649,0.009272219],"study_design_scores_gemma":[0.004193916,0.00017351583,0.000013003491,0.0032081786,0.0006815808,0.00014559316,0.00007181202,0.00004327071,0.00084463577,0.0009244877,0.9889608,0.00073922414],"about_ca_topic_score_codex":0.0019076283,"about_ca_topic_score_gemma":0.00029785142,"teacher_disagreement_score":0.15286276,"about_ca_system_score_codex":0.0033777156,"about_ca_system_score_gemma":0.0025757025,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W4403678777","doi":"10.1530/erc-24-0187","title":"Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple endocrine neoplasia type 2; Proto-Oncogene Proteins c-ret; Cancer research; Receptor tyrosine kinase; Multiple endocrine neoplasia; Mutation; Tyrosine kinase; Medullary thyroid cancer; Phenotype; Biology; Receptor; Downregulation and upregulation; Pheochromocytoma; Genetics; Endocrinology; Cancer; Germline mutation; Gene; Thyroid cancer","score_opus":0.03740499220856751,"score_gpt":0.35412523959535447,"score_spread":0.31672024738678695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403678777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023544232,0.9919049,0.000020192989,0.0004108284,0.0021998186,0.0031051121,0.0002912737,0.00032114948,0.0015112703],"genre_scores_gemma":[0.0008689277,0.9785477,0.00038132875,0.000031299944,0.0003327001,0.0011643528,0.00058542204,0.0003780833,0.01771021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938143,0.00035531665,0.0020820242,0.0014221943,0.0010766097,0.0012495386],"domain_scores_gemma":[0.99735564,0.00033807915,0.0006174659,0.001085757,0.00020434053,0.0003987231],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023351685,0.0010765119,0.0036284523,0.0016627664,0.000058593432,0.00003382849,0.00044073482,0.000114059556,0.0023705775],"category_scores_gemma":[0.00059800246,0.00085782824,0.0010153693,0.0025651013,0.00017977695,0.00019317864,0.00036590287,0.0030822745,0.00071704155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006082897,0.00073541375,0.00011233133,0.12774283,0.002234333,0.0289745,0.00006349961,0.000048314578,0.0027430153,0.0018434925,0.018781502,0.81611246],"study_design_scores_gemma":[0.0023297875,0.0005676643,0.000002299158,0.030496938,0.0019355759,0.002731028,0.000031853004,0.000076461474,0.00402486,0.00037489345,0.95684683,0.00058182346],"about_ca_topic_score_codex":0.00059701677,"about_ca_topic_score_gemma":0.00015447405,"teacher_disagreement_score":0.9380653,"about_ca_system_score_codex":0.0010311117,"about_ca_system_score_gemma":0.0010389428,"threshold_uncertainty_score":0.99938726},"labels":[],"label_agreement":null},{"id":"W4404186630","doi":"10.1530/erc-24-0208","title":"Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer","year":2024,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Prostate cancer; Androgen receptor; Action (physics); Medicine; Androgen; Oncology; Cancer research; Internal medicine; Cancer; Hormone; Physics","score_opus":0.07290575837906706,"score_gpt":0.43238443650603164,"score_spread":0.3594786781269646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404186630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000597473,0.9838773,0.000007564364,0.00093817554,0.0025445758,0.009658258,0.0019428422,0.0003023113,0.00013148328],"genre_scores_gemma":[0.000015719927,0.9287719,0.00020016031,0.00007821246,0.001160856,0.01511531,0.00060121616,0.00040219043,0.05365441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958901,0.00009022337,0.0009358793,0.0013574392,0.00053703546,0.0011893698],"domain_scores_gemma":[0.9981243,0.00012330625,0.00028573794,0.00062297896,0.00028303903,0.0005606345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002267434,0.0009570097,0.0021074198,0.00052653183,0.00020807023,0.0001234582,0.00026901806,0.00039140915,0.0016498842],"category_scores_gemma":[0.000062344865,0.00058502285,0.0008216012,0.0013992698,0.00007824321,0.00016331862,0.000146884,0.0010265138,0.00020990736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015185461,0.00010161354,0.000034159613,0.014586819,0.0039675557,0.00018658506,0.00027199968,0.000003897516,0.00027207113,0.000008051489,0.014851316,0.9641974],"study_design_scores_gemma":[0.003370165,0.0010955768,0.0000013380322,0.014985269,0.0028209235,0.00013709362,0.00004448026,0.000021955417,0.0028401352,0.00001863375,0.974019,0.0006454429],"about_ca_topic_score_codex":0.0005889559,"about_ca_topic_score_gemma":0.00016943773,"teacher_disagreement_score":0.96355194,"about_ca_system_score_codex":0.002167525,"about_ca_system_score_gemma":0.002674137,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W4407319642","doi":"10.1530/erc-24-0292","title":"Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms","year":2025,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; Surrey Memorial Hospital; Abbotsford Veterinary Clinic; Burnaby Hospital; Sunnybrook Hospital; BC Cancer Agency","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Cohort; Neuroendocrine tumors; Oncology; Systemic therapy; Gastroenterology; Diarrhea; Surgery; Cancer; Sorafenib; Hepatocellular carcinoma","score_opus":0.02118000165129208,"score_gpt":0.38192139906709394,"score_spread":0.36074139741580186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407319642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95030147,0.0036939478,0.00004306007,0.019688876,0.0011975166,0.003597827,0.000120703706,0.00041708857,0.020939495],"genre_scores_gemma":[0.8779063,0.013479506,0.0019160508,0.0010616443,0.0000865841,0.0013106108,0.00006630149,0.00012960317,0.1040434],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686533,0.00008010603,0.00093686325,0.0007079968,0.0005000042,0.0009096733],"domain_scores_gemma":[0.99763256,0.00068819826,0.00028515118,0.0008007706,0.0003862217,0.00020710504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008691817,0.000441367,0.0010709674,0.0007165729,0.0001170934,0.000017161226,0.00032705092,0.000012409143,0.0005044691],"category_scores_gemma":[0.00053396466,0.0003625138,0.0003912505,0.0013620039,0.00020656889,0.00019606588,0.0001251746,0.0005447305,0.000011731196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012640384,0.0020742926,0.5674425,0.0019754064,0.0030757207,0.0026958317,0.00010037591,0.0016296305,0.14364254,0.024071112,0.03780386,0.20284837],"study_design_scores_gemma":[0.029720332,0.001790451,0.08494725,0.0005697184,0.00029371807,0.000283484,0.00008752157,0.00038533413,0.49562916,0.0025099108,0.38321444,0.00056865986],"about_ca_topic_score_codex":0.0005156621,"about_ca_topic_score_gemma":0.0002487528,"teacher_disagreement_score":0.48249522,"about_ca_system_score_codex":0.00017197942,"about_ca_system_score_gemma":0.00044308385,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W4410162857","doi":"10.1530/erc-24-0219","title":"Efficacy and safety of RET-kinase inhibitors in RET-altered thyroid cancers: a systematic review and single-arm meta-analysis","year":2025,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Thyroid cancer; Adverse effect; Medullary thyroid cancer; Vandetanib; Oncology; Thyroid; Cancer; Gastroenterology; Tyrosine kinase; Receptor","score_opus":0.047451778592254475,"score_gpt":0.35446531314171453,"score_spread":0.30701353454946007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410162857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023027325,0.99146754,8.3559013e-7,0.00068521703,0.00013850378,0.006754532,0.00036670678,0.000048023627,0.0005156018],"genre_scores_gemma":[0.0005557198,0.99458873,0.000041943724,0.00019546457,0.00004866257,0.0028886073,0.00019986297,0.00007372477,0.0014072787],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99448895,0.0005784337,0.0028448661,0.0011291148,0.0004593116,0.0004993299],"domain_scores_gemma":[0.99629706,0.00070587883,0.0014700497,0.0011115223,0.00016086816,0.00025460136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049158087,0.0009513281,0.013643625,0.0009265037,0.000059191643,0.000026367365,0.00018395197,0.00025359352,0.00036540054],"category_scores_gemma":[0.00036990238,0.0006337243,0.0020738984,0.0027768845,0.00013744656,0.00007879614,0.00016480655,0.00071729865,0.0000035068822],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059191974,0.0003314528,0.000020314763,0.8212188,0.15025567,0.00016486905,0.0000682065,0.0000072423913,5.9057135e-7,0.000045251247,0.0006585017,0.027169945],"study_design_scores_gemma":[0.0017155401,0.00029869672,0.000009277233,0.32256135,0.63863426,0.0000694736,0.000010755026,0.0000022332472,0.000008674126,0.0000052441032,0.036335666,0.00034883255],"about_ca_topic_score_codex":0.0014244824,"about_ca_topic_score_gemma":0.00047707505,"teacher_disagreement_score":0.49865744,"about_ca_system_score_codex":0.0013794688,"about_ca_system_score_gemma":0.00071545166,"threshold_uncertainty_score":0.9996114},"labels":[],"label_agreement":null},{"id":"W4414436421","doi":"10.1530/erc-24-0338","title":"Reciprocal cancer risks between thyroid and breast cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Endocrine Related Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thyroid cancer; Incidence (geometry); Breast cancer; Thyroid; Radiation therapy; Epidemiology; Cancer; Systematic review","score_opus":0.08159025883510884,"score_gpt":0.4207137439304475,"score_spread":0.3391234850953387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414436421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000048133666,0.9839266,0.0000022364648,0.0043555,0.00013009633,0.0066192145,0.0045855925,0.00012835342,0.00024762284],"genre_scores_gemma":[0.00008282937,0.9715053,0.000023536899,0.00071731536,0.0001597973,0.019801259,0.0002757558,0.00012232707,0.0073118703],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944442,0.0004953701,0.0021383087,0.0015891978,0.00059431326,0.00073861866],"domain_scores_gemma":[0.99629647,0.0005133506,0.0012740025,0.0011396137,0.00026814244,0.000508399],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00036958975,0.001370822,0.017825501,0.00066458277,0.00017647237,0.00007165807,0.0002695805,0.00037393585,0.001880134],"category_scores_gemma":[0.00007754187,0.00085470255,0.0031194133,0.002345077,0.00014911957,0.00010897806,0.00023664103,0.0010818375,0.00001599449],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007759449,0.000054746564,0.0002666468,0.6008147,0.3503169,0.00007316969,0.000016082899,0.0000018312996,2.0495461e-8,0.00001967053,0.0018236144,0.04660486],"study_design_scores_gemma":[0.0006587853,0.00006008061,0.000108044485,0.16147546,0.7640262,0.0001663341,0.00000451731,0.0000015554245,7.0829816e-7,0.000006639469,0.072967075,0.00052458834],"about_ca_topic_score_codex":0.0067358175,"about_ca_topic_score_gemma":0.00061455456,"teacher_disagreement_score":0.43933922,"about_ca_system_score_codex":0.0010775606,"about_ca_system_score_gemma":0.0010349246,"threshold_uncertainty_score":0.9999043},"labels":[],"label_agreement":null},{"id":"W4415862069","doi":"10.1530/erc-25-0326","title":"Sig27 stratifies prostate cancer recurrence by assessing the immunosuppressive properties of tumors","year":2025,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Prostate cancer; Immune system; Cancer; Cancer recurrence; Immune checkpoint; Prostate","score_opus":0.009273371622796707,"score_gpt":0.275231592657912,"score_spread":0.2659582210351153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415862069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346407,0.06270425,0.000030133528,0.0008508666,0.00041024102,0.0002835571,0.00005825918,0.00001544839,0.001006558],"genre_scores_gemma":[0.9887956,0.0058997367,0.000020004278,0.00011493076,0.00004243902,0.00014681568,0.00002798134,0.000016677659,0.004935832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897826,0.00007313182,0.00031113162,0.00027253368,0.00012405239,0.0002408874],"domain_scores_gemma":[0.9994429,0.000012420364,0.00013643861,0.00022280875,0.00015990167,0.000025529784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007078987,0.0001707717,0.0001795434,0.000028031938,0.00013277566,0.000042598313,0.00024163775,0.0000726323,0.00003605757],"category_scores_gemma":[0.000042253443,0.00011641819,0.00007458173,0.00016992138,0.00022018212,0.000011444453,0.00005911547,0.00022749272,6.7919945e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068940724,0.000044645123,0.005873431,0.00008937917,0.00016619948,0.0000013802866,0.00019610744,0.0004575925,0.9837489,0.000040785835,0.003905582,0.0054070526],"study_design_scores_gemma":[0.0004887747,0.000050462215,0.0010771129,0.0004279518,0.000054757696,0.0000034638904,0.0002201461,0.00013296884,0.98527783,0.000046813944,0.012065899,0.00015384115],"about_ca_topic_score_codex":0.0014542681,"about_ca_topic_score_gemma":0.000111382375,"teacher_disagreement_score":0.056804515,"about_ca_system_score_codex":0.000028061811,"about_ca_system_score_gemma":0.00032239113,"threshold_uncertainty_score":0.47473958},"labels":[],"label_agreement":null}]}